Heterocyclyl pyridazines as fungicidal compounds

By developing the combination of new heterocyclylpyridazine compounds and agricultural additives, the problem of insufficient prevention and treatment of existing crop protectors on broad-spectrum plant pathogenic microorganisms has been solved, and low toxicity, high selectivity and low application volume have been achieved The prevention and treatment effect reduces the risk of resistance.

CN119080765APending Publication Date: 2024-12-06BAYER AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411135979.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-12-20
Filing Date
2019-12-19
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing crop protection agents are difficult to effectively prevent and control broad-spectrum plant pathogenic microorganisms, especially fungi, and have problems with low toxicity and high application rates, and are prone to resistance problems.

Method used

Develop a new heterocyclylpyridazine compound and its salts, N-oxides and solvates for the preparation of compounds for the prevention and control of plant pathogenic fungi, and combine them with agricultural additives, by applying them to plants and plants Parts, seeds or in soil to prevent fungi.

Benefits of technology

It provides effective prevention and treatment of broad-spectrum phytopathogenic fungi, with low toxicity and high selectivity, reducing the amount of application and reducing the risk of resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present disclosure relates to heterocyclyl pyridazine compounds, processes and intermediates for their preparation and their use for controlling phytopathogenic microorganisms, such as phytopathogenic fungi.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of Chinese Patent Application No. 201980092481.4, filed on December 19, 2019, entitled "Heterocyclic pyridazine as a fungicidal compound". Technical Field

[0002] This invention relates to heterocyclic pyridazine compounds and their use in controlling plant pathogenic microorganisms (e.g., plant pathogenic fungi). The invention also relates to methods for preparing these compounds and intermediates. Background Technology

[0003] To date, numerous crop protectants have been developed to prevent or mitigate microbial infection. However, there remains a need to develop new compounds that are effective against a broad spectrum of plant pathogenic microorganisms (e.g., fungi), exhibiting low toxicity, high selectivity, or the ability to be applied at low rates while still effectively controlling pests. New compounds are also desired to prevent the emergence of resistance.

[0004] The present invention provides novel compounds for controlling plant pathogenic microorganisms (e.g., fungi), which are superior to known compounds and compositions in at least some of these respects. Summary of the Invention

[0005] This invention relates to compounds of formula (I) and their salts, N-oxides, and solvates:

[0006]

[0007] Where A, T, m, R 3 R 4 R 5 R 6 R 7 R 8 L and Q are as described in this article.

[0008] The present invention relates to a composition comprising at least one compound of formula (I) as defined herein and at least one suitable agricultural adjuvant.

[0009] The present invention also relates to the use of compounds of formula (I) as defined herein or compositions as defined herein for the control of plant pathogenic fungi.

[0010] This invention relates to a method for controlling plant pathogenic fungi, the method comprising the step of applying at least one compound of formula (I) as defined herein or a composition as defined herein to a plant, plant part, seed, fruit or soil in which the plant grows.

[0011] The present invention also relates to methods and intermediates for preparing compounds of formula (I) disclosed herein.

[0012] definition

[0013] As used in this article, the term "halogen" refers to fluorine, chlorine, bromine, or iodine atoms.

[0014] As used in this article, the term "methylene" refers to a CH2 group in which a carbon atom is linked by a double bond.

[0015] As used in this article, the term "halomethylene" refers to a CX2 group with a carbon atom linked by a double bond, where X is a halogen.

[0016] As used in this article, the term "oxo" refers to an oxygen atom bonded to a carbon or sulfur atom via a double bond.

[0017] As used in this article, the term "formyl group" refers to -CH (=O).

[0018] As used herein, the term "C1-C6-alkyl" refers to a branched or straight-chain saturated hydrocarbon chain having 1, 2, 3, 4, 5, or 6 carbon atoms. Examples of C1-C6-alkyl include, but are not limited to, methyl, ethyl, propyl (n-propyl), 1-methylethyl (isopropyl), butyl (n-butyl), 1-methylpropyl (sec-butyl), 2-methylpropyl (isobutyl), 1,1-dimethylethyl (tert-butyl), pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, and hexyl. The hydrocarbon chain comprises 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, and 1-ethyl-2-methylpropyl. In particular, the hydrocarbon chain has 1, 2, 3, or 4 carbon atoms (“C1-C4-alkyl”), such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, or tert-butyl.

[0019] As used herein, the term "C1-C6-alkylene" refers to a divalent C1-C6-alkyl group as defined herein. Examples of C1-C6-alkylene include, but are not limited to, -CH2-, -CH2-CH2-, -CH2-CH2-CH2-, -CH2-C(CH3)-CH2-, -CH2-CH2-CH2-CH2-, -CH2-C(CH3)-CH2-CH2-, -CH2-CH2-CH2-CH2-CH2- and -CH2-CH2-CH2-CH2-CH2-.

[0020] As used herein, the term "C2-C6-alkenyl" or "alkadiyl" refers to a branched or straight-chain unsaturated hydrocarbon chain having 2, 3, 4, 5, or 6 carbon atoms and containing at least one double bond. Examples of C2-C6-alkenyl include, but are not limited to, vinyl (or "ethene"), propen-2-en-1-yl (or "allyl"), propen-1-en-1-yl, but-3-enyl, but-2-enyl, but-1-enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-1-enyl, hex-5-enyl, hex-4-enyl, hex-3-enyl, hex-2-enyl, hex-1-enyl, propen-1-en-2-yl (or "isopropenyl"), 2-methylpropen-2-enyl, 1-methylpropen-2-enyl, 2-methylpropen-1-enyl, 1- Methylprop-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, 2-methylbut-2-enyl, 1-methylbut-2-enyl, 3-methylbut-1-enyl, 2-methylbut-1-enyl, 1-methylbut-1-enyl, 1,1-dimethylprop-2-enyl, 1-ethylprop-1-enyl, 1-propylvinyl, 1-isopropylvinyl, 4-methylpent-4-enyl, 3-methylpent-4-enyl, 2-methylpent-4-enyl, 1-methylpent-4-enyl, 4 -Methylpent-3-enyl, 3-methylpent-3-enyl, 2-methylpent-3-enyl, 1-methylpent-3-enyl, 4-methylpent-2-enyl, 3-methylpent-2-enyl, 2-methylpent-2-enyl, 1-methylpent-2-enyl, 4-methylpent-1-enyl, 3-methylpent-1-enyl, 2-methylpent-1-enyl, 1-methylpent-1-enyl, 3-ethylbut-3-enyl, 2-ethylbut-3-enyl, 1-ethylbut-3-enyl, 3-ethylbut-2-enyl, 2-ethylbut-2-enyl, 1-ethylbut-2-enyl 3-ethylbut-1-enyl, 2-ethylbut-1-enyl, 1-ethylbut-1-enyl, 2-propylprop-2-enyl, 1-propylprop-2-enyl, 2-isopropylprop-2-enyl, 1-isopropylprop-2-enyl, 2-propylprop-1-enyl, 1-propylprop-1-enyl, 2-isopropylprop-1-enyl, 1-isopropylprop-1-enyl, 3,3-dimethylprop-1-enyl, 1-(1,1-dimethylethyl)vinyl, but-1,3-dienyl, pent-1,4-dienyl, hex-1,5-dienyl or methylhexadienyl.

[0021] As used herein, the term "C2-C6-alkenyl" refers to the divalent C2-C6-alkenyl group as defined herein. Examples of C2-C6-alkenyl groups include, but are not limited to, vinylene, propenene, butenene, pentenene, hexenene, heptenene, octenene, nonenene, decenene, undecenene, and dodecenene.

[0022] As used herein, the term "C2-C6-ynyl" refers to a branched or straight hydrocarbon chain having 2, 3, 4, 5, or 6 carbon atoms and containing at least one triple bond. Examples of C2-C6-ynyl include, but are not limited to, ethynyl, propynyl-1-ynyl, propynyl-2-ynyl (or "propynyl"), butynyl-1-ynyl, butynyl-2-ynyl, butynyl-3-ynyl, pentynyl-1-ynyl, pentynyl-2-ynyl, pentynyl-3-ynyl, pentynyl-4-ynyl, hexynyl-1-ynyl, hexynyl-2-ynyl, hexynyl-3-ynyl, hexynyl-4-ynyl, hexynyl-5-ynyl, 1-methylpropynyl-2-ynyl, 2-methylbutynyl-3-ynyl, 1-methylbutynyl-3-ynyl, 1-methylbutynyl-2-ynyl, 3-methylbutynyl-1-ynyl, 1-ethylpropynyl-2-ynyl, and 3-methylpentynyl-4-ynyl. 2-Methylpent-4-ynyl, 1-Methylpent-4-ynyl, 2-Methylpent-3-ynyl, 1-Methylpent-3-ynyl, 4-Methylpent-2-ynyl, 1-Methylpent-2-ynyl, 4-Methylpent-1-ynyl, 3-Methylpent-1-ynyl, 2-Ethylbut-3-ynyl, 1-Ethylbut-3-ynyl, 1-Ethylbut-2-ynyl, 1-Prop-2-ynyl, 1-Isopropylprop-2-ynyl, 2,2-Dimethylbut-3-ynyl, 1,1-Dimethylbut-3-ynyl, 1,1-Dimethylbut-2-ynyl or 3,3-Dimethylbut-1-ynyl.

[0023] As used in this paper, the term "C2-C6-ethynyl" refers to the divalent C2-C6-ethynyl group as defined herein.

[0024] As used herein, the term “C1-C6-haloalkyl” refers to the C1-C6-alkyl group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0025] As used in this article, the term “C2-C6-haloalkenyl” refers to the C2-C6-alkenyl group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0026] As used in this article, the term "C2-C6-haloalkynyl" refers to the C2-C6-alkynyl group as defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0027] As used herein, the term “C1-C6-alkoxy” refers to a group of the formula (C1-C6-alkyl)-O-, wherein the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkoxy groups include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, n-hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy.

[0028] As used herein, the term "C1-C6-haloalkoxy" refers to the C1-C6-alkoxy group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms, which may be the same or different. Examples of C1-C6-haloalkoxy groups include, but are not limited to, chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, and 1,1,1-trifluoroprop-2-oxy.

[0029] As used herein, the term “C1-C6-haloalkoxy” refers to the C1-C6-alkoxy group defined above, in which one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0030] As used herein, the term "C1-C6-hydroxyalkyl" refers to the C1-C6-alkyl group as defined above, wherein at least one hydrogen atom is replaced by a hydroxyl group. Examples of C1-C6-hydroxyalkyl groups include, but are not limited to, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxypropyl-2-yl, 2-hydroxypropyl-2-yl, 2,3-dihydroxypropyl, and 1,3-dihydroxypropyl-2-yl.

[0031] As used herein, the term “C1-C6-alkylthioalkyl” refers to a straight-chain or branched saturated group of the formula (C1-C6-alkyl)-S-, wherein the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkylthioalkyl include, but are not limited to, methylthioalkyl, ethylthioalkyl, propylthioalkyl, isopropylthioalkyl, butylthioalkyl, sec-butylthioalkyl, isobutylthioalkyl, tert-butylthioalkyl, pentylthioalkyl, isopentylthioalkyl, and hexylthioalkyl.

[0032] As used herein, the term “C1-C6-haloalkylthioalkyl” refers to the C1-C6-alkylthioalkyl group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0033] As used herein, the term “C1-C6-alkylsulfinyl” refers to a straight-chain or branched saturated group of the formula (C1-C6-alkyl)-S(=O)-, wherein the term “C1-C6-alkyl” is as defined herein. Examples of C1-C6-alkylsulfinyl groups include, but are not limited to, saturated alkylsulfinyl groups having 1 to 8, preferably 1 to 6, and more preferably 1 to 4 carbon atoms, either straight-chain or branched, such as (but not limited to) C1-C6-alkylsulfinyl groups, such as methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1,1-dimethylpropylsulfinyl 1,2-Dimethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl, and 1-ethyl-2-methylpropylsulfinyl.

[0034] As used herein, the term “C1-C6-haloalkylsulfinyl” refers to the C1-C6-alkylsulfinyl group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0035] As used herein, the term "C1-C6-alkylsulfonyl" refers to a straight-chain or branched saturated group of the formula (C1-C6-alkyl)-S(=O)2-, wherein the term "C1-C6-alkyl" is as defined herein. Examples of C1-C6-alkylsulfonyl include, but are not limited to, methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl. 2-Methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl, and 1-ethyl-2-methylpropylsulfonyl.

[0036] As used herein, the term “C1-C6-haloalkylsulfonyl” refers to the C1-C6-alkylsulfonyl group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0037] As used herein, the term “C1-C6-alkylcarbonyl” refers to a straight-chain or branched saturated group of the formula (C1-C6-alkyl)-C(=O)-, wherein the term “C1-C6-alkyl” is as defined herein.

[0038] As used herein, the term “C1-C6-haloalkylcarbonyl” refers to the C1-C6-alkylcarbonyl group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0039] As used herein, the term “C1-C6-alkoxycarbonyl” refers to a straight-chain or branched saturated group of the formula (C1-C6-alkoxy)-C(=O)-, wherein the term “C1-C6-alkoxy” is as defined herein.

[0040] As used herein, the term “C1-C6-haloalkoxycarbonyl” refers to the C1-C6-alkoxycarbonyl group as defined above, wherein one or more hydrogen atoms are replaced by one or more halogen atoms that may be the same or different.

[0041] As used herein, the term "C1-C6-dialkylamino" refers to a substance having two independent amino groups selected from C1-C6-alkyl groups as defined herein. Examples of C1-C6-dialkylamino include, but are not limited to, N,N-dimethylamino, N,N-diethylamino, N,N-diisopropylamino, N-ethyl-N-methylamino, N-methyl-N-n-propylamino, N-isopropyl-N-n-propylamino, and N-tert-butyl-N-methylamino.

[0042] The term "non-aromatic C3-C" used in this article 12 "Carbon ring" refers to a saturated or unsaturated non-aromatic hydrocarbon ring system in which all ring members (which can be 3 to 12) are carbon atoms. The ring system can be monocyclic or polycyclic (fused, spiro, or bridged). Non-aromatic C3-C 12 -Carbon rings include, but are not limited to, C3-C 12 -Cycloalkyl (monocyclic or bicyclic), C3-C 12 - Cycloalkenyl (monocyclic or bicyclic), bicyclic systems comprising an aryl group (such as phenyl) fused to a monocyclic C3-C8-cycloalkyl group (such as tetrahydronaphthyl, dihydroindenyl), bicyclic systems comprising an aryl group (such as phenyl) fused to a monocyclic C3-C8-cycloalkenyl group (such as indenyl, dihydronaphthyl), and tricyclic systems comprising a cyclopropyl group linked to the bicyclic system by one carbon atom, wherein the bicyclic system comprises an aryl group (such as phenyl) fused to a monocyclic C3-C8-cycloalkyl or monocyclic C3-C8-cycloalkenyl group. The non-aromatic C3-C... 12 - A carbon ring can be connected to any part of the parent molecule via any carbon atom.

[0043] The term "C3-C" used in this article 12 "Cycloalkyl" refers to a monovalent saturated monocyclic or bicyclic hydrocarbon ring containing 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 carbon atoms. Examples of monocyclic C3-C8 cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, or cyclooctyl. Bicyclic C6-C8 cycloalkyl groups... 12 Examples of cycloalkyl groups include, but are not limited to, bicyclo[3.1.1]heptane, bicyclo[2.2.1]heptane, bicyclo[2.2.2]octane, bicyclo[3.2.2]nonane, bicyclo[3.3.1]nonane, bicyclo[4.2.0]octyl, octahydropentalenyl, and bicyclo[4.2.1]nonane.

[0044] The term "C3-C" used in this article 12 "-cycloalkylene" refers to a divalent C3-C alkylene oxide as defined in this article. 12 - Cycloalkyl groups, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and bicyclic [2.2.1]hept-2-ylene.

[0045] The term "C3-C" used in this article 12 "-Cycloalkenyl" refers to a monovalent unsaturated monocyclic or bicyclic hydrocarbon ring containing 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12 carbon atoms. Examples of monocyclic C3-C8-cycloalkenyl rings include, but are not limited to, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, and cyclooctenyl. Bicyclic C6-C... 12 Examples of cycloalkenyl groups include, but are not limited to, bicyclo[2.2.1]hept-2-enyl or bicyclo[2.2.2]oct-2-enyl.

[0046] The term "C3-C" used in this article 12 "-cyclohexene group" refers to the divalent C3-C disclosed in this paper. 12 - Cycloalkenyl.

[0047] The term “aromatic C6-C” used in this article 14 "Carbocyclic" or "aryl" refers to an aromatic hydrocarbon ring system in which all ring members (which may be 6 to 14, preferably 6 to 10) are carbon atoms. This ring system can be monocyclic or fused polycyclic (e.g., bicyclic or tricyclic). Examples of aryl groups include, but are not limited to, phenyl, azulenyl, and naphthyl. An aryl group can be attached to a portion of the parent molecule via any carbon atom. It should also be understood that when the aryl group is substituted by one or more substituents, the one or more substituents can be located at any position on the aryl ring. In particular, in the case of a phenyl group, the one or more substituents can occupy one or two ortho positions, one or two meta positions, or para positions, or any combination of these positions.

[0048] As used herein, the term "non-aromatic 3- to 14-membered heterocycle" refers to a saturated or unsaturated non-aromatic ring system containing one to four heteroatoms, independently selected from oxygen, nitrogen, and sulfur. If the ring system contains more than one oxygen atom, they are not directly adjacent. Non-aromatic heterocycles include, but are not limited to, 3- to 7-membered monocyclic non-aromatic heterocycles and 6- to 14-membered polycyclic (e.g., bicyclic or tricyclic) non-aromatic heterocycles. Non-aromatic 3- to 14-membered heterocycles can be attached to a portion of the parent molecule via any carbon or nitrogen atom contained in the heterocycle.

[0049] As used herein, the term "non-aromatic 3- to 7-membered monocyclic heterocycle" refers to a 3, 4, 5, 6, or 7-membered monocyclic ring system containing one, two, or three heteroatoms independently selected from oxygen, nitrogen, and sulfur, wherein the ring system is saturated or unsaturated but not aromatic. For example, the heterocycle may contain one to three nitrogen atoms, or one or two oxygen atoms, or one or two sulfur atoms, or one to three nitrogen atoms and one oxygen atom, or one to three nitrogen atoms and one sulfur atom, or one sulfur atom and one oxygen atom. Examples of saturated non-aromatic heterocycles include, but are not limited to, 3-membered rings, such as oxiranyl and aziridinyl; 4-membered rings, such as azetidinyl, oxetanyl, and thietanyl; and 5-membered rings, such as tetrahydrofuranyl, 1,3-dioxacyclopentyl, tetrahydrothiophenyl, pyrrolidinyl, pyrazolyl, imidazoyl, triazolyl, isoxazolyl, oxazolyl, oxadiazolyl, and thiazole. Alkyl, isothiazolyl, thiadiazolyl; 6-membered ring, such as piperidinyl, hexahydropyridinyl, hexahydropyrimidinyl, piperazine, triazinanyl, hexahydrotriazine, tetrahydropyranyl, dioxacyclohexyl, tetrahydrothiaranyl, dithiaalkyl, morpholinyl, 1,2-oxacyclohexyl, oxothiocyclohexyl, thiomorpholinyl; or 7-membered ring, such as oxepanyl, azepanyl, 1,4-diazacyclohexyl and 1,4-oxacyclohexyl. Examples of unsaturated non-aromatic heterocyclic groups include, but are not limited to, 5-membered rings such as dihydrofuranyl, 1,3-dioxacyclopentenyl, dihydrothiophenyl, pyrrolinyl, dihydroimidazolyl, dihydropyrazolyl, isoxazolinyl, dihydrooxazolyl, and dihydrothiazolyl; or 6-membered rings such as pyranyl, thiaranyl, thiazinyl, and thiadiazinyl.

[0050] As used herein, the term "non-aromatic 6- to 14-membered polycyclic heterocycle" refers to a 6, 7, 8, 9, 10, 11, 12, 13, or 14-membered polycyclic (e.g., bicyclic or tricyclic) ring system containing one, two, or three heteroatoms independently selected from oxygen, nitrogen, and sulfur, wherein the ring system is saturated or unsaturated but not aromatic. A non-aromatic bicyclic heterocycle may consist of a monocyclic heteroaryl group as defined herein fused with a monocyclic C3-C8-cycloalkyl, monocyclic C3-C8-cycloalkenyl, or monocyclic non-aromatic heterocycle, or may consist of a monocyclic non-aromatic heterocycle fused with an aryl (e.g., phenyl), a monocyclic C3-C8-cycloalkyl, a monocyclic C3-C8-cycloalkenyl, or a monocyclic non-aromatic heterocycle. When two monocyclic heterocycles (aromatic or non-aromatic) containing a nitrogen atom are fused, the nitrogen atom can be located at the bridging site (e.g., 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridyl, 5,6,7,8-tetrahydroimidazo[1,2-a]pyridyl). Non-aromatic tricyclic heterocycles can consist of monocyclic cycloalkyl groups connected to non-aromatic bicyclic heterocycles by a shared atom.

[0051] The term “non-aromatic 3 to 7-membered monocyclic subheterocyclic group” as used herein refers to the divalent non-aromatic 3 to 7-membered monocyclic heterocyclic group disclosed herein.

[0052] As used herein, the terms "aromatic 5- to 14-membered heterocycles" or "heteroaryl" refer to aromatic ring systems containing one to four independent heteroatoms selected from oxygen, nitrogen, and sulfur. If the ring system contains more than one oxygen atom, they are not directly adjacent. Aromatic heterocycles include 5- or 6-membered monocyclic aromatic heterocycles and 6- to 14-membered polycyclic aromatic heterocycles (such as bicyclic or tricyclic). 5- to 14-membered aromatic heterocycles can be attached to a portion of the parent molecule via any carbon or nitrogen atom contained within the heterocycle.

[0053] As used herein, the terms "aromatic 5- or 6-membered monocyclic heterocycle" or "monocyclic heteroaryl" refer to a 5- or 6-membered monocyclic ring system comprising 1, 2, 3, or 4 heteroatoms independently selected from oxygen, nitrogen, and sulfur. Examples of 5-membered monocyclic heteroaryls include, but are not limited to, furanyl, thiophene, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, isoxazolyl, oxazolyl, oxadiazolyl, oxtriazolyl, isothiazolyl, thiazolyl, thiadiazolyl, and thiatriazolyl. Examples of 6-membered monocyclic heteroaryls include, but are not limited to, pyridinyl, pyrimidinyl, pyrazinyl, triazinyl, and tetraazinyl.

[0054] As used herein, the terms “6- to 14-membered polycyclic aromatic heterocycle” or “polycyclic heteroaryl” refer to 6, 7, 8, 9, 10, 11, 12, 13, or 14-membered polycyclic (e.g., bicyclic or tricyclic) ring systems containing one, two, or three heteroatoms independently selected from oxygen, nitrogen, and sulfur. Aromatic bicyclic heterocycles may consist of a monocyclic heteroaryl group as defined herein fused with an aryl group (e.g., phenyl) or a monocyclic heteroaryl group. Examples of bicyclic aromatic heterocycles include, but are not limited to, 9-membered rings such as indolyl, indolizinyl, isoindolyl, benzimidazolyl, imidazopyridyl, indolazolyl, benzotriazolyl, purinyl, benzofuranyl, benzothiophenyl, benzothiazolyl, benzoxazolyl, and benzoisoxazolyl, or 10-membered rings such as quinolinyl, isoquinolinyl, cenolinyl, quinazolinyl, quinoxolinyl, phthalazinyl, naphridyl, pteridinal, and benzodioxinyl. In 9- or 10-membered aromatic bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic aromatic heterocycles, the nitrogen atom may be located at the bridging site (e.g., imidazo[1,2-a]pyridyl, [1,2,4]triazolo[4,3-a]pyridyl, imidazo[1,2-a]pyridyl, imidazo[2,1-b]oxazolyl, furano[2,3-d]isooxazolyl). Examples of tricyclic aromatic heterocycles include, but are not limited to, carbazoyl, acridineyl, and phenazinyl.

[0055] The term "non-aromatic C3-C" used in this article 12 -Carbocyclic oxy group", "C3-C8-cycloalkyl oxy group", "Aromatic C6-C 14 "-Carbocyclic oxy group", "aromatic 5- to 14-membered heterocyclic oxy group", and "non-aromatic 5- to 14-membered heterocyclic oxy group" refer to groups of formula -OR, where R are non-aromatic C3-C6 groups as defined in this paper. 12 -Carbocyclic, C3-C8-cycloalkyl, Aromatic C6-C 14 -Carbocyclic, aromatic 5 to 14-membered heterocyclic or non-aromatic 5 to 14-membered heterocyclic.

[0056] As used herein, when a group is “substituted,” that group can be replaced by one or more substituents. The expression “one or more substituents” refers to the number of substituents from one substituent to the maximum possible number of substituents, based on the number of available binding sites, provided that conditions of stability and chemical feasibility are met.

[0057] The term “leaving group” as used in this article should be understood as a group that is transferred from a compound in a substitution or elimination reaction, such as a halogen atom, a trifluoromethanesulfonate (“trifluoromethanesulfonate”) group, an alkoxy group, a methanesulfonate group, a p-toluenesulfonate group, etc.

[0058] When variables A, Q, L, m, T, R are involved 1 R 2 R 3 R 4 R 5 R 6 R 7 R 8 In this context, the term "as described herein" combines the broad definition of the variable with the definitions of preferred, more preferred, and even more preferred (if any). Detailed Implementation

[0059] Compound of formula (I)

[0060] This invention relates to compounds of formula (I):

[0061]

[0062] in

[0063] A is selected from O, S, C (=O), S (=O), S (=O)2, NR 1 and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, or R 1 and R 2 Together with the carbon atoms they are attached to, they form C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles;

[0064] m is 0, 1, or 2;

[0065] T is selected from hydrogen, hydroxyl group, C1-C6-alkyl group, -C(=O)R a1 -C(=O)(OR) a1 -C(=O)N(R) a2 )2、-S(=O)R a1 -S(=O)2R a1 and S(=O)2N(R) a2 )2,

[0066] Where R a1 Selected from C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkenyl.

[0067] Where R a2 It is independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkenyl;

[0068] R 3 and R4 Independently selected from hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylcarbonyl, C1-C6-alkoxycarbonyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, aromatic 5- to 14-membered heterocycles, non-aromatic 3- to 14-membered heterocycles, and -O-Si(C1-C6-alkyl)3, or R 3 and R 4 Together with the carbon atoms they are attached to, they form carbonyl, methylene, C3-C8-cycloalkyl, or non-aromatic 3- to 7-membered monocyclic heterocycles;

[0069] R 5 Selected from hydrogen, hydroxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylcarbonyloxy, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl and -O-Si(C1-C6-alkyl)3;

[0070] Among them, aliphatic R 1 R 2 R 3 R 4 and R 5 The substituent may be replaced by one or more substituents independently selected from the following: halogen, cyano, amino, nitro, hydroxy, formyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3, and non-aromatic 3 to 7-membered monocyclic heterocycles;

[0071] Among them, the circular R 1 R 2 R 3 R 4 and R 5 The substituent may be replaced by one or more substituents independently selected from the following: halogen, cyano, nitro, hydroxyl, formyl, oxo, methylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3, and non-aromatic 3 to 7-membered monocyclic heterocycles;

[0072] R 3 or R 4 , and R 5 They can form C3-C8 cycloalkyl groups together with the carbon atoms they are attached to;

[0073] L represents a direct bond or L is selected from carbonyl; C1-C6-alkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle; C2-C6-alkenyl; C2-C6-ynylene; C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-alkylene Cycloalkyl; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-(C=O); C(=O)-C1-C6-alkylene; C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; Non-aromatic 3- to 7-membered monocyclic heterocyclic groups; -NR aL1 -;-NR aL1 (C=O)-;-C(=O)NR aL1 -;-NR aL1 S(=O)2-;-S(=O)2NR aL1 -;-C(=NOR aL2 )-;-C(=NN(R aL2 )2) and -C(=NR aL2 )-;

[0074] Where R aL1 Selected from hydrogen and C1-C6-alkyl,

[0075] Where R aL2 Independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C2-C6-alkylene (C2-C6-alkylenyl),

[0076] The aliphatic L substituent can be one or more L substituents that can be the same or different. Sa Substituent substitution,

[0077] The cyclic L-substituent or the cyclic portion of the L-substituent may be one or more L-substituents that may be the same or different. Sc Substituent substitution,

[0078] L saSelected from halogens, cyano groups, hydroxyl groups, carboxyl groups, methylene groups, halomethylene groups, C1-C6-alkoxy groups, C1-C6-haloalkoxy groups, C3-C8-cycloalkyl groups, C3-C8-halocycloalkyl groups, C1-C6-alkoxycarbonyl groups, -O-Si(C1-C6-alkyl)3, and non-aromatic 3- to 7-membered monocyclic heterocycles, L Sc Selected from halogens, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3, and non-aromatic 3- to 7-membered monocyclic heterocycles, and / or two L... Sc Substituents, together with the carbon atoms they are attached to, form C3-C8 cycloalkyl groups;

[0079] R 6 Selected from non-aromatic C3-C 12 -Carbon ring; Aromatic C6-C 14 -Carbon ring; non-aromatic 3- to 14-membered heterocycles; aromatic 5- to 14-membered heterocycles; non-aromatic C3-C 12 -Carbocyclic oxy group; Aromatic C6-C 14 -Carbocyclic hydroxyl group; Aromatic 5- to 14-membered heterocyclic hydroxyl group; Non-aromatic 5- to 14-membered heterocyclic hydroxyl group; Non-aromatic C3-C 12 -Carbocyclothioalkyl; Aromatic C6-C 14 -Carbocyclic thioalkyl; Aromatic 5- to 14-membered heterocyclic thioalkyl; Non-aromatic 5- to 14-membered heterocyclic thioalkyl; Non-aromatic C3-C 12 -Carbocyclic sulfinyl group; Aromatic C6-C 14 -Carbocyclic sulfinyl group; Aromatic 5- to 14-membered heterocyclic sulfinyl group; Non-aromatic 5- to 14-membered heterocyclic sulfinyl group; Non-aromatic C3-C 12 -Carbocyclic sulfonyl group; Aromatic C6-C 14 -Carbocyclic sulfonyl group; Aromatic 5- to 14-membered heterocyclic sulfonyl group; Non-aromatic 5- to 14-membered heterocyclic sulfonyl group; Non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-alkoxy group; Aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-alkoxy; aromatic 5- to 14-membered heterocyclic substituted C1-C3-alkoxy; non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-haloalkoxy; Aromatic C6-C 14 -Carbocyclic substituted C1-C3-haloalkoxy; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-haloalkoxy; aromatic 5- to 14-membered heterocyclic substituted C1-C3-haloalkoxy; non-aromatic C3-C12 -Carbocyclic substituted C1-C3-thioalkyl; Aromatic C6-C 14 -Carbocyclic substituted C1-C3-thioalkyl; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-thioalkyl and aromatic 5- to 14-membered heterocyclic substituted C1-C3-thioalkyl; non-aromatic C3-C 12 -Carbocyclic-substituted C1-C3-sulfinyl group; Aromatic C6-C 14 -Carbocyclic substituted C1-C3-sulfinyl groups; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-sulfinyl groups and aromatic 5- to 14-membered heterocyclic substituted C1-C3-sulfinyl groups; non-aromatic C3-C 12 -Carbocyclic-substituted C1-C3-sulfonyl group; Aromatic C6-C 14 -Carbocyclic substituted C1-C3-sulfonyl groups; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-sulfonyl groups and aromatic 5- to 14-membered heterocyclic substituted C1-C3-sulfonyl groups;

[0080] Among them, the circular R 6 Substituents or R 6 The cyclic portion of the substituent can be one or more R groups that may be the same or different. 6S Substituent substitution,

[0081] R 6S Selected from halogen, cyano, isocyano, nitro, hydroxyl, mercapto, pentafluorosulfuryl, oxo, methylene, halomethylene, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6- Haloacetyloxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C8-cycloalkyl, C3-C8-cycloalkyloxy, C3-C8-cycloalkenyl, aromatic C6-C 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R) c )2、-O-(C=O)R d -C(=O)R d -C(=O)(OR) d -C(=O)N(R) d )2、-S(=O)2N(R d)2, -O-Si(C1-C6-alkyl)3 and -Si(C1-C6-alkyl)3, or two R 6S Substituents can form C3-C8 cycloalkyl groups together with the carbon atoms they are attached to.

[0082] Where R c Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0083] Where R d Independently selected from hydrogen, C1-C6-alkyl, and C1-C6-haloalkyl.

[0084] Among them, aliphatic R 6S R c and R d The substituents may be substituted by one or more substituents independently selected from the following: cyano, halogen, hydroxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0085] Among them, the circular R 6S or R 6S The annular portion and the annular R c The substituent may be replaced by one or more substituents independently selected from the following: halogen, cyano, nitro, hydroxy, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl and C3-C8-halocycloalkyl, and / or cyclic R 6S Substituents or R 6S The cyclic portion of the substituent may be replaced by two substituents, which together with the carbon atoms to which they are attached form a C3-C8 cycloalkyl group;

[0086] R 7Selected from hydrogen, halogen, cyano, isocyano, hydroxyl, mercapto, nitro, amino, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenoxy, C2-C6-haloalkenoxy C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C2-C6-alkenylthioalkyl, C2-C6-alkynylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, C3-C8-cycloalkyloxy groups, aromatic C6-C 14 -Carbocyclic oxy group, aromatic 5- or 6-membered monocyclic heterocyclic oxy group, non-aromatic 3- to 7-membered monocyclic heterocyclic oxy group, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -N(R e )2、-C(=NR f )R f NR g C(=O)R g -C(=O)(OR) g -C(=O)N(R) g )2、-S(=O)2N(R g )2 and -S(=O)(=NR g )R g ,

[0087] Where R e Independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0088] Where R fIndependently selected from hydroxyl, amino, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkylamino and di(C1-C6-alkyl)amino,

[0089] Where R g Independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, and C3-C8-cycloalkyl.

[0090] Among them, aliphatic R 7 R e R f and R g Substituents can be one or more R groups that are the same or different. 7Sa Substituent substitution,

[0091] Among them, the circular R 7 or R 7 The annular portion, the annular R e and circular R g Substituents can be one or more R groups that are the same or different. 7Sc Substituent substitution,

[0092] R 7Sa Selected from cyano, hydroxy, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkoxycarbonyl, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, aromatic C6-C 14 -Carbon rings and non-aromatic 3- to 7-membered monocyclic heterocycles

[0093] R 7Sc Selected from halogens, cyano, nitro, hydroxyl, formyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3, and non-aromatic 3- to 7-membered monocyclic heterocycles, or two R... 7Sc Substituents, together with the carbon atoms they are attached to, form C3-C8 cycloalkyl groups;

[0094] R 8Selected from hydrogen, halogen, cyano, isocyano, amino, nitro, hydroxy, mercapto, carboxyl, C1-C6-alkoxycarbonyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbocyclic, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, C3-C8-cycloalkyloxy groups, aromatic C6-C 14 -Carbocyclic oxy group, non-aromatic 3- to 14-membered heterocyclic oxy group, aromatic 5- to 14-membered heterocyclic oxy group, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -N(R h )2、-SR i -S(=O)R i and -S(=O)2R i ,

[0095] Where R h Independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C 6- Haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 -Carbon rings, aromatic 5- to 14-membered heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0096] Where R i Selected from C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 -Carbon rings, aromatic 5- to 14-membered heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0097] Among them, aliphatic R 8 R h and R i Substituents can be one or more R groups that are the same or different. 8Sa Substituent substitution,

[0098] Among them, the circular R 8 or R 8 The annular portion, the annular R h and circular R iSubstituents can be one or more R groups that are the same or different. 8Sc Substituent substitution,

[0099] R 8Sa Selected from cyano, amino, nitro, hydroxy, formyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C1-C6-haloalkylsulfonyl

[0100] -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, non-aromatic 3- to 7-membered monocyclic heterocycles and -N(R a’ )2, where R a’ Independently selected from hydrogen, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, and C1-C6-alkylcarbonyl, wherein the non-aromatic 3- to 7-membered monocyclic heterocyclic R 8Sa It can be substituted by one or more C1-C6-alkyl substituents, which may be the same or different.

[0101] R 8Sc Selected from halogen, cyano, amino, nitro, hydroxy, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl.

[0102] -O-Si(C1-C6-alkyl)3 and non-aromatic 3- to 7-membered monocyclic heterocycles that may be substituted by one or more C1-C6-alkyl substituents, which may be the same or different, or two R 8Sc The substituents together with the carbon atoms to which they are attached form C3-C8-cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles, wherein the non-aromatic 3- to 7-membered monocyclic heterocycles may be substituted by one or more C1-C6-alkyl substituents that may be the same or different.

[0103] Q is selected from Fang ethnic group C6-C 14 -Carbon ring, non-aromatic C3-C 12-Carbon rings, non-aromatic 3- to 14-membered heterocycles, and aromatic 5- to 14-membered heterocycles, wherein any one of the carbon rings or heterocyclic groups can be one or more Q groups that may be the same or different. S Substituent substitution,

[0104] Q S Selected from halogen, cyano, isocyano, nitro, hydroxyl, mercapto, formyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C 6- Haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenoxy, C2-C6-haloalkenoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkyl, C3-C8-cycloalkyloxy, C3-C6-cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocycles, aromatic C6-C 14 -Carbocyclic rings, aromatic 5- to 14-membered heterocycles, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -OC(=O)R j ,

[0105] -NR j C(=O)R j -C(=O)N(R) j )2、-C(=S)R j -C(=S)N(R) j )2、-C(=NR j )R j and -C(=NOR) j )R j and -N(R) k )2

[0106] Where R j Independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, and C1-C6-alkoxy.

[0107] Where R k Independently selected from hydrogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl and C3-C8-cycloalkyl, wherein aliphatic Q S R j and R kThe substituent may be substituted by one or more substituents independently selected from the following: cyano, amino, nitro, hydroxy, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -Si(C1-C6-alkyl)3, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0108] Among them, cyclic Q S Or Q S The annular portion and the annular R k The substituents may be selected independently from the following R groups. Qs Substituents: halogen, cyano, amino, nitro, hydroxyl, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C2-C6-alkenyl, and non-aromatic 3- to 7-membered monocyclic heterocycles, wherein cyclic R Qs The substituent may be replaced by two substituents, which together with the carbon atom to which they are attached form a C3-C8 cycloalkyl group.

[0109] The implementation plan disclosed above is referred to as "Implementation Plan 1" in this document.

[0110] This document does not cover compounds derived from combinations that contradict the laws of nature and that would therefore be excluded by a person skilled in the art based on his / her expertise. For example, ring structures with three or more adjacent oxygen atoms are excluded.

[0111] The compounds of formula (I) may suitably be in their free form, salt form, N-oxide form or solvate form (e.g., hydrate).

[0112] Depending on the nature of the substituents, compounds of formula (I) can exist in different stereoisomers. These stereoisomers are, for example, enantiomers, diastereomers, transisomers, or geometric isomers. Therefore, the present invention covers pure stereoisomers and any mixtures of these isomers. When a compound can exist in two or more tautomer forms in equilibrium, a compound mentioned by way of a tautomer description should be considered to include all tautomer forms.

[0113] Depending on the number of double bonds in the compound, any compound of the present invention may also exist in one or more geometric isomers. Depending on the nature of the substituents relating to the double bonds or rings, the geometric isomers may exist in cis (=Z-) or trans (=E-) forms. Therefore, the present invention also relates to all geometric isomers and all possible mixtures in all proportions.

[0114] Depending on the nature of the substituents, compounds of formula (I) can exist in the form of free compounds and / or their salts (such as active salts in agrochemistry).

[0115] Reactive salts in agricultural chemistry include acid addition salts of inorganic and organic acids, as well as salts of common bases. Examples of inorganic acids are hydrohalic acids (such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, and hydroiodic acid), sulfuric acid, phosphoric acid, and nitric acid, as well as acid salts (such as sodium bisulfate and potassium bisulfate). Useful organic acids include, for example, formic acid, carbonic acid and alkyl acids (such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid), as well as glycolic acid, thiocyanate, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or monounsaturated or diunsaturated fatty acids having 6 to 20 carbon atoms, alkyl sulfate monoesters, alkyl sulfonic acids (sulfonic acids having straight-chain or branched alkyl groups with 1 to 20 carbon atoms), aryl sulfonic acids or aryl disulfonic acids (aromatic groups with one or two sulfonic acid groups, such as phenyl and naphthyl), alkyl phosphonic acids (phosphonic acids having straight-chain or branched alkyl groups with 1 to 20 carbon atoms), aryl phosphonic acids or aryl diphosphonic acids (aromatic groups with one or two phosphonic acid groups, such as phenyl and naphthyl), wherein the alkyl and aryl groups may have other substituents, such as p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc.

[0116] The solvates of the compounds or their salts of the present invention are stoichiometric compositions of the compounds and solvents.

[0117] The compounds of this invention can exist in various crystalline and / or amorphous forms. Crystalline forms include unsolvated crystalline forms, solvates, and hydrates.

[0118] This article describes "aliphatic R" 1 R 2 R 3 R 4 and R 5 Aliphatic R used in "Substituents can be replaced by one or more substituents" 1 and R 2 Substituents refer to C1-C6 alkyl groups.

[0119] This article describes "aliphatic R" 1 R 2 R 3 R 4 and R 5 Aliphatic R used in "Substituents can be replaced by one or more substituents" 3 and R 4Substituents refer to the C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, and C1-C6-alkyl moiety of -Si(C1-C6-alkyl)3.

[0120] This article describes "aliphatic R" 1 R 2 R 3 R 4 and R 5 Aliphatic R used in "Substituents can be replaced by one or more substituents" 5 Substituents refer to the C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, and the C1-C6-alkyl moiety of -O-Si(C1-C6-alkyl)3.

[0121] This article states that "aliphatic L-substituents can be one or more L..." Sa The aliphatic L-substituents used in "substituent substitution" refer to the C1-C6-alkylene; C2-C6-alkenyl; C2-C6-ynylene; and the C1-C6-alkylene-C3-C8-cycloalkylene, C3-C8-cycloalkylene-C1-C6-alkylene, C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene, C1-C6-alkylene-(C=O)-, C1-C6-alkylene-C3-C8-cycloalkylene, C3-C8-cycloalkylene-C1-C6-alkylene, and C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene.

[0122] This article describes "aliphatic R" 6S R c and R d The aliphatic R used in "Substituents can be replaced by one or more substituents" 6S Substituents represent the C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenoxy, C2-C6-haloalkenoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, and the C1-C6-alkyl moiety of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0123] This article describes "aliphatic R" 6S R c and Rd The aliphatic R used in "Substituents can be replaced by one or more substituents" c Substituents represent C1-C6-alkyl groups.

[0124] This article describes "aliphatic R" 6S R c and R d The aliphatic R used in "Substituents can be replaced by one or more substituents" d Substituents represent C1-C6-alkyl and C1-C6-haloalkyl.

[0125] This article describes "aliphatic R" 7 R e R f and R g Substituents can be one or more R 7Sa The aliphatic R used in "substituent substitution" 7 Substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy. C2-C6-haloalkenoxy, C2-C6-alkynoxy, C2-C6-haloalynoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, and the C1-C6-alkyl portion of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0126] This article describes "aliphatic R" 7 R e R f and R g Substituents can be one or more R 7Sa The aliphatic R used in "substituent substitution" e Substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, and C2-C6-haloynyl.

[0127] This article describes "aliphatic R" 7 R e R f and R g Substituents can be one or more R 7SaThe aliphatic R used in "substituent substitution" f Substituents represent the C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, and C1-C6-alkylamino and di(C1-C6-alkyl)amino C1-C6-alkyl moiety.

[0128] This article describes "aliphatic R" 7 R e R f and R g Substituents can be one or more R 7Sa The aliphatic R used in "substituent substitution" g Substituents represent C1-C6-alkyl and C1-C6-haloalkyl.

[0129] This article describes "aliphatic R" 8 R h and R i Substituents can be one or more R 8Sa The aliphatic R used in "substituent substitution" 8 Substituents represent the C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, and the C1-C6-alkyl moiety of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0130] This article describes "aliphatic R" 8 R h and R i Substituents can be one or more R 8Sa The aliphatic R used in "substituent substitution" h Substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, and C2-C6-alkyl. 6- Halogenated alkynyl group.

[0131] This article describes "aliphatic R" 8 R h and R i Substituents can be one or more R 8Sa The aliphatic R used in "substituent substitution"i Substituents represent C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, and C2-C6-alkenyl. 6- Halogenated alkynyl group.

[0132] This article describes "aliphatic Q" S R j and R k The aliphatic Q used in "Substituents can be replaced by one or more substituents" S Substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C 6-Alkenoxy, C2-C6-haloalkenoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, and the C1-C6-alkyl portion of -Si(C1-C6-alkyl)3 and -O-Si(C1-C6-alkyl)3.

[0133] This article describes "aliphatic Q" S R j and R k The aliphatic R used in "Substituents can be replaced by one or more substituents" j Substituents represent C1-C6-alkyl, C1-C6-haloalkyl, and C1-C6-alkoxy groups.

[0134] This article describes "aliphatic Q" S R j and R k The aliphatic R used in "Substituents can be replaced by one or more substituents" k Substituents represent C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, and C2-C6-haloalkenyl.

[0135] This article describes "circular R" 1 R 2 R 3 R 4 and R 5 The cyclic R used in "substituents can be replaced by one or more substituents" 1 R 2 and R 5 Substituents refer to C3-C8 cycloalkyl groups.

[0136] This article describes "circular R" 1 R 2 R 3 R 4 and R 5 The cyclic R used in "substituents can be replaced by one or more substituents" 3 and R 4 Substituents refer to C3-C8 cycloalkyl groups and aromatic C6-C6 groups. 14 -Carbon rings, non-aromatic 3 to 14-membered heterocycles and aromatic 5 to 14-membered heterocycles.

[0137] This article states that "a cyclic L-substituent or the cyclic portion of an L-substituent can be one or more L..." Sc The cyclic L-substituents used in "substituent substitution" refer to C3-C8-cycloalkylene, C3-C8-cycloolefin, and non-aromatic 3 to 7-membered monocyclic heterocyclic groups.

[0138] This article states that "a cyclic L-substituent or the cyclic portion of an L-substituent can be one or more L..." Sc The cyclic L-substituents used in "substituent substitution" refer to the C3-C8-cycloalkyl moiety of C1-C6-alkylene-C3-C8-cycloalkylene, C3-C8-cycloalkylene-C1-C6-alkylene, C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene, and the C3-C8-cycloalkylene moiety of C1-C6-alkylene-C3-C8-cycloalkylene, C3-C8-cycloalkylene-C1-C6-alkylene, and C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene.

[0139] This article describes "circular R" 6 Substituents, or R 6 The cyclic portion of the substituent can be replaced by one or more R 6S The cyclic R used in "substituent substitution" 6 Substituents indicate non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings, non-aromatic 3 to 14-membered heterocycles and aromatic 5 to 14-membered heterocycles.

[0140] This article describes "circular R" 6 Substituents, or R 6 The cyclic portion of the substituent can be replaced by one or more R 6S The R used in "substituent substitution" 6 The cyclic moiety of the substituent indicates a non-aromatic C3-C group. 12 -Non-aromatic C3-C of the carbon epoxide group 12 -Carbon rings, aromatic C6-C 14 -Aromatic C6-C of carbocyclic oxy group 14-Carbocyclic group, aromatic 5- to 14-membered heterocyclic group, non-aromatic 5- to 14-membered heterocyclic group, non-aromatic C3-C 12 - Nonaromatic C3-C cyclic substituted C1-C3-alkoxy group 12 -Carbon rings, aromatic C6-C 14 -Carbocyclic-substituted C1-C3-alkoxy aromatic C6-C 14 -Carbocyclic, non-aromatic 3- to 14-membered heterocyclic C1-C3-alkoxy non-aromatic 3- to 14-membered heterocyclic, aromatic 5- to 14-membered heterocyclic C1-C3-alkoxy aromatic 5- to 14-membered heterocyclic, non-aromatic C3-C 12 -Non-aromatic C3-C cyclic substituted C1-C3-haloalkoxy group 12 -Carbon rings, aromatic C6-C 14 -Carbocyclic-substituted C1-C3-haloalkoxy aromatic C6-C 14 -Carbon ring, non-aromatic 3 to 14-membered heterocyclic C1-C3-haloalkoxy non-aromatic 3 to 14-membered heterocyclic and aromatic 5 to 14-membered heterocyclic C1-C3-haloalkoxy aromatic 5 to 14-membered heterocyclic.

[0141] This article describes "circular R" 6S and R c The cyclic R used in "substituents can be replaced by one or more substituents" 6S Substituents represent C3-C8 cycloalkyl, C3-C8 cycloalkenyl, and aromatic C6-C... 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0142] This article describes "circular R" 6S or R 6S The annular portion and the annular R c The R used in "Substituents can be replaced by one or more substituents" 6S The cyclic moiety of the substituent represents the C3-C8-cycloalkyl group of the C3-C8-cycloalkyloxy group.

[0143] This article describes "circular R" 6S or R 6S The annular portion and the annular R c The cyclic R used in "substituents can be replaced by one or more substituents" c Substituents indicate C3-C8 cycloalkyl groups.

[0144] This article describes "circular R" 7 R e and R g Substituents can be one or more R 7ScThe cyclic R used in "substituent substitution" 7 Substituents represent C3-C8 cycloalkyl, C3-C6 cycloalkenyl, and aromatic C6-C... 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0145] This article describes "circular R" 7 or R 7 The ring part, the ring-shaped R e and circular R g Substituents can be one or more R 7Sc The R used in "substituent substitution" 7 The cyclic moiety of the substituent represents a C3-C8-cycloalkyl group with a C3-C8 cycloalkyl group; an aromatic C6-C... 14 -Aromatic C6-C of carbocyclic oxy group 14 -Carbon ring; Aromatic 5 or 6-membered monocyclic heterocyclic radicals and non-aromatic 3 to 7-membered monocyclic heterocyclic radicals.

[0146] This article describes "circular R" 7 R e and R g Substituents can be one or more R 7Sc The cyclic R used in "substituent substitution" e Substituents represent C3-C8 cycloalkyl, C3-C8 halocycloalkyl, and aromatic C6-C... 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0147] This article describes "circular R" 7 R e and R g Substituents can be one or more R 7Sc The cyclic R used in "substituent substitution" g Substituents indicate C3-C8 cycloalkyl groups.

[0148] This article states that "among which the circumferential R..." 8 R h and R i Substituents can be one or more R 8Sc The cyclic R used in "substituent substitution" 8 Substituents represent C3-C8 cycloalkyl, C3-C6 cycloalkenyl, and aromatic C6-C... 14 -Carbon rings, non-aromatic 3 to 14-membered heterocycles and aromatic 5 to 14-membered heterocycles.

[0149] This article states that "among which the circumferential R..." 8 or R 8 The annular portion, the annular Rh and circular R i Substituents can be one or more R 8Sc The R used in "substituent substitution" 8 The cyclic moiety of the substituent represents C3-C8-cycloalkyl groups of C3-C8-cycloalkyl groups, or aromatic C6-C... 14 -Aromatic C6-C of carbocyclic oxy group 14 -Carbon rings, non-aromatic 3- to 14-membered heterocycles with non-aromatic 3- to 14-membered heterocycles with non-aromatic 3- to 14-membered heterocycles with aromatic 5 ...

[0150] This article states that "among which the circumferential R..." 8 or R 8 The annular portion, the annular R h and circular R i Substituents can be one or more R 8Sc The cyclic R used in "substituent substitution" h Substituents represent C3-C8 cycloalkyl, C3-C8 halocycloalkyl, and aromatic C6-C... 14 -Carbon rings, aromatic 5- to 14-membered heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0151] This article states that "among which the circumferential R..." 8 R h and R i Substituents can be one or more R 8Sc The cyclic R used in "substituent substitution" i Substituents represent C3-C8 cycloalkyl, C3-C8 halocycloalkyl, and aromatic C6-C... 14 -Carbon rings, aromatic 5- to 14-membered heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0152] This article describes "cyclic Q" S Or Q S The annular portion and the annular R k Substituents can be one or more R Qs The cyclic Q used in "substituent substitution" S Substituents represent C3-C8-cycloalkyl, C3-C6-cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocycles, and aromatic 5- to 14-membered heterocycles.

[0153] This article describes "cyclic Q" S Or Q S The annular portion and the annular R k Substituents can be one or more R Qs The Q used in "substituent substitution" S The cyclic moiety of the substituent represents the C3-C8-cycloalkyl group of the C3-C8-cycloalkyloxy group.

[0154] This article describes "circular Q" S and R k Substituents can be one or more R Qs The cyclic R used in "substituent substitution" k Substituents indicate C3-C8 cycloalkyl groups.

[0155] In the above formula (I), A is preferably selected from O, C (=O), S (=O)2, NR 1 and CR 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 It is hydrogen or C1-C4-alkyl (such as methyl, ethyl) and R 2 It is a hydrogen atom.

[0156] In equation (I) above, A is more preferably selected from O, C (=O), and NR. 1 and CR 1 R 2 , where R 1 and R 2 It is hydrogen.

[0157] In equation (I) above, A is even more preferably selected from O, C (=O), and NR. 1 and CR 1 R 2 , where R 1 and R 2 It is hydrogen.

[0158] In some implementations, when m is 0, A is preferably CR. 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 and R 2 A is a hydrogen atom, or A is O.

[0159] In some implementations, when m is 0, A is more preferably CR. 1 R 2 , where R 1 and R 2 It is hydrogen.

[0160] In some implementations, when m is 1, A is preferably O, C (=O), S (=O)2, NR 1 and CR 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 and R 2It is a hydrogen atom.

[0161] In some implementations, when m is 2, A is preferably O, C (=O), and CR. 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 It is hydrogen or C1-C6-alkyl (e.g., methyl, ethyl) and R 2 It is a hydrogen atom.

[0162] In a more preferred embodiment, T is selected from hydrogen and C1-C4-alkyl.

[0163] R 3 and R 4 Independently selected from hydrogen, fluorine, chlorine, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-ynyl, and C3-C6-cycloalkyl.

[0164] and

[0165] R 5 It is selected from hydrogen, hydroxyl, C1-C4-alkyl and C1-C4-alkoxy.

[0166] In equation (I) above, m is more preferably 1.

[0167] In the above formula (I), T is preferably hydrogen or -C(=O)(OR) a1 ), where R a1 As mentioned above, R is preferred. a1 It is a C1-C6-alkyl group, or more preferably, T is hydrogen.

[0168] In equation (I) above, R 3 and R 4 When present, it is preferably selected from hydrogen, halogens, C1-C6-alkyl, C3-C8-cycloalkyl and aromatic C6-C 14 -Carbon ring (e.g., phenyl), or R 3 and R 4 Together with the carbon atoms to which they are attached, they form C3-C8 cycloalkyl groups (e.g., cyclopropyl), more preferably R. 3 and R 4 It is hydrogen, fluorine, methyl or ethyl, or even more preferably R. 3 and R 4 It consists of hydrogen and fluorine.

[0169] In equation (I) above, R 5 Preferably selected from hydrogen, hydroxyl and C1-C6-alkoxy groups, more preferably R 5 It is hydrogen.

[0170] In formula (I) above, when L is a C1-C6-alkylene group substituted with two substituents on the same carbon atom, and the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl group, L is preferably:

[0171]

[0172] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0173] In formula (I) above, when L is a C1-C6-alkylene group substituted with two substituents on the same carbon atom, and the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle, L is preferably:

[0174]

[0175] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0176] In formula (I) above, when L is C3-C8-cycloalkyl or contains C3-C8-cycloalkyl (C1-C6-alkylene-C3-C8-cycloalkylene, C3-C8-cycloalkylene-C1-C6-cycloalkylene and C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-cycloalkylene), L is more preferably C3-C8-cycloalkyl (x=0, y=0, C3-cycloalkylene).

[0177]

[0178] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0179] In formula (I) above, when L is C3-C8-cycloeneyl or contains C3-C8-cycloeneyl (C1-C6-alkylene-C3-C8-cycloeneyl, C3-C8-cycloeneyl-C1-C6-alkyleneyl and C1-C6-alkylene-C3-C8-cycloeneyl-C1-C6-alkyleneyl), L is preferably:

[0180]

[0181] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0182] In a preferred embodiment, L represents a direct bond or L is selected from C1-C6-alkylene; a C1-C6-alkylene with two substituents on the same carbon atom, wherein the two substituents together with the carbon atom to which they are attached form a C3-C6-cycloalkylene; a C1-C6-alkylene with two substituents on the same carbon atom, wherein the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle.

[0183] The aliphatic L substituent can be selected independently by one to three L groups from the following L groups. Sa Substituents: fluorine, chlorine, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, and C3-C6-halocycloalkyl.

[0184] The cyclic L-substituent or the cyclic portion of the L-substituent may be one to three independently selected from the following L-substituents. Sa Substituents: fluorine, chlorine, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C3-C6-cycloalkyl and C3-C6-halocycloalkyl.

[0185] In a more preferred embodiment, L represents a direct bond or L is selected from C1-C6-alkylene groups.

[0186] The aliphatic L substituent can be selected independently by one to three L groups from the following L groups. Sa Substituents: fluorine, chlorine, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0187] The cyclic L-substituent or the cyclic portion of the L-substituent may be one to three independently selected from the following L-substituents. Sc Substituents: fluorine, chlorine, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0188] In formula (I) above, L is preferably a direct bond or a C1-C6-alkylene group that can be substituted as described herein, and even more preferably L is a direct bond, -CH2- or -CF2-.

[0189] When L stands for "direct key", this means R. 6 The group directly interacts with R 5 The carbon atoms to which the group is attached are linked, thus forming a "-CR" group. 5 R 6 -"part.

[0190] In equation (I) above, R 6 Preferred selections are from non-aromatic C3-C.12 -Carbon rings, aromatic C6-C 14 -Carbon rings, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, aromatic C6-C 14 -Carbocyclic oxy group, aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy groups and aromatic C6-C 14 -Carbocyclic thioalkyl.

[0191] When R 6 Non-aromatic C3-C 12 -Carbon ring, R 6 Preferably, it comprises an aryl group fused with a C3-C8 cycloalkyl group. 12 Bicyclic system; C7-C aryl group fused with C3-C8 cycloalkenyl group. 12 Bicyclic systems; or cyclopropyl groups comprising a C9-C1 cyclopropyl group connected by a shared atom—which contains an aryl group fused to a C3-C8 cycloalkyl or C3-C8 cycloalkenyl group. 12 Three-ring system.

[0192] Preferred C7-C alkyl groups containing aryl groups fused with C3-C8 cycloalkyl groups. 12 The bicyclic system includes dihydroindenyl, 1,2,3,4-tetrahydronaphthyl, bicyclic [4.2.0]octyl-1,3,5-trienyl, and bicyclic...

[0193] [4.2.0]Octo-1(6),2,4-trienyl.

[0194] Preferred C7-C aryl groups containing aryl groups fused with C3-C8 cycloalkenyl groups. 12 The bicyclic system includes indanyl and 1,2-dihydronaphthyl.

[0195] Preferred C9-C group comprises a cyclopropyl group connected by a shared atom in a bicyclic system—which contains an aryl group fused with a C3-C8 cycloalkyl or C3-C8 cycloalkenyl group. 12 The tricyclic system includes spiro[cyclopropane-2,1'-dihydroindene]-1-yl and spiro[cyclopropane]

[0196] -2,1'-tetrahydronaphthalene]-1-yl.

[0197] When R 6 Non-aromatic C3-C 12 -Carbon ring, R 6 More preferably, it is dihydroindenyl or 1,2,3,4-tetrahydronaphthyl, and even more preferably R. 6 It is dihydroindene-5-yl.

[0198] When R 6 For the aromatic C6-C 14 -Carbon ring, R6 Preferably phenyl or naphthyl, more preferably phenyl or naphth-2-yl.

[0199] When R 6 When R is a non-aromatic 3- to 14-membered heterocycle, 6 Typically non-aromatic 6- to 14-membered polycyclic heterocyclic compounds, R 6 Preferably, it is a non-aromatic bicyclic heterocycle comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group; a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8-cycloalkyl group; a non-aromatic bicyclic heterocycle comprising a 5- or 6-membered monocyclic heteroaryl group fused with a 3- to 7-membered monocyclic non-aromatic heterocycle; a non-aromatic tricyclic heterocycle comprising a cyclopropyl group connected to a non-aromatic bicyclic heterocycle via a shared atom, wherein the heterocycle comprises a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group (e.g., phenyl); or a non-aromatic tricyclic heterocycle comprising a cyclopropyl group connected to a non-aromatic bicyclic heterocycle via a shared atom, wherein the non-aromatic bicyclic heterocycle comprises a 5- or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8-cycloalkyl group.

[0200] Preferred non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group include 2,3-dihydrobenzofuranyl, 2,3-dihydrobenzothiophenyl, dihydroindolyl, 1,3-benzodioxanepentyl, 1,2,3,4-tetrahydroquinolinyl, benzodihydropyranyl, isobenzodihydropyranyl, thiobenzodihydropyranyl, and 2,3-dihydro-1,4-benzodioxanehexyl.

[0201] Preferred non-aromatic bicyclic heterocyclic compounds comprising a 5- or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8 cycloalkyl group include 6,7-dihydro-5H-cyclopentano[b]pyridyl, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiopheneyl, 4,5,6,7-tetrahydrobenzofuranyl, 4,5,6,7-tetrahydro-1,3-benzoxazolyl, 4,5,6 ,7-Tetrahydro-1,3-benzothiazolyl, 4,5,6,7-Tetrahydro-1H-benzimidazolyl, 4,5,6,7-Tetrahydro-1H-indazolyl, 4,5,6,7-Tetrahydro-2H-isoindolyl, 4,5,6,7-Tetrahydro-2-benzothiophenyl, 5,6-dihydro-4H-cyclopentano[b]thiophenyl and 5,6-dihydro-4H-cyclopentano[d]thiazolyl.

[0202] Preferred non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl group fused with a 3- to 7-membered monocyclic non-aromatic heterocycle include 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridyl, 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridyl, and 5,6,7,8-tetrahydroimidazo[1,5-a]pyridyl.

[0203] [1,2-a]pyridyl and 6,7-dihydro-5H-thiopheno[3,2-b]pyranyl.

[0204] Preferred non-aromatic tricyclic heterocycles comprising a cyclopropyl group containing a non-aromatic bicyclic heterocycle linked by a shared atom—which includes a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group—include spiro[benzodihydropyran-3,1'-cyclopropane]-yl.

[0205] Preferred non-aromatic tricyclic heterocycles comprising a cyclopropyl group containing a non-aromatic bicyclic heterocycle linked by a shared atom—which comprises a 5- or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8-cycloalkyl group—include spiro[7,8-dihydro-5H-quinoline-6,1'-cyclopropane]-yl.

[0206] When R 6 When R is a non-aromatic 3- to 14-membered heterocycle, 6 More preferably, it is a 4- to 6-membered monocyclic nonaromatic heterocycle fused with a phenyl group (preferably selected from 2,3-dihydrobenzofuranyl, dihydroindolyl, 1,3-benzodioxanepentyl, benzodihydropyranyl, isobenzodihydropyranyl, thiobenzodihydropyranyl and 2,3-dihydro-1,4-benzodioxanehexyl) or a 5- or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8-cycloalkyl group (preferably 5,6,7,8-tetrahydroquinolinyl or 4,5,6,7-tetrahydrobenzothiophene).

[0207] When R 6 When R is a non-aromatic 3- to 14-membered heterocycle, 6 Even more preferred are 2,3-dihydrobenzofuran-5-yl, 2,3-dihydrobenzofuran-7-yl, dihydroindol-5-yl, 1,3-benzodioxane-5-yl, benzodihydropyran-6-yl, benzodihydropyran-7-yl, isobenzodihydropyran-6-yl, isobenzodihydropyran-7-yl, thiobenzodihydropyran-6-yl, thiobenzodihydropyran-7-yl, and 2,3-dihydro -1,4-benzodioxane-5-yl, 2,3-dihydro-1,4-benzodioxane-6-yl, 5,6,7,8-tetrahydroquinoline-2-yl, 5,6,7,8-tetrahydroquinoline-3-yl or 4,5,6,7-tetrahydrobenzothiophene-3-yl, more specifically 2,3-dihydrobenzofuran-5-yl or 2,3-dihydro-1,4-benzodioxane-6-yl.

[0208] When R 6 When the R group consists of 5 to 14 heterocyclic rings, 6 Preferably, it is a 5- or 6-membered aromatic monocyclic heterocycle, a 9- or 10-membered aromatic bicyclic heterocycle containing a 5- or 6-membered aromatic monocyclic heterocycle fused with an aryl group, or a 9- or 10-membered aromatic bicyclic heterocycle containing two fused 5- or 6-membered aromatic monocyclic heterocycles.

[0209] Preferred aromatic 5- or 6-membered monocyclic heterocycles include furanyl, thiophene, pyrazolyl, imidazole, triazolyl, oxazolyl, oxadiazolyl, thiazolyl, thiazolyl, pyridinyl, pyridazinyl, and pyrimidinyl.

[0210] Preferred 9- or 10-membered aromatic bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl (phenyl) group include indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl (e.g., 1,3-benzothiazolyl, 2,1-benzothiazolyl, 1,2-benzothiazolyl), benzoxazolyl (e.g., 1,3-benzoxazolyl, 2,1-benzoxazolyl, 1,2-benzoxazolyl), quinolinyl, isoquinolinyl, and quinoxalinyl.

[0211] Preferred 9- or 10-membered aromatic bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic aromatic heterocycles include pyrrolo[2,3-b]pyridin-3-yl, imidazo[1,2-a]pyridinyl,

[0212] [1,2,4]triazolo[4,3-a]pyridyl, thieno[3,2-b]pyrrolo-6-yl, thieno ...

[0213] [3,2-b]thiophene, imidazo[2,1-b]oxazolyl, furano[2,3-d]isooxazolyl and thiopheno[2,3-d]isothiazolyl.

[0214] When R 6 When the R group consists of 5 to 14 heterocyclic rings, 6 More preferably, it is an aromatic 5- or 6-membered monocyclic heterocycle selected from furanyl, thiophene, and pyridinyl; or a 9- or 10-membered aromatic bicyclic heterocycle containing a 5- or 6-membered monocyclic aromatic heterocycle fused with an aryl group, selected from indolyl, benzofuranyl, benzothiophene, or pyrrolo[2,3-b]pyridin-3-yl.

[0215] When R 6 When the R group consists of 5 to 14 heterocyclic rings, 6 Even more preferred are furan-2-yl, furan-3-yl, thiophene-2-yl, thiophene-3-yl, pyridin-2-yl, indole-3-yl, indole-5-yl, benzofuran-2-yl, benzothiophene-3-yl, or pyrrolo[2,3-b]pyridin-3-yl, more specifically R 6 It is pyridin-2-yl, furan-2-yl, furan-3-yl, thiophene-2-yl, thiophene-3-yl, benzofuran-2-yl, benzothiophene-3-yl, or indole-3-yl.

[0216] When R 6 For the aromatic C6-C 14 When -carbocyclic hydroxyl group, R 6 Phenoxy group is preferred.

[0217] When R 6 For the aromatic C6-C 14 When a C1-C3-alkoxy group is substituted with a carbocyclic alkyl group, R 6 Preferably, it is a phenyl-substituted C1-C3-alkoxy group, more preferably a benzyloxy group.

[0218] When R 6 For the aromatic C6-C 14 When a C1-C3-haloalkoxy group is substituted with a carbocyclic ring, R 6 Preferably, it is a phenyl-substituted C1-C3-haloalkoxy group, more preferably -OCF2-phenyl.

[0219] When R 6 For the aromatic C6-C 14 When - carbocyclic thioalkyl, R 6 Phenylthioalkyl is preferred.

[0220] In some implementation schemes, R 6 It is selected from dihydroindene, 1,2,3,4-tetrahydronaphthyl, spiro[cyclopropane-1,2'-dihydroindene]-1-yl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, dihydroindolyl, 1,3-benzodioxanepentyl, benzodihydropyranyl, isobenzodihydropyranyl, thiobenzodihydropyranyl, 2,3-dihydro-1,4-benzodioxane, 5,6,7,8-tetrahydroquinolinyl, 4,5,6,7-tetrahydrobenzothiophenyl, furanyl, thiophenyl, pyridyl, pyrimidinyl, indolyl, benzofuranyl, benzothiophenyl, benzooxazolyl, quinolinyl, isoquinolinyl, pyrrolo[2,3-b]pyridin-3-yl, phenoxy, benzyloxy, and phenylthioalkyl.

[0221] In equation (I) above, R 6 More preferably selected from non-aromatic C3-C 12 -Carbocyclic rings (e.g., dihydroindenyl-5-yl), aromatic C6-C 14 -Carbocyclic rings (e.g., phenyl or 2-naphthyl) and aromatic 5 to 14-membered heterocycles (e.g., 2-furanyl, 2-thienyl, indole-3-yl).

[0222] In some implementation schemes, R 6 It is selected from dihydroindenyl, phenyl, naphthyl, furanyl, thiophenyl and indoleyl.

[0223] Preferred R 6 Selected from non-aromatic C5-C 10 -Carbocyclic rings, phenyl groups, naphthyl groups, non-aromatic 5- to 10-membered heterocycles, aromatic 5- to 10-membered heterocycles, non-aromatic C5-C 10 -Carbocyclic oxy, phenoxy, naphthyl oxy, aromatic 5 to 10-membered heterocyclic oxy, non-aromatic 5 to 10-membered heterocyclic oxy and phenylthioalkyl.

[0224] More preferably R 6 It is selected from dihydroindene, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxanepentyl, furanyl, thiophene, pyridyl, indolyl, benzofuranyl, benzothiophene, pyrrolo[2,3-b]pyridin-3-yl, phenoxy, benzyloxy and phenylthioalkyl.

[0225] Even better R 6 It is selected from dihydroindene, 1,2,3,4-tetrahydronaphthyl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, 2,3-dihydro-1,4-benzodioxanehexyl, thienyl, pyridyl, indolyl, benzofuranyl, benzothienyl and phenoxy.

[0226] In some implementation schemes, R 6 for

[0227]

[0228] in

[0229] R 6s1 For hydrogen or R 6s ,

[0230] R 6s2 For hydrogen or R 6s ,

[0231] R 6s As described in this article (above or below), R is preferred. 6s1 and R 6s2 At least one of them is different from hydrogen.

[0232] The R disclosed in this article 6 The group may be one or more of the R disclosed above or below. 6S Substituent substitution.

[0233] The R disclosed in this article 6 The group may preferably be one to three identical or different R groups disclosed above or below. 6S Substituent substitution.

[0234] The R disclosed in this article 6 The group may more preferably be one to three identical or different R groups disclosed above or below. 6S Substituent substitution.

[0235] The R disclosed in this article 6 The group may, or even more preferably, be one or two identical or different R groups disclosed above or below. 6S Substituent substitution.

[0236] In some implementation schemes, R 6 The same or different R disclosed above or below 6S Substituent substitution.

[0237] R 6S Substituents are preferably selected from halogens, nitro groups, cyano groups, hydroxyl groups, C1-C6-alkyl groups, C1-C6-haloalkyl groups, C1-C6-alkoxy groups, C1-C6-haloalkoxy groups, C2-C6-alkenyl groups, C2-C6-alkynyl groups, C1-C6-haloalkyl-thioalkyl groups, C3-C8-cycloalkyl groups (e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl), and aromatic C6-C... 14 -Carbocyclic rings (e.g., phenyl), aromatic 5- or 6-membered monocyclic heterocycles (e.g., pyridinyl, pyrimidinyl, thiopheneyl, furanyl, imidazoleyl, triazolyl, pyrazolyl, oxazolyl, thiazolyl, preferably pyridinyl, pyrazolyl, imidazoleyl, triazolyl), and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxanebutyl, tetrahydrofuranyl, tetrahydropyranyl (oxanyl), pyrrolidinyl, azanebutyl, morpholinyl, preferably oxanebutyl, tetrahydrofuranyl, tetrahydropyranyl (oxanyl)), wherein the cyclic R 6S The substituent may be replaced by one or more substituents, which are independently selected from halogens, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxycarbonyl.

[0238] R 6S The substituent is more preferably selected from halogens (e.g., chlorine, bromine, fluorine), nitro, hydroxyl, C1-C6-alkyl (e.g., methyl, isopropyl), C1-C6-haloalkyl (e.g., CF3, CHF2), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., difluoromethoxy, trifluoromethoxy), C2-C6-enyl (e.g., prop-1-en-2-yl), C2-C6-ynyl (e.g., ethynyl), C1-C6-haloalkylthioalkyl (e.g., -SCF3), cyclopropyl, cyclobutyl, cyclopentyl, pyridin-3-yl, oxetane-3-yl, and tetrahydrofuran-3-yl, wherein the cyclic R 6S The substituent may be replaced by one or more substituents, which are independently selected from halogens (e.g., chlorine), C1-C6-alkyl (e.g., methyl), C1-C6-haloalkyl (e.g., CF3), and C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl).

[0239] R 6SThe substituents are also more preferably selected from halogens, nitro groups, hydroxyl groups, C1-C4-alkyl groups, C1-C4-haloalkyl groups, C1-C4-alkoxy groups, C1-C4-haloalkoxy groups, C2-C4-alkenyl groups, C2-C4-alkynyl groups, C1-C4-haloalkylthioalkyl groups, cyclopropyl groups, cyclobutyl groups, cyclopentyl groups, pyridyl groups, oxacyclobutyl groups, and tetrahydrofuranyl groups, wherein the cyclic R group is selected from halogens, nitro groups, hydroxyl groups, C1-C4-alkyl groups, C1-C4-haloalkylthioalkyl groups, cyclopropyl groups, cyclobutyl groups, cyclopentyl groups, pyridyl groups, oxacyclobutyl groups, and tetrahydrofuranyl groups. 6S The substituents may be replaced by one or two substituents independently selected from the following: halogen, C1-C4-alkyl, C1-C4-haloalkyl and C1-C4-alkoxycarbonyl.

[0240] R 6S The substituents are even more preferably selected from chlorine, bromine, nitro, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, difluoromethoxy, trifluoromethoxy, C2-C4-alkenyl, C2-C4-alkynyl, difluoromethylthio, trifluoromethylthioalkyl, cyclopropyl, cyclobutyl, cyclopentyl, pyridyl, oxetyl, and tetrahydrofuranyl.

[0241] Suitable -LR 6 Non-limiting examples of groups include “-LR” in Table 1. 6 Any -LR disclosed in the column 6 Group.

[0242] In equation (I) above, when L represents a direct bond, R 6 Preferred selections are from non-aromatic C3-C. 12 -Carbon rings, aromatic C6-C 14 -Carbon rings and aromatic 5- to 14-membered heterocycles, more preferably R 6 It is selected from dihydroindene, phenyl, naphthyl, furanyl, thiophene, pyridyl, dihydrobenzofuranyl, benzofuranyl, benzothiophene, benzodihydropyranyl, isobenzodihydropyranyl, quinolinyl, isoquinolinyl, and indoleyl.

[0243] In equation (I) above, when L represents a direct bond, R 6 Even more preferably, it is selected from dihydroindene-5-yl, phenyl, naphthyl, furan-2-yl, furan-3-yl, pyridin-2-yl, thiophene-2-yl, thiophene-3-yl, benzofuran-2-yl, benzothiophene-3-yl, and indole-3-yl.

[0244] In equation (I) above, when L represents a C1-C6-alkylene group, R 6 Preferred selection from aromatic C6-C 14 -Carbocyclic rings (e.g., phenyl) and aromatic 5 to 14-membered heterocycles (pyridine, thiophene).

[0245] In equation (I) above, when L represents a C1-C4-alkylene group, R 6More preferably, it is selected from phenyl, thienyl, furanyl, pyrazolyl, pyridyl and pyrimidinyl.

[0246] In equation (I) above, R 7 Preferably selected from halogens, cyano groups, C1-C6-alkyl groups, C1-C6-haloalkyl groups, C1-C6-hydroxyalkyl groups, C1-C6-alkylcarbonyl groups, C1-C6-alkoxy groups, C2-C6-alkenyl groups, C2-C6-alkynyl groups, C1-C6-alkylthioalkyl groups, C1-C6-alkylsulfonyl groups, C3-C8-cycloalkyl groups, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, and -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0247] Where R e As disclosed above, R is preferred. e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl (e.g., cyclopropyl),

[0248] Where R f As disclosed above, R is preferred. f Independently selected from C1-C6-alkyl and C1-C6-alkoxy groups,

[0249] Where R g As disclosed above, R is preferred. g It is independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl.

[0250] When R 7 When it is a C3-C8-cycloalkyl group, R 7 Cyclopropyl is preferred.

[0251] When R 7 When R is a 5- or 6-membered monocyclic heterocycle of the aromatic group, 7 Preferably selected from pyridinyl, pyrimidinyl, thiopheneyl, furanyl, imidazoleyl, triazolyl, pyrazolyl, oxazolyl and thiazolyl, more preferably pyridinyl (e.g. pyridin-4-yl), thiazolyl (e.g. thiazolyl-5-yl), imidazoleyl (e.g. imidazole-1-yl) and pyrazolyl (e.g. pyrazol-1-yl).

[0252] When R 7 When R is a non-aromatic 3- to 7-membered monocyclic heterocycle, 7Preferably selected from oxetane, oxetane, tetrahydrofuranyl, tetrahydropyranyl, pyrrolidinyl, azirnebutane, azirnepropane, morpholinyl and 2-oxa-6-azaspiro[3.3]heptyl, more preferably oxetane (e.g. oxetane-3-yl), tetrahydrofuranyl (e.g. tetrahydrofuran-3-yl), tetrahydropyranyl (e.g. tetrahydropyran-4-yl), pyrrolidinyl (e.g. pyrrolidin-1-yl) and azirnebutane (e.g. azirne-1-yl).

[0253] When R 7 When R is a non-aromatic 3- to 7-membered monocyclic heterocycle, 7 More preferably, it is selected from oxobutane, tetrahydrofuranyl, and pyrrolidinyl.

[0254] When R 7 -N(R) e At 2 o'clock, R 7 Preferably, it is methylamino or cyclopropylamino.

[0255] When R 7 -C(=NR) f )R f At that time, R 7 Preferably, it is 1-(methoxyimino)ethyl.

[0256] When R 7 -C(=O)N(R) g At 2 o'clock, R g Preferably, the components are independently selected from hydrogen and cyclopropyl.

[0257] R 7 More preferably, it is selected from hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C2-C4-alkenyl, C2-C4-ynyl, C1-C4-alkylthioalkyl, C1-C4-alkenylthioalkyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, pyridinyl, imidazolyl, pyrazolyl, thiazolyl, oxetanebutylyl, tetrahydrofuranyl, pyrrolidinyl, -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0258] Where R e Independently selected from hydrogen, C1-C4-alkyl, and C3-C6-cycloalkyl.

[0259] Where R f Independently selected from C1-C4-alkyl and C1-C4-alkoxy groups,

[0260] Where Rg It is independently selected from hydrogen, C1-C4-alkyl and C3-C6-cycloalkyl.

[0261] More preferably, the aliphatic R disclosed herein 7 R e and R g The substituents can be selected independently from one to three of the following R groups. 7Sa Substituents: hydroxyl, C1-C4-alkoxy and C3-C6-cycloalkyl.

[0262] More preferably, the annular R disclosed herein 7 R e and R g The substituents can be selected independently from one to three of the following R groups. 7Sc Substituents: halogen, hydroxyl, C1-C4-alkyl and C1-C4-alkoxy.

[0263] R 7 Even more preferred are those selected from halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C3-C6-cycloalkyl, pyridinyl, imidazolyl, pyrazolyl, and thiazolyl.

[0264] Even more preferred are the aliphatic R disclosed herein. 7 The substituents may be one or two independently selected from the following R... 7Sa Substituents: cyano, C1-C4-alkoxy, C3-C6-cycloalkyl and -Si(C1-C6-alkyl)3.

[0265] More preferably, the annular R disclosed herein 7 The substituents may be one or two independently selected from the following R... 7Sc Substituents: fluorine, chlorine, hydroxyl, C1-C4-alkyl and C1-C4-alkoxy.

[0266] The preferred aliphatic R disclosed herein 7 R e Substituents may be one or more identical or different R groups disclosed above or below. 7Sa Substituent substitution.

[0267] R 7Sa The substituents are preferably selected from hydroxyl, C1-C6-alkoxy (e.g., methoxy, ethoxy), C3-C8-cycloalkyl (e.g., cyclobutyl), C1-C6-alkoxycarbonyl (e.g., ethoxycarbonyl), and aromatic C6-C... 14 -Carbocyclic (e.g., phenyl), more preferably C1-C6-alkoxy.

[0268] More preferably R7Sa The substituents are C1-C4-alkoxy groups.

[0269] In some implementation schemes, R 7 It is an unsubstituted C1-C6-alkenyl or a C1-C6-alkoxy-substituted C1-C6-alkenyl.

[0270] The preferred annular R disclosed herein 7 and R e Substituents may be one or more identical or different R groups disclosed above or below. 7Sc Substituent substitution.

[0271] The preferred annular R disclosed herein 7 and R e Substituents may be one or more identical or different R groups disclosed above or below. 7Sc Substituent substitution.

[0272] R 7Sc The substituents are preferably selected from halogens (e.g., fluorine, chlorine), hydroxyl groups, C1-C6-alkyl groups (e.g., methyl groups), and C1-C6-alkoxy groups (e.g., methoxy groups), more preferably chlorine groups.

[0273] In some implementation schemes, R 7 It is an unsubstituted pyridinyl group (e.g., pyridin-4-yl) or a pyridinyl group substituted with a halogen atom (e.g., chlorine).

[0274] Suitable R 7 Non-restrictive examples include “R” in Table 1. 7 Any R listed in the column 7 Group.

[0275] In equation (I) above, R 8 Preferably selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, C3-C8-cycloalkyloxy groups, non-aromatic 3- to 14-membered heterocyclic alkyloxy groups, and -N(R) h )2,

[0276] Where R h As disclosed above, R is preferred. h Independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C14 -Carbocyclic (e.g., phenyl) and non-aromatic 3 to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0277] Preferred aliphatic R as disclosed herein 8 and R h The substituents may be one to three preferably independently selected from the following R 8Sa Substituents: hydroxyl, carboxyl, C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C3-C6-cycloalkyl, C1-C4-alkylthioalkyl, and non-aromatic 3 to 7-membered monocyclic heterocycles.

[0278] Preferred circular R 8 and R h The substituents may be one to three preferably independently selected from the following R 8Sc Substituents: oxo, halogen, cyano, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C3-C6-cycloalkyl, and non-aromatic 3- to 7-membered monocyclic heterocycles, or two R groups. 8Sc Substituents, together with the carbon atoms to which they are attached, form non-aromatic 3- to 7-membered monocyclic heterocycles.

[0279] When R 8 When it is a C3-C8-cycloalkyl group, R 8 Preferably, it is cyclopropyl or cyclopentyl.

[0280] When R 8 For the aromatic C6-C 14 -Carbon ring, R 8 Phenyl is preferred.

[0281] When R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8 Preferably, it is a non-aromatic 3- to 7-membered monocyclic heterocyclic compound.

[0282] Preferred non-aromatic 3- to 7-membered monocyclic heterocycles include oxetane propane, azirne propane, oxetane butane, azirne butane, tetrahydrofuranyl, pyrrolidinyl, tetrahydropyranyl (oxetane hexane), and morpholinyl.

[0283] When R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8 More preferably, it is selected from oxetane, azirnebutane, pyrrolidinyl, tetrahydropyranyl, and morpholinyl.

[0284] When R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8 Even more preferably, it is selected from oxetane, azirne, and pyrrole.

[0285] When R 8 When R is a non-aromatic 3- to 14-membered heterocycle, 8 The preferred selection is from oxetane-3-yl, azirane-1-yl, and pyrrolidine-1-yl.

[0286] When R 8 When the R group consists of 5 to 14 heterocyclic rings, 8 Preferably, it is a 5- or 6-membered aromatic monocyclic heterocyclic ring.

[0287] Preferred 5- or 6-membered aromatic monocyclic heterocycles include furanyl, thiophene, pyrazolyl, imidazole, triazolyl, oxazolyl, thiazolyl, pyridinyl, and pyrimidinyl.

[0288] When R 8 When the R group consists of 5 to 14 heterocyclic rings, 8 More preferably, it is selected from pyrazolyl, imidazoleyl, thiazolyl and pyridinyl.

[0289] When R 8 When the R group consists of 5 to 14 heterocyclic rings, 8 Even more preferred are those selected from pyrazolyl, thiazolyl, and pyridyl groups.

[0290] When R 8 When the R group consists of 5 to 14 heterocyclic rings, 8 The preferred selection is pyrazol-1-yl, thiazolyl-4-yl, and pyridin-4-yl.

[0291] When R 8 When it is a C3-C8-cycloalkyloxy group, R 8 Preferably, it is cyclopropyloxy.

[0292] When R 8 When R is a non-aromatic 3- to 14-membered heterocyclic oxygen group, 8 Preferably, it is a non-aromatic 3 to 7-membered monocyclic heterocyclic hydroxyl group.

[0293] Preferred non-aromatic 3- to 7-membered monocyclic heterocyclic oxy groups include oxo-heterocyclic butyloxy groups and aziro-heterocyclic butyloxy groups.

[0294] When R 8 When R is a non-aromatic 3- to 14-membered heterocyclic oxygen group, 8 More preferably, it is oxetane-3-yloxy or azirane-3-yloxy.

[0295] When R 8 For N(R) h At 2 o'clock, R hPreferably, the groups are independently selected from hydrogen, C1-C6-alkyl (e.g., methyl, ethyl, propyl, isobutyl), C1-C6-haloalkyl (e.g., trifluoropropyl), C2-C6-enyl (e.g., but-3-en-2-yl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), and aromatic C6-C... 14 -Carbocyclic (e.g., phenyl) and non-aromatic 3 to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0296] When R 8 For N(R) h At 2 o'clock, R h More preferably, it is independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0297] In equation (I) above, R 8 More preferably, the group selected from hydrogen, halogen, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C2-C4-alkenyl, C1-C4-alkylthioalkyl, C1-C4-haloalkylthioalkyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, phenyl, naphthyl, oxacyclobutyl, azacyclobutyl, tetrahydrofuranyl, pyrrolyl, tetrahydropyranyl, piperidinyl, piperazine, morpholinyl, furanyl, thiophene, pyrrolyl, pyrazolyl, thiazolyl, imidazole, oxazolyl, isoxazolyl, pyridinyl, pyrimidinyl, C3-C6-cycloalkyloxy, and -N(R) h )2,

[0298] Where R h It is independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, phenyl, oxetane, azirane, pyrrolidinyl and tetrahydrofuranyl.

[0299] More preferably, the aliphatic R disclosed herein 8 and R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sa Substituents: hydroxyl, C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C3-C6-cycloalkyl, C1-C4-alkylthioalkyl, oxetane, azirane, pyrrolidinyl, and tetrahydrofuranyl.

[0300] More preferably, annular R 8 and R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8ScSubstituents: oxo, fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, oxetane, azirane, pyrrolidinyl, and tetrahydrofuranyl.

[0301] In equation (I) above, R 8 Even more preferably, the compounds are selected from hydrogen, halogen, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthioalkyl, C3-C6-cycloalkyl, oxetane, azanebutane, pyrrolidinyl, pyrazolyl, thiazolyl, pyridinyl, and -N(R) h )2, where R h It is independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, oxetane, azirane, pyrrolidinyl and tetrahydrofuranyl.

[0302] In equation (I) above, R 8 The most preferred selection is from hydrogen, halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C3-C6-cycloalkyloxy, and -N(R) h )2,

[0303] Where R h It is independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl and C3-C6-cycloalkyl.

[0304] The optimal aliphatic R 8 and R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sa Substituents: hydroxyl, methoxy, and ethoxy.

[0305] The most preferred annular R 8 or R 8 The annular portion and the annular R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sc Substituents: fluorine, methyl, ethyl and cyclopropyl.

[0306] In some implementation schemes, R 8Selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, cyclopropyl, cyclobutyl, cyclopentyl, phenyl, oxetane, azirne, pyrrolidinyl, tetrahydropyranyl, morpholinyl, pyrazolyl, imidazolyl, thiazolyl, pyridinyl, cyclopropyloxy, oxetaneyloxy, azirneyloxy, and -N(R) h )2, where R h Preferably, the groups are independently selected from hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), and aromatic C6-C... 14 -Carbocyclic (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0307] In equation (I) above, R 8 More preferably, it is selected from hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy, and -N(R) h )2, where R h It is independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl.

[0308] The preferred aliphatic R disclosed herein 8 and R h The substituent may be one or more of the R disclosed above or below. 8Sa Substituent substitution.

[0309] R 8Sa The substituents are preferably selected from hydroxyl, carboxyl, C1-C6-alkoxy (e.g., methoxy), C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl), C3-C8-cycloalkyl (e.g., cyclopropyl), C1-C6-alkylthioalkyl (e.g., methylthioalkyl), and non-aromatic 3 to 7-membered monocyclic heterocycles (e.g., 1,3-dioxanehexyl).

[0310] Preferred circular R 8 and R h Substituents may be one or more identical or different Rs disclosed above or below. 8Sc Substituent substitution.

[0311] R 8ScSubstituents are preferably selected from oxo, halogen (e.g., chlorine), cyano, hydroxyl, C1-C6-alkyl (e.g., methyl), C1-C6-haloalkyl (e.g., difluoromethyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-alkoxycarbonyl (e.g., ethoxycarbonyl, propyloxycarbonyl), C3-C8-cycloalkyl (e.g., cyclopropyl), and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetyl, oxetyl, tetrahydrofuranyl) or two R groups. 8Sc Substituents, together with the carbon atoms to which they are attached, form non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0312] R 8Sc The substituents are more preferably selected from oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, and non-aromatic 4- to 7-membered monocyclic heterocycles or two R groups. 8Sc Substituents, together with the carbon atoms to which they are attached, form non-aromatic 4- to 7-membered monocyclic heterocycles.

[0313] Suitable R 8 Non-restrictive examples include “R” in Table 1. 8 Any R listed in the column 8 Group.

[0314] In equation (I) above, when Q is an aromatic C6-C 14 When -a carbon ring is present, Q is preferably phenyl or naphthyl, more preferably phenyl.

[0315] In equation (I) above, when Q is a non-aromatic C3-C 12 When the ring is carbocyclic, Q is preferably a C7-C1 carbocyclic ring containing an aryl group fused with a C3-C8 cycloalkyl group. 12 Bicyclic systems or C7-C aryl groups fused with C3-C8 cycloalkenyl groups. 12 A two-ring system.

[0316] Preferred C7-C alkyl groups containing aryl groups fused with C3-C8 cycloalkyl groups. 12 The bicyclic system includes bicyclic [4.2.0]octyl-1,3,5-trienyl, dihydroindenyl, and 1,2,3,4-tetrahydronaphthyl.

[0317] Preferred C7-C aryl groups containing aryl groups fused with C3-C8 cycloalkenyl groups. 12 The bicyclic system includes indene and dihydronaphthyl.

[0318] When Q is a non-aromatic C3-C 12 When - carbocyclic, Q is more preferably a C7-C1 carbocyclic ring containing an aryl group (e.g., phenyl) fused with a C3-C8 cycloalkyl group. 12Bicyclic systems, even more preferably bicyclic [4.2.0]oct-1,3,5-trienyl, more specifically 3-bicyclic [4.2.0]oct-1,3,5-trienyl, dihydroinden-4-yl and dihydroinden-5-yl.

[0319] In formula (I) above, when Q is a non-aromatic 3 to 14-membered heterocycle, Q is usually a non-aromatic 6 to 14-membered bicyclic heterocycle, preferably a non-aromatic bicyclic heterocycle containing a 4 to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group, or a non-aromatic bicyclic heterocycle containing a 5 or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8-cycloalkyl group.

[0320] Preferred non-aromatic bicyclic heterocycles comprising a 4- to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group include 2,3-dihydrobenzofuranyl, 1,3-dihydroisobenzofuranyl, dihydroindolyl, 1,3-benzodioxanepentyl, benzodihydropyranyl, 2,3-dihydro-1,4-benzodioxanehexyl, and [1,3]dioxanepentyl[4,5-b]pyridyl.

[0321] Preferred non-aromatic bicyclic heterocycles comprising a 5- or 6-membered monocyclic heteroaryl group fused with a monocyclic C3-C8-cycloalkyl group include 5,6,7,8-tetrahydroquinolinyl and 6,7-dihydro-5H-cyclopentanyl.

[0322] [b]Pyridyl.

[0323] When Q is a non-aromatic 3 to 14-membered heterocycle, Q is more preferably a non-aromatic bicyclic heterocycle containing a 4 to 6-membered monocyclic non-aromatic heterocycle fused with an aryl group, and even more preferably Q is 1,3-benzodioxane-pentyl or 2,3-dihydrobenzofuranyl, more specifically Q is 1,3-benzodioxane-pentyl-5-yl or 2,3-dihydrobenzofuran-5-yl.

[0324] In formula (I) above, when Q is an aromatic 5 to 14-membered heterocycle, Q is preferably an aromatic 5 or 6-membered monocyclic heterocycle, an aromatic 9 or 10-membered bicyclic heterocycle containing an aromatic 5 or 6-membered monocyclic heterocycle fused with an aryl (phenyl) group, or a 9 or 10-membered aromatic bicyclic heterocycle containing two fused aromatic 5 or 6-membered monocyclic heterocycles.

[0325] Preferred aromatic 5- or 6-membered monocyclic heterocycles include pyrrole, pyrazolyl, furanyl, thiophene, imidazole, triazolyl, oxazolyl, thiazolyl, pyridinyl, pyridazinyl, and pyrimidinyl.

[0326] Preferred aromatic 9- or 10-membered bicyclic heterocycles comprising an aromatic 5- or 6-membered monocyclic heterocycle fused with an aryl (phenyl) group include indolyl, benzimidazolyl, indazolyl, benzofuranyl, benzothiophenyl, and benzothiazolyl (e.g., 1,2-benzothiazolyl, ...).

[0327] 1,3-benzothiazolyl), benzoxazolyl (e.g., 1,2-benzoxazolyl, 1,3-benzoxazolyl), and quinolinyl.

[0328] Preferred aromatic 9- or 10-membered bicyclic heterocycles comprising two fused 5- or 6-membered monocyclic aromatic heterocycles include furano[3,2-b]pyridyl, thieno[3,2-b]thienoyl, and thieno[2,3-d]thiazolyl.

[0329] When Q is an aromatic 5- to 14-membered heterocycle, Q is more preferably an aromatic 5- or 6-membered monocyclic heterocycle (quinolinyl, benzothiopheneyl, or indoleyl), and even more preferably Q is pyrazolyl, thiazolyl, thiopheneyl, pyridinyl, or indoleyl. More specifically, Q is pyrazol-4-yl, thiazolyl-4-yl, pyridin-2-yl, pyridin-3-yl, thiophene-3-yl, or indole-5-yl.

[0330] Preferably, Q is selected from phenyl, naphthyl, bicyclo[4.2.0]oct-1,3,5-trienyl, benzodioxanepentyl, 2,3-dihydrobenzofuranyl, dihydroindolyl, benzofuranyl, benzothiophenyl, quinolinyl, pyridyl, pyrazolyl, thiazolyl, thiophenyl, and indolyl.

[0331] The preferred Q group may be one to three independently selected from the following Q groups. S Substituents: halogen, cyano, nitro, formyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylthioalkyl, C1-C4-haloalkylthioalkyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, non-aromatic 3- to 7-membered monocyclic heterocycles, phenyl, aromatic 5- or 6-membered heterocycles, and -N(R) k )2, where R k It is independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl and C3-C6-cycloalkyl.

[0332] The preferred aliphatic Q S The substituents may be replaced by one or two substituents independently selected from the following: hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, and C3-C6-cycloalkyl.

[0333] More preferably, Q is selected from phenyl, 1,3-benzodioxanepentyl-5-yl, 2,3-dihydrobenzofuranyl, pyridyl, thiophenyl, and indole-5-yl.

[0334] More preferably, the Q group may be one or two independently selected from the following Q groups. SSubstituents: halogen, cyano, nitro, formyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylthioalkyl, C3-C6-cycloalkyl, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0335] The more preferred aliphatic Q S The substituents may be replaced by one or two substituents independently selected from the following: hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, and C3-C6-cycloalkyl.

[0336] Even more preferably, Q is selected from phenyl, pyridyl and thiophene.

[0337] Even more preferably, the Q group may be one or two independently selected from the following Q groups. S Substituents: halogen, cyano, nitro, formyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylthioalkyl, C3-C5-cycloalkyl, oxecyclopropane, and oxecyclobutane.

[0338] The even more preferred aliphatic Q S The substituents may be replaced by one or two independently selected from the following substituents: hydroxyl, methoxy, ethoxy, difluoromethoxy, and trifluoromethoxy.

[0339] The Q group disclosed herein may be one or more of the same or different Q groups disclosed above or below. S Substituent substitution.

[0340] In some implementations, Q is one or more of the same or different Q disclosed above or below. S Substituent substitution.

[0341] Q SThe substituents are preferably selected from halogens (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, formyl, C1-C6-alkyl (e.g., methyl, ethyl, propyl, isopropyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methylcarbonyl), C1-C6-alkoxycarbonyl (e.g., methoxycarbonyl), C1-C6-alkoxy (e.g., methoxy, ethoxy), and C1-C6-haloalkoxy (e.g., difluoromethoxy, trifluoroalkyl). fluoromethoxy), C2-C6-alkenyl (e.g., vinyl), C2-C6-ynyl (e.g., ethynyl), C1-C6-alkylthioalkyl (e.g., methylthioalkyl), C1-C6-haloalkylthioalkyl (e.g., trifluoromethylthioalkyl), C1-C6-alkylsulfonyl (e.g., methylsulfonyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl), non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetanepropyl, oxetanebutyl), aromatic C6-C 14 -Carbocyclic rings (e.g., phenyl), aromatic 5- to 14-membered heterocycles (e.g., pyrazole), and -N(R) rings. k )2, where R k It is a methyl group.

[0342] The aliphatic Q S The substituents may be replaced by one or two substituents independently selected from the following: hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, and C3-C6-cycloalkyl.

[0343] The ring Q S Substituents may be substituted as described herein or preferably substituted with one or more halogen atoms (e.g., fluorine).

[0344] Q S The substituents are more preferably selected from halogens (e.g., chlorine, bromine, iodine, fluorine), C1-C4-alkyl (e.g., methyl, ethyl), C1-C4-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C4-alkoxy (e.g., methoxy, ethoxy), C1-C4-haloalkoxy (e.g., difluoromethoxy, trifluoromethoxy), C2-C4-alkenyl (e.g., vinyl), C2-C4-alkynyl (e.g., ethynyl), C1-C4-alkylthioalkyl (e.g., methylthioalkyl), and C3-C6-cycloalkyl (e.g., cyclopropyl).

[0345] The aliphatic Q S The substituents may be replaced by one or two independently selected from the following substituents: hydroxyl, methoxy, ethoxy, difluoromethoxy, and trifluoromethoxy.

[0346] The ring Q S Substituents may be substituted as described herein or preferably substituted with one or more halogen atoms (e.g., fluorine).

[0347] Suitable non-limiting examples of Q include any Q group listed in the “Q” column of Table 1.

[0348] In some embodiments, Q is an unsubstituted phenyl group or is substituted by one or more of the Q groups described herein. S A phenyl group that has been substituted with a substituent.

[0349] In some implementations, Q is

[0350]

[0351] in

[0352] Q s1 It is hydrogen or halogen (preferably fluorine).

[0353] Q s2 For hydrogen or Q s Q s As mentioned above, Q is preferred. S2 The group is selected from hydrogen, halogens (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, amino, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methoxycarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., trifluoromethoxy), C2-C6-alkenyl (e.g., vinyl), C2-C6-ynyl (e.g., ethynyl), C1-C6-alkylthioalkyl (e.g., methylthioalkyl), C1-C6-haloalkylthioalkyl (e.g., trifluoromethylthioalkyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl) that may be substituted with one or more halogen atoms, and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetane) that may be substituted with one or more halogen atoms, more preferably Q. S2 Selected from fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, trifluoromethoxy, vinyl, ethynyl, methylthioalkyl, trifluoromethylthioalkyl, cyclopropyl which may be substituted with one or more halogen atoms, and oxocyclobutyl which may be substituted with one or more halogen atoms, preferably Q. s1 and Q s2 At least one of them is different from hydrogen.

[0354] R 1 R 2 R 3 R 4 R 5 R 6 R 7 R 8The specific definitions of L, m, and Q (broad definitions as well as preferred, more preferred, and even more preferred definitions) described above can be combined in different ways. These combinations of definitions thus provide subsets of the compounds of the present invention, such as those disclosed below.

[0355] Preferably, the present invention relates to compounds of formula (I),

[0356] in

[0357] A is selected from O, S, C (=O), S (=O), S (=O)2, NR 1 and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C4-alkyl, and C3-C6-cycloalkyl.

[0358] m is 0, 1, or 2;

[0359] T is selected from hydrogen and C1-C4-alkyl.

[0360] R 3 and R 4 Independently selected from hydrogen, fluorine, chlorine, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-ynyl, and C3-C6-cycloalkyl.

[0361] R 5 Selected from hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthioalkyl,

[0362] Among them, aliphatic R 1 R 2 R 3 R 4 and R 5 The substituents may be substituted by one to three independently selected from the following: fluorine, chlorine, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, and C3-C6-halocycloalkyl.

[0363] Among them, the circular R 1 R 2 R 3 R 4 and R 5 The substituent may be replaced by one to three independently selected from the following substituents: fluorine, chlorine, oxo, methylene, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl.

[0364] R 3 or R 4, and R 5 They can form C3-C6-cycloalkyl groups together with the carbon atoms they are attached to;

[0365] L represents a direct bond or L is selected from C1-C6-alkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a C3-C6-cycloalkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3 to 7-membered monocyclic heterocycle;

[0366] The aliphatic L substituent can be selected independently by one to three L groups from the following L groups. Sa Substituents: fluorine, chlorine, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, and C3-C6-halocycloalkyl.

[0367] The cyclic L-substituent or the cyclic portion of the L-substituent may be one to three independently selected from the following L-substituents. Sc Substituents: fluorine, chlorine, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C3-C6-cycloalkyl, and C3-C6-halocycloalkyl.

[0368] R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, non-aromatic C3-C 12 -Carbocyclic oxy group, aromatic C6-C 14 -Carbocyclic oxy group, aromatic 5- to 14-membered heterocyclic oxy group, non-aromatic 5- to 14-membered heterocyclic oxy group, non-aromatic C3-C 12 -Carbocyclic thioalkyl, aromatic C6-C 14 -Carbocyclic thioalkyl, aromatic 5- to 14-membered heterocyclic thioalkyl, and non-aromatic 5- to 14-membered heterocyclic thioalkyl

[0369] Among them, the circular R 6 Substituents or R 6 The cyclic moiety of the substituent can be one to three identical or different R groups. 6S Substituent substitution,

[0370] R 6SSelected from halogens, cyano, nitro, hydroxyl, mercapto, pentafluorothioalkyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C6-cycloalkylthioalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkyloxy, phenyl, naphthyl, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -C(=O)(OR d ) and -C(=O)N(R d )2,

[0371] Where R d Independently selected from hydrogen, C1-C4-alkyl, and C1-C4-haloalkyl.

[0372] Among them, aliphatic R 6S R c and R d The substituent may be replaced by one to three independently selected from the following substituents: fluorine, chlorine, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, and C3-C6-halocycloalkyl, wherein the cyclic R 6S or R 6S The annular portion and the annular R c The substituents may be substituted by one to three independently selected from the following substituents: fluorine, chlorine, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy.

[0373] R 7 Selected from hydrogen, halogen, cyano, hydroxyl, mercapto, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C1-C4-alkylthioalkyl, C1-C4-haloalkylthioalkyl, C 3-C6-cycloalkylthioalkyl, C1-C4-alkylsulfinyl, C1-C4-haloalkylsulfinyl, C3-C6-cycloalkylsulfinyl, C1-C4-alkylsulfonyl, C1-C4-haloalkylsulfonyl, C3-C6-cycloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, phenyl, naphthyl, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, C3-C8-cycloalkyloxy, aromatic C6-C 14-Carbocyclic oxy group, aromatic 5- or 6-membered monocyclic heterocyclic oxy group, non-aromatic 3- to 7-membered monocyclic heterocyclic oxy group, -N(R e )2、-C(=NR f )R f NR g C(=O)R g -C(=O)(OR) g -C(=O)N(R) g )2、-S(=O)2N(R g )2 and -S(=O)(=NR g )R g ,

[0374] Where R e Independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-ynyl, C2-C4-haloynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl.

[0375] Where R f Independently selected from hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, and C1-C4-alkoxy groups.

[0376] Where R g Independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, and C3-C6-cycloalkyl.

[0377] Among them, aliphatic R 7 R e R f and R g Substituents can be one to three R groups, which may be the same or different. 7Sa Substituent substitution,

[0378] Among them, the circular R 7 or R 7 The annular portion, the annular R e and circular R g Substituents can be one to three R groups, which may be the same or different. 7Sc Substituent substitution,

[0379] R 7Sa Selected from hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, R 7Sc Selected from fluorine, chlorine, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl.

[0380] R 8Selected from hydrogen, halogen, amino, hydroxyl, mercapto, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C2-C4-alkenyloxy, C2-C4-haloalkyneoxy, C2-C4-haloalkynoxy, C2-C4-haloalkynoxy, C2-C4-haloalkynoxy, C2-C4-haloalkynoxy, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, phenyl, naphthyl, non-aromatic 3- to 7-membered heterocycles, aromatic 5- or 6-membered heterocycles, C3-C6-cycloalkyloxy, phenyloxy, naphthyloxy, non-aromatic 3- to 7-membered heterocyclic oxy, aromatic 5- or 6-membered heterocyclic oxy, -N(R h )2、-SR i -S(=O)R i and -S(=O)2R i ,

[0381] Where R h Independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, phenyl, naphthyl, aromatic 5 or 6-membered heterocycles, and non-aromatic 3 to 7-membered monocyclic heterocycles.

[0382] Where R i Selected from C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-ynyl, C2-C4-haloynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, phenyl, naphthyl, aromatic 5- or 6-membered heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0383] Among them, aliphatic R 8 R h and R i Substituents can be one to three R groups, which may be the same or different. 8Sa Substituent substitution,

[0384] Among them, the circular R 8 or R 8 The annular portion, the annular R h and circular R i Substituents can be one to three R groups, which may be the same or different. 8Sc Substituent substitution,

[0385] R 8SaSelected from hydroxyl, carboxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C1-C4-alkylthioalkyl, C1-C4-haloalkylthioalkyl, C1-C4-alkylsulfinyl, C1-C4-haloalkylsulfinyl, C1-C4-alkylsulfonyl, C1-C4-haloalkylsulfonyl and non-aromatic 3- to 7-membered monocyclic heterocycles, wherein the non-aromatic 3- to 7-membered monocyclic heterocycle R 8Sa It can be substituted by one or two C1-C4-alkyl substituents, which may be the same or different.

[0386] R 8Sc Selected from halogens, oxo-, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0387] Q is selected from phenyl, naphthyl, and non-aromatic C5-C. 10 -Carbon rings, non-aromatic 5- to 10-membered heterocycles, and aromatic 5- to 10-membered heterocycles, wherein any one of the carbon rings or heterocyclic groups can be one to three identical or different Q groups. S Substituent substitution,

[0388] Q S Selected from halogen, cyano, nitro, formyl, carboxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkylcarbonyl, C1-C4-haloalkylcarbonyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, C2-C4-alkenyl, C2-C 4- Haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C1-C4-alkylthioalkyl, C1-C4-haloalkylthioalkyl, C1-C4-alkylsulfinyl, C1-C4-haloalkylsulfinyl, C1-C4-alkylsulfonyl, C1-C4-haloalkylsulfonyl, C3-C6-cycloalkyl, non-aromatic 3- to 7-membered monocyclic heterocycles, phenyl, naphthyl, and aromatic 5- to 10-membered heterocycles.

[0389] Among them, aliphatic Q S R j and R k The substituent may be replaced by one to three independently selected substituents from the following: hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, and C3-C6-halocycloalkyl, wherein the cyclic group is Q S Or Q S The annular portion and the annular R k The substituents can be selected independently from one to three of the following R groups.Qs Substituents: fluorine, chlorine, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0390] More preferably, the present invention relates to compounds of formula (I),

[0391] in

[0392] A is selected from O, S(=O)2, NR 1 and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C4-alkyl, and C3-C6-cycloalkyl.

[0393] m is 0, 1, or 2;

[0394] T is selected from hydrogen and C1-C4-alkyl.

[0395] R 3 and R 4 Independently selected from hydrogen, fluorine, chlorine, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-ynyl, and C3-C6-cycloalkyl.

[0396] R 5 Selected from hydrogen, hydroxyl, C1-C4-alkyl, and C1-C4-alkoxy.

[0397] L represents a direct bond or L is selected from C1-C6-alkylene groups.

[0398] The aliphatic L substituent can be selected independently by one to three L groups from the following L groups: Sa Substituents: fluorine, chlorine, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0399] The cyclic L-substituent or the cyclic portion of the L-substituent may be one to three independently selected from the following L-substituents. Sc Substituents: fluorine, chlorine, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0400] R 6 Selected from non-aromatic C5-C 10 -Carbocyclic rings, phenyl groups, naphthyl groups, non-aromatic 5- to 10-membered heterocycles, aromatic 5- to 10-membered heterocycles, non-aromatic C5-C 10 -Carbocyclic hydroxyl groups, phenoxy groups, naphthyl hydroxyl groups, aromatic 5- to 10-membered heterocyclic hydroxyl groups, non-aromatic 5- to 10-membered heterocyclic hydroxyl groups, and phenylthioalkyl groups.

[0401] Among them, the circular R 6 Substituents or R 6 The cyclic moiety of the substituent may be one to three independently selected from the following R... 6S Substituents: halogen, nitro, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-haloalkylthioalkyl, cyclopropyl, cyclobutyl, cyclopentyl, pyridyl, oxetyl, and tetrahydrofuranyl, wherein the cyclic R 6S The substituents may be replaced by one or two independently selected from the following substituents: halogen, C1-C4-alkyl, C1-C4-haloalkyl, and C1-C4-alkoxycarbonyl.

[0402] R 7 Selected from hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylthioalkyl, C1-C4-alkenylthioalkyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, pyridinyl, imidazolyl, pyrazolyl, thiazolyl, oxetanebutylyl, tetrahydrofuranyl, pyrrolidinyl, -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0403] Where R e Independently selected from hydrogen, C1-C4-alkyl, and C3-C6-cycloalkyl.

[0404] Where R f Independently selected from C1-C4-alkyl and C1-C4-alkoxy groups,

[0405] Where R g Independently selected from hydrogen, C1-C4-alkyl, and C3-C6-cycloalkyl.

[0406] The aliphatic R 7 R e and R g The substituents can be selected independently from one to three of the following R groups. 7Sa Substituents: hydroxyl, C1-C4-alkoxy, and C3-C6-cycloalkyl.

[0407] The annular R 7 R e and R g The substituents can be selected independently from one to three of the following R groups. 7ScSubstituents: halogen, hydroxyl, C1-C4-alkyl, and C1-C4-alkoxy.

[0408] R 8 Selected from hydrogen, halogen, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C2-C4-alkenyl, C1-C4-alkylthioalkyl, C1-C4-haloalkylthioalkyl, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, phenyl, naphthyl, oxacyclobutyl, aziroxybutyl, tetrahydrofuranyl, pyrrolidinyl, tetrahydropyranyl, piperidinyl, piperazine, morpholinyl, furanyl, thiophene, pyrrolidinyl, pyrazolyl, thiazolyl, imidazole, oxazolyl, isoxazolyl, pyridinyl, pyrimidinyl, C3-C6-cycloalkyloxy, and -N(R h )2,

[0409] Where R h Independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, phenyl, oxetane, azirane, pyrrolidinyl, and tetrahydrofuranyl.

[0410] Among them, the aliphatic R disclosed in this article 8 and R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sa Substituents: hydroxyl, C1-C4-alkoxy, C1-C4-alkoxycarbonyl, C3-C6-cycloalkyl, C1-C4-alkylthioalkyl, oxetane, azirane, pyrrolidinyl, and tetrahydrofuranyl.

[0411] Among them, the annular R disclosed in this article 8 and R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sc Substituents: oxo, fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C3-C6-cycloalkyl, oxetane, azirane, pyrrolidinyl, and tetrahydrofuranyl

[0412] Q is selected from phenyl, 1,3-benzodioxanepentyl-5-yl, 2,3-dihydrobenzofuranyl, pyridyl, thiophenyl, and indole-5-yl.

[0413] More preferably, the Q group disclosed herein may be selected independently from one or two of the following Q groups. SSubstituents: halogen, cyano, nitro, formyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylthioalkyl, C3-C6-cycloalkyl, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0414] The more preferred aliphatic Q S The substituents may be replaced by one or two substituents independently selected from the following: hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl, and C3-C6-cycloalkyl.

[0415] The most preferred embodiment of the present invention relates to a compound of formula (I), wherein

[0416] A is selected from O and NR. 1 and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, methyl, or ethyl.

[0417] m is 1;

[0418] T is hydrogen.

[0419] R 3 and R 4 Independently selected from hydrogen or fluorine,

[0420] R 5 It is hydrogen.

[0421] L represents a direct bond or L is a methylene group.

[0422] R 6 It is dihydroindene, 1,2,3,4-tetrahydronaphthyl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, 2,3-dihydro-1,4-benzodioxanehexyl, thienyl, pyridyl, indolyl, benzofuranyl, benzothienyl, or phenoxy.

[0423] Among them, the circular R 6 Substituents or R 6 The cyclic portion of the substituent can be one or two identical or different R groups. 6S Substituent substitution,

[0424] R 6S Selected from halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-haloalkylthioalkyl, C3-C5-cycloalkyl, pyridinyl, oxetaneyl, and tetrahydrofuranyl.

[0425] R 7 Selected from halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkoxy, C1-C4-alkylcarbonyl, C3-C6-cycloalkyl, imidazolyl, pyrazolyl, thiazolyl, and pyridinyl.

[0426] Among them, aliphatic R 7 The substituents may be selected independently from the following R groups, one or two of which are R groups. 7Sa Substituents: hydroxyl, methoxy, ethoxy, and cyclopropyl.

[0427] Among them, the circular R 7 Substituents or R 7 The cyclic moiety of the substituent may be selected independently by one or two of the following R... 7Sc Substituents: fluorine, methyl, ethyl, and cyclopropyl.

[0428] R 8 Selected from hydrogen, halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C3-C6-cycloalkyloxy and -N(R) h )2,

[0429] Where R h Independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, and C3-C6-cycloalkyl.

[0430] Among them, aliphatic R 8 and R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sa Substituents: hydroxyl, methoxy, and ethoxy

[0431] Among them, the circular R 8 or R 8 The annular portion and the annular R h The substituents may be selected independently from the following R groups, one or two of which are R groups. 8Sc Substituents: fluorine, methyl, ethyl, and cyclopropyl.

[0432] Q is selected from phenyl, 3-bicyclo[4.2.0]oct-1,3,5-trienyl, pyrazolyl, thiazolyl, thiophene, and pyridinyl.

[0433] Any one of the carbocyclic or heterocyclic groups can be one to three identical or different Q groups. S Substituent substitution,

[0434] Q SIt is selected from halogen, cyano, nitro, formyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylthioalkyl, C3-C5-cycloalkyl, oxecyclopropane and oxecyclobutane.

[0435] In some embodiments (referred to herein as Embodiment 2), the compound of the present invention is a compound of formula (I):

[0436]

[0437] in

[0438] A is selected from O, C (=O) and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, or R 1 and R 2 Together with the carbon atoms they are attached to, they form C3-C8 cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 1 and R 2 It is hydrogen;

[0439] m is 0, 1, or 2;

[0440] T represents hydrogen or -C(=O)(OR) a1 ), where R a1 Selected from C1-C6-alkyl, C1-C6-haloalkyl and C2-C6-alkylene, preferably T is hydrogen;

[0441] R 3 and R 4 Independently selected from hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles, -O-Si(C1-C6-alkyl)3 and aromatic 5- to 14-membered heterocycles, or R 3 and R 4 Together with the carbon atoms they are attached to, they form carbonyl, methylene, C3-C8-cycloalkyl, or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 3 and R 4 It is hydrogen;

[0442] R 5 It is hydrogen, hydroxyl, or C1-C6-alkoxy, with hydrogen being preferred;

[0443] Among them, aliphatic R 1 R2 R 3 R 4 and R 5 The substituent may be replaced by one or more substituents disclosed herein;

[0444] Among them, the circular R 1 R 2 R 3 and R 4 The substituent may be replaced by one or more substituents disclosed herein;

[0445] L represents a direct bond or L is selected from carbonyl; C1-C6-alkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle; C2-C6-alkenyl; C2-C6-ynylene; C3-C8-cycloalkylene; C1-C6-alkylene Alkyl-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-(C=O); C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; Non-aromatic 3- to 7-membered monocyclic heterocyclic groups;

[0446] The aliphatic L substituent can be one or more L substituents, which may be the same or different as described herein. Sa Substituent substitution,

[0447] The cyclic L-substituent or the cyclic portion of the L-substituent may be one or more L-substituents disclosed herein, which may be the same or different. Sc Substituent substitution,

[0448] R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, aromatic C6-C 14 -Carbocyclic oxy group, aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy groups and aromatic C6-C 14 -Carbocyclic-substituted C1-C3-haloalkoxy group, preferably R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14-Carbon rings and aromatic 5- to 14-membered heterocycles

[0449] The annular R 6 Substituents or R 6 The cyclic moiety of the substituent may be one or more of the R disclosed herein. 6S Substituent substitution (including preferred and more preferred R) 6S (substituents);

[0450] R 7 Selected from hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0451] Where R e As disclosed above, R is preferred. e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl (e.g., cyclopropyl),

[0452] Where R f As disclosed above, R is preferred. f Independently selected from hydroxyl, amino, C1-C6-alkyl, and C1-C6-alkoxy groups.

[0453] Where R g As disclosed above, R is preferred. g Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0454] Preferred R 7 Selected from halogens, C1-C6-alkyl, C1-C6-alkylcarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, and -N(R) e )2, where R e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0455] Among them, aliphatic R 7 R e R f and R g Substituents can be one or more R groups that are the same or different. 7Sa Substituent substitution, R 7SaAs disclosed herein (including preferred R) 7Sa ),

[0456] Among them, the circular R 7 or R 7 The annular portion, the annular R e and circular R g Substituents can be one or more R groups that are the same or different. 7Sc Substituent substitution, R 7Sc As disclosed herein (including preferred R) 7Sc );

[0457] R 8 Selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles (preferably non-aromatic 3- to 7-membered monocyclic heterocycles), aromatic 5- to 14-membered heterocycles (preferably 5- or 6-membered aromatic monocyclic heterocycles), C3-C8-cycloalkyloxy groups, non-aromatic 3- to 14-membered heterocyclic alkyloxy groups (preferably non-aromatic 3- to 7-membered monocyclic heterocyclic alkyloxy groups), and -N(R h )2, where R h As disclosed above, R is preferred. h Independently selected from hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 -Carbocyclic (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0458] Preferred R 8 Selected from hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy and -N(R) h )2, where R h Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0459] Among them, aliphatic R 8 and R h Substituents can be one or more R groups that are the same or different. 8Sa Substituent substitution, R 8Sa As disclosed herein (including preferred R) 8Sa ),

[0460] Among them, the circular R 8 or R 8 The annular portion and the annular R h Substituents can be one or more R groups that are the same or different.8Sc Substituent substitution, R 8Sc As disclosed herein (including preferred R) 8Sc );

[0461] Q is selected from Fang ethnic group C6-C 14 -Carbon ring, non-aromatic C3-C 12 -Carbon rings, non-aromatic 3- to 14-membered heterocycles, and aromatic 5- to 14-membered heterocycles, wherein each of the said carbon rings or heterocyclic groups may be represented by one or more Q groups that may be the same or different. S Substituent substitution, Q S As described herein (including preferred Q) S ).

[0462] In some embodiments (referred to herein as Embodiment 3), the compound of the present invention is a compound of formula (I):

[0463]

[0464] in

[0465] A is selected from O, C (=O) and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, or R 1 and R 2 Together with the carbon atoms they are attached to, they form C3-C8 cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 1 and R 2 It is hydrogen;

[0466] m is 0, 1, or 2;

[0467] T represents hydrogen or -C(=O)(OR) a1 ), where R a1 Selected from C1-C6-alkyl, C1-C6-haloalkyl and C2-C6-alkylene, preferably T is hydrogen;

[0468] R 3 and R 4 Independently selected from hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles, -O-Si(C1-C6-alkyl)3 and aromatic 5- to 14-membered heterocycles, or R 3 and R 4 Together with the carbon atoms they are attached to, they form carbonyl, methylene, C3-C8-cycloalkyl, or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R.3 and R 4 It is hydrogen;

[0469] R 5 It is hydrogen, hydroxyl, or C1-C6-alkoxy, with hydrogen being preferred;

[0470] Among them, aliphatic R 1 R 2 R 3 R 4 and R 5 The substituent may be replaced by one or more substituents disclosed herein;

[0471] Among them, the circular R 1 R 2 R 3 and R 4 The substituent may be replaced by one or more substituents disclosed herein;

[0472] L represents a direct bond or L is selected from carbonyl; C1-C6-alkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle; C2-C6-alkenyl; C2-C6-ynylene; C3-C8-cycloalkylene; C1-C6-alkylene Alkyl-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-(C=O); C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; Non-aromatic 3- to 7-membered monocyclic heterocyclic groups;

[0473] The aliphatic L substituent can be one or more L substituents disclosed herein, which may be the same or different. Sa Substituent substitution,

[0474] The cyclic L-substituent or the cyclic portion of the L-substituent may be one or more L-substituents disclosed herein, which may be the same or different. Sc Substituent substitution,

[0475] R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, aromatic C6-C 14-Carbocyclic oxy group, aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy groups and aromatic C6-C 14 -Carbocyclic-substituted C1-C3-haloalkoxy group, preferably R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings and aromatic 5- to 14-membered heterocycles.

[0476] The annular R 6 Substituents or R 6 The cyclic moiety of the substituent may be one or more of the R disclosed herein. 6S Substituent substitution (including preferred and more preferred R) 6S (substituents);

[0477] R 7 Selected from hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0478] Where R e As disclosed above, R is preferred. e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl (e.g., cyclopropyl),

[0479] Where R f As disclosed above, R is preferred. f Independently selected from hydroxyl, amino, C1-C6-alkyl, and C1-C6-alkoxy groups.

[0480] Where R g As disclosed above, R is preferred. g Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0481] Preferred R 7 Selected from halogens, C1-C6-alkyl, C1-C6-alkylcarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, and -N(R) e )2, where R e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0482] Among them, aliphatic R 7 R e R f and R g Substituents can be one or more R groups that are the same or different. 7Sa Substituent substitution, R 7Sa As disclosed herein (including preferred R) 7Sa ),

[0483] Among them, the circular R 7 or R 7 The annular portion, the annular R e and circular R g Substituents can be one or more R groups that are the same or different. 7Sc Substituent substitution, R 7Sc As disclosed herein (including preferred R) 7Sc );

[0484] R 8 Selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles (preferably non-aromatic 3- to 7-membered monocyclic heterocycles), aromatic 5- to 14-membered heterocycles (preferably 5- or 6-membered aromatic monocyclic heterocycles), C3-C8-cycloalkyloxy groups, non-aromatic 3- to 14-membered heterocyclic alkyloxy groups (preferably non-aromatic 3- to 7-membered monocyclic heterocyclic alkyloxy groups), and -N(R h )2, where R h As disclosed above, R is preferred. h Independently selected from hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 -Carbocyclic (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0485] Preferred R 8 Selected from hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy and -N(R) h )2, where R h Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0486] Among them, aliphatic R 8 and R h Substituents can be one or more R groups that are the same or different. 8Sa Substituent substitution, R8Sa As disclosed herein (including preferred R) 8Sa ),

[0487] Among them, the circular R 8 or R 8 The annular portion and the annular R h Substituents can be one or more R groups that are the same or different. 8Sc Substituent substitution, R 8Sc As disclosed herein (including preferred R) 8Sc );

[0488] Q can be one or more Qs that are the same or different. S Substituent-substituted aromatic C6-C 14 -Carbon ring, Q S As described herein (including preferred Q) S ).

[0489] In some embodiments (referred to herein as Embodiment 4), the compound of the present invention is a compound of formula (I):

[0490]

[0491] in

[0492] A is selected from O, C (=O) and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, or R 1 and R 2 Together with the carbon atoms they are attached to, they form C3-C8 cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 1 and R 2 It is hydrogen;

[0493] m is 0, 1, or 2;

[0494] T represents hydrogen or -C(=O)(OR) a1 ), where R a1 Selected from C1-C6-alkyl, C1-C6-haloalkyl and C2-C6-alkylene, preferably T is hydrogen;

[0495] R 3 and R 4 Independently selected from hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, aromatic C6-C 14-Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles, -O-Si(C1-C6-alkyl)3 and aromatic 5- to 14-membered heterocycles, or R 3 and R 4 Together with the carbon atoms they are attached to, they form carbonyl, methylene, C3-C8-cycloalkyl, or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 3 and R 4 It is hydrogen;

[0496] R 5 It is hydrogen, hydroxyl, or C1-C6-alkoxy, with hydrogen being preferred;

[0497] Among them, aliphatic R 1 R 2 R 3 R 4 and R 5 The substituent may be replaced by one or more substituents disclosed herein;

[0498] Among them, the circular R 1 R 2 R 3 and R 4 The substituent may be replaced by one or more substituents disclosed herein;

[0499] L represents a direct bond or L is selected from carbonyl; C1-C6-alkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle; C2-C6-alkenyl; C2-C6-ynylene; C3-C8-cycloalkylene; C1-C6-alkylene Alkyl-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-(C=O); C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; Non-aromatic 3- to 7-membered monocyclic heterocyclic groups;

[0500] The aliphatic L substituent may be one or more L substituents disclosed herein, which may be the same or different. Sa Substituent substitution,

[0501] The cyclic L-substituent or the cyclic portion of the L-substituent may be one or more L-substituents disclosed herein, which may be the same or different. Sc Substituent substitution,

[0502] R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings, non-aromatic 3- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, aromatic C6-C 14 -Carbocyclic oxy group, aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy groups and aromatic C6-C 14 -Carbocyclic-substituted C1-C3-haloalkoxy group, preferably R 6 Selected from non-aromatic C3-C 12 -Carbon rings, aromatic C6-C 14 -Carbon rings and aromatic 5- to 14-membered heterocycles.

[0503] The annular R 6 Substituents or R 6 The cyclic moiety of the substituent may be one or more of the R disclosed herein. 6S Substituent substitution (including preferred and more preferred R) 6S (substituents);

[0504] R 7 Selected from hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0505] Where R e As disclosed above, R is preferred. e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl (e.g., cyclopropyl),

[0506] Where R f As disclosed above, R is preferred. f Independently selected from hydroxyl, amino, C1-C6-alkyl, and C1-C6-alkoxy groups.

[0507] Where R g As disclosed above, R is preferred. g Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0508] Preferred R 7Selected from halogens, C1-C6-alkyl, C1-C6-alkylcarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, and -N(R) e )2, where R e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0509] Among them, aliphatic R 7 R e R f and R g Substituents can be one or more R groups that are the same or different. 7Sa Substituent substitution, R 7Sa As disclosed herein (including preferred R) 7Sa ),

[0510] Among them, the circular R 7 or R 7 The annular portion, the annular R e and circular R g Substituents can be one or more R groups that are the same or different. 7Sc Substituent substitution, R 7Sc As disclosed herein (including preferred R) 7Sc );

[0511] R 8 Selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles (preferably non-aromatic 3- to 7-membered monocyclic heterocycles), aromatic 5- to 14-membered heterocycles (preferably 5- or 6-membered aromatic monocyclic heterocycles), C3-C8-cycloalkyloxy groups, non-aromatic 3- to 14-membered heterocyclic alkyloxy groups (preferably non-aromatic 3- to 7-membered monocyclic heterocyclic alkyloxy groups), and -N(R h )2, where R h As disclosed above, R is preferred. h Independently selected from hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 -Carbocyclic (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0512] Preferred R 8 Selected from hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy and -N(R) h )2, where R hIndependently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0513] Among them, aliphatic R 8 and R h Substituents can be one or more R groups that are the same or different. 8Sa Substituent substitution, R 8Sa As disclosed herein (including preferred R) 8Sa ),

[0514] Among them, the circular R 8 or R 8 The annular portion and the annular R h Substituents can be one or more R groups that are the same or different. 8Sc Substituent substitution, R 8Sc As disclosed herein (including preferred R) 8Sc );

[0515] Q is

[0516]

[0517] in

[0518] Q s1 It is hydrogen or halogen (preferably fluorine).

[0519] Q s2 For hydrogen or Q s Q s As mentioned above, Q is preferred. S2 The group is selected from hydrogen, halogens (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, amino, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methoxycarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., trifluoromethoxy), C2-C6-alkenyl (e.g., vinyl), C2-C6-ynyl (e.g., ethynyl), C1-C6-alkylthioalkyl (e.g., methylthioalkyl), C1-C6-haloalkylthioalkyl (e.g., trifluoromethylthioalkyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl) that may be substituted with one or more halogen atoms, and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetane butyl) that may be substituted with one or more halogen atoms, more preferably Q. S2 Selected from fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, trifluoromethoxy, vinyl, ethynyl, methylthioalkyl, trifluoromethylthioalkyl, cyclopropyl which may be substituted with one or more halogen atoms, and oxocyclobutyl which may be substituted with one or more halogen atoms, preferably Q. s1 and Q s2At least one of them is different from hydrogen.

[0520] In some embodiments (referred to herein as Embodiment 5), the compound of the present invention is a compound of formula (I):

[0521]

[0522] in

[0523] A is selected from O, C (=O) and CR 1 R 2 , where R 1 and R 2 Independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, or R 1 and R 2 Together with the carbon atoms they are attached to, they form C3-C8 cycloalkyl or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 1 and R 2 It is hydrogen;

[0524] m is 0, 1, or 2;

[0525] T represents hydrogen or -C(=O)(OR) a1 ), where R a1 Selected from C1-C6-alkyl, C1-C6-haloalkyl and C2-C6-alkylene, preferably T is hydrogen;

[0526] R 3 and R 4 Independently selected from hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles, -O-Si(C1-C6-alkyl)3 and aromatic 5- to 14-membered heterocycles, or R 3 and R 4 Together with the carbon atoms they are attached to, they form carbonyl, methylene, C3-C8-cycloalkyl, or non-aromatic 3- to 7-membered monocyclic heterocycles, preferably R. 3 and R 4 It is hydrogen;

[0527] R 5 It is hydrogen, hydroxyl, or C1-C6-alkoxy, with hydrogen being preferred;

[0528] Among them, aliphatic R 1 R 2 R 3 R 4 and R 5 The substituent may be replaced by one or more substituents as disclosed herein;

[0529] Among them, the circular R 1 R 2 R 3 and R 4 The substituent may be replaced by one or more substituents as disclosed herein;

[0530] L represents a direct bond or L is selected from carbonyl; C1-C6-alkylene; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl; C1-C6-alkylene with two substituents on the same carbon atom, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3- to 7-membered monocyclic heterocycle; C2-C6-alkenyl; C2-C6-ynylene; C3-C8-cycloalkylene; C1-C6-alkylene Alkyl-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-(C=O); C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-cycloalkylene; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; Non-aromatic 3- to 7-membered monocyclic heterocyclic groups;

[0531] The aliphatic L substituent can be one or more L substituents, which may be the same or different as disclosed herein. Sa Substituent substitution,

[0532] The cyclic L-substituent or the cyclic portion of the L-substituent may be one or more L-substituents that may be the same or different as disclosed herein. Sc Substituent substitution,

[0533] R 6 for

[0534]

[0535] in

[0536] R 6s1 For hydrogen or R 6s ,

[0537] R 6s2 For hydrogen or R 6s ,

[0538] R 6s As described herein (including preferred and more preferred R) 6s ), preferred R 6s1 and R 6s2 At least one of them is different from hydrogen;

[0539] R 7 Selected from hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkylcarbonyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkylthioalkyl, C1-C6-alkylsulfinyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R e )2、-C(=NR f )R f and -C(=O)N(R) g )2,

[0540] Where R e As disclosed above, R is preferred. e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl (e.g., cyclopropyl),

[0541] Where R f As disclosed above, R is preferred. f Independently selected from hydroxyl, amino, C1-C6-alkyl, and C1-C6-alkoxy groups.

[0542] Where R g As disclosed above, R is preferred. g Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0543] Preferred R 7 Selected from halogens, C1-C6-alkyl, C1-C6-alkylcarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl, aromatic 5- or 6-membered monocyclic heterocycles, and -N(R) e )2, where R e Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0544] Among them, aliphatic R 7 R e R f and R g Substituents can be one or more R groups that are the same or different. 7Sa Substituent substitution, R 7Sa As disclosed herein (including preferred R) 7Sa ),

[0545] Among them, the circular R 7 or R 7 The annular portion, the annular R e and circular R g Substituents can be one or more R groups that are the same or different. 7Sc Substituent substitution, R7Sc As disclosed herein (including preferred R) 7Sc );

[0546] R 8 Selected from hydrogen, halogen, hydroxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, aromatic C6-C 14 -Carbocyclic rings, non-aromatic 3- to 14-membered heterocycles (preferably non-aromatic 3- to 7-membered monocyclic heterocycles), aromatic 5- to 14-membered heterocycles (preferably 5- or 6-membered aromatic monocyclic heterocycles), C3-C8-cycloalkyloxy groups, non-aromatic 3- to 14-membered heterocyclic alkyloxy groups (preferably non-aromatic 3- to 7-membered monocyclic heterocyclic alkyloxy groups), and -N(R h )2, where R h As disclosed above, R is preferred. h Independently selected from hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl (e.g., cyclopropyl, cyclohexyl), aromatic C6-C 14 -Carbocyclic (e.g., phenyl) and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxobutyric).

[0547] Preferred R 8 Selected from hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy and -N(R) h )2, where R h Independently selected from hydrogen, C1-C6-alkyl, and C3-C8-cycloalkyl.

[0548] Among them, aliphatic R 8 and R h Substituents can be one or more R groups that are the same or different. 8Sa Substituent substitution, R 8Sa As disclosed herein (including preferred R) 8Sa ),

[0549] Among them, the circular R 8 or R 8 The annular portion and the annular R h Substituents can be one or more R groups that are the same or different. 8Sc Substituent substitution, R 8Sc As disclosed herein (including preferred R) 8Sc );

[0550] Q is

[0551]

[0552] in

[0553] Q s1 It is hydrogen or halogen (preferably fluorine).

[0554] Q s2 For hydrogen or Q s Q s As mentioned above, Q is preferred. S2 The group is selected from hydrogen, halogens (e.g., fluorine, chlorine, bromine, iodine), cyano, nitro, hydroxyl, amino, C1-C6-alkyl (e.g., methyl, ethyl), C1-C6-haloalkyl (e.g., trifluoromethyl, difluoromethyl), C1-C6-alkylcarbonyl (e.g., methoxycarbonyl), C1-C6-alkoxy (e.g., methoxy), C1-C6-haloalkoxy (e.g., trifluoromethoxy), C2-C6-alkenyl (e.g., vinyl), C2-C6-ynyl (e.g., ethynyl), C1-C6-alkylthioalkyl (e.g., methylthioalkyl), C1-C6-haloalkylthioalkyl (e.g., trifluoromethylthioalkyl), C3-C8-cycloalkyl (e.g., cyclopropyl, cyclobutyl) that may be substituted with one or more halogen atoms, and non-aromatic 3- to 7-membered monocyclic heterocycles (e.g., oxetane butyl) that may be substituted with one or more halogen atoms, more preferably Q. S2 Selected from fluorine, chlorine, bromine, iodine, cyano, nitro, hydroxyl, amino, methyl, trifluoromethyl, difluoromethyl, methoxy, trifluoromethoxy, vinyl, ethynyl, methylthioalkyl, trifluoromethylthioalkyl, cyclopropyl which may be substituted with one or more halogen atoms, and oxocyclobutyl which may be substituted with one or more halogen atoms, preferably Q. s1 and Q s2 At least one of them is not used for hydrogen.

[0555] In some embodiments, the compounds of the present invention are compounds of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein m is 0 and A is CR. 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 and R 2 A is a hydrogen atom, or A is O.

[0556] In some embodiments, the compounds of the present invention are compounds of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein m is 1 and A is O, C (=O) or CR. 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 and R 2 It is a hydrogen atom.

[0557] In some embodiments, the compounds of the present invention are compounds of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein m is 2 and A is O, C (=O) or CR. 1 R 2 , where R 1 and R 2 As mentioned above, R is preferred. 1 and R 2 It is a hydrogen atom.

[0558] In some embodiments, the compounds of the present invention are compounds of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L is a direct bond or a C1-C6-alkylene bond (e.g., -CH2-).

[0559] In some embodiments, the compound of the present invention is a compound of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L is

[0560]

[0561] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0562] In some embodiments, the compound of the present invention is a compound of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L is

[0563]

[0564] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0565] In some embodiments, the compound of the present invention is a compound of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L is

[0566]

[0567] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0568] In some embodiments, the compound of the present invention is a compound of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L is

[0569]

[0570] Where x is 0 or 1 and y is 0 or 1, preferably x and y are 0.

[0571] In some embodiments, the compounds of the present invention are compounds of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L represents a direct bond and R 6 Selected from non-aromatic C3-C12 -Carbon rings, aromatic C6-C 14 -Carbon rings and aromatic 5- to 14-membered heterocycles, preferably R 6 It is selected from dihydroindene-5-yl, phenyl, naphthyl, furan-2-yl and indole-3-yl.

[0572] In some embodiments, the compounds of the present invention are compounds of formula (I) according to embodiments 1, 2, 3, 4 or 5, wherein L represents a C1-C6-alkylene group and R 6 For the aromatic C6-C 14 -Carbon ring (e.g., phenyl).

[0573] In a more preferred embodiment, L represents a direct bond or L is selected from C1-C6-alkylene groups.

[0574] The aliphatic L substituent can be selected independently by one to three L groups from the following L groups. Sa Substituents: fluorine, chlorine, hydroxyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0575] The cyclic L-substituent or the cyclic portion of the L-substituent may be one to three independently selected from the following L-substituents. Sa Substituents: fluorine, chlorine, hydroxyl, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, and C3-C6-cycloalkyl.

[0576] The present invention also relates to compounds of any formula (I) disclosed in Table 1.

[0577] The compounds of formula (I) can be used as fungicides (for the control of plant pathogenic fungi), particularly in methods for the control of plant pathogenic fungi, the method comprising the step of applying one or more compounds of formula (I) to a plant, plant part, seed, fruit or soil in which the plant grows.

[0578] Methods for preparing compounds and intermediates of formula (I)

[0579] This invention relates to methods for preparing compounds of formula (I) and intermediates thereof. Unless otherwise stated, groups A, Q, T, L, R... 1 R 2 R 3 R 4 R 5 R 6 R 7 R 8 , m have the meanings given above for compounds of formula (I). These definitions apply not only to the final product of formula (I) but also to all intermediates.

[0580] The compounds of formula (Ia)-(If) are various subsets of formula (I). The compounds of formula (Ia-1)-(Ia-7) are various subsets of formula (Ia). Unless otherwise stated, all substituents used in formulas (Ia)-(If) and (Ia-1)-(Ia-7) are as defined above with respect to formula (I).

[0581] Compounds of formula (I) can be prepared by various methods similar to those known (see examples and references herein). Non-limiting examples of suitable methods are described herein.

[0582] Compounds of formula (I) can be obtained directly by performing methods A to I, or by converting or derivatizing another compound of formula (I) prepared according to the methods described herein. For example, a compound of formula (I) can be converted into a compound of another formula (I) by replacing one or more substituents of a starting compound of formula (I) with other substituents. Non-limiting examples of such conversion or derivatization (methods J and L) are described below.

[0583] The methods described herein can be carried out appropriately using one or more organic solvents that are generally inert to the reaction under consideration. Suitable inert organic solvents may be selected from the following substances: aliphatic, alicyclic, or aromatic hydrocarbons (e.g., petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, light petroleum, benzene, toluene, xylene, or decahydronaphthalene), halogenated aliphatic, alicyclic, or aromatic hydrocarbons (e.g., chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, or trichloroethane), ethers (e.g., diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane, or anisole), and ketones (e.g., acetone, methyl ethyl ketone). Methyl isopropyl ketone and methyl isobutyl ketone), esters (e.g., methyl acetate, ethyl acetate or butyl acetate), alcohols (e.g., methanol, ethanol, propanol, isopropanol, butanol, tert-butanol), nitriles (e.g., acetonitrile, propionitrile, n-butyronitrile or isobutyronitrile or benzonitrile), amides (e.g., N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamine), sulfoxides (e.g., dimethyl sulfoxide) or sulfones (e.g., sulfolane), ureas (e.g., 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone) or any mixture thereof.

[0584] Some of the methods described herein may require, or optionally use, one or more inorganic or organic bases commonly used in the reaction. Examples of suitable inorganic and organic bases include, but are not limited to, alkaline earth metal or alkali metal carbonates (e.g., sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, or cesium carbonate), alkali metal hydrides (e.g., sodium hydride), alkaline earth metal or alkali metal hydroxides (e.g., sodium hydroxide, calcium hydroxide, potassium hydroxide, or other ammonium hydroxide derivatives), fluorides of alkaline earth metals, alkali metals, or ammonium (e.g., potassium fluoride, cesium fluoride, or tetrabutylammonium fluoride), alkali metal or alkaline earth metal acetates (e.g., sodium acetate, lithium acetate, potassium acetate, or calcium acetate), and alkali metal alkoxides (e.g., sodium acetate, lithium acetate, potassium acetate, or calcium acetate). Examples include potassium tert-butoxide, sodium tert-butoxide), alkali metal phosphates (e.g., tripotassium phosphate), tertiary amines (e.g., trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dicyclohexylmethylamine, N,N-diisopropylethylamine, N-methylpiperidine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN), diazabicycloundecene (DBU), quinine ring, 3-acetoxyquinine ring, guanidine, or aromatic bases (e.g., pyridine, methylpyridine, dimethylpyridine, or trimethylpyridine).

[0585] Some of the methods described herein can optionally be carried out in the presence of a transition metal catalyst (e.g., a metal (e.g., a copper or palladium) salt or complex), and, if appropriate, in the presence of a ligand.

[0586] Suitable copper salts or complexes and their hydrates include, but are not limited to, copper metal, cuprous iodide (I), cuprous chloride (I), cuprous bromide (I), cuprous chloride (II), cuprous bromide (II), copper oxide (II), cuprous oxide (I), copper acetate (II), cuprous acetate (I), cuprous thiophene-2-carboxylate (I), cuprous cyanide (I), copper sulfate (II), bis(2,2,6,6-tetramethyl-3,5-heptadecanoic acid)copper (II), copper trifluoromethanesulfonate (II), tetra(acetonitrile)copper (I) hexafluorophosphate, and tetra(acetonitrile)copper (I) tetrafluorophosphate.

[0587] By adding copper salts and ligands or salts separately to the reaction mixture, suitable copper complexes can also be generated in situ in the reaction mixture. The ligands or salts are, for example, ethylenediamine, N,N-dimethylethylenediamine, N,N'-dimethylethylenediamine, rac-trans-1,2-diaminocyclohexane, rac-trans-N,N'-dimethylcyclohexane-1,2-diamine, 1,1'-bisnaphthyl-2,2'-diamine, N,N,N',N'-tetramethylethylenediamine, proline, N,N-dimethylglycine, quinoline-8-ol, pyridine, 2-aminopyridine, 4-(dimethylamino)pyridine, 2,2'-bipyridyl, 2,6-bis(2-pyridyl)pyridine, 2-pyridinecarboxylic acid, 2-(dimethylaminomethyl)-3-hydroxypyridine, 1,10-o-diazaphenanthroline, 3,4,7,8-tetramethyl-1,10-o-diazaphenanthroline. Phenanthrene, 2,9-dimethyl-1,10-o-diaphenanthrene, 4,7-dimethoxy-1,10-o-diaphenanthrene, N,N'-bis[(E)-pyridin-2-ylmethylene]cyclohexane-1,2-diamine, N-[(E)-phenylmethylene], N-[(E)-phenylmethylene]-cyclohexylamine, 1,1,1-tris(hydroxymethyl)ethane, n-butylimidazolium, ethylene glycol, 2,2,6,6-tetrachlorophenanthrene Methylheptane-3,5-dione, 2-(2,2-dimethylpropionamide)cyclohexanone, acetylacetone, dibenzoylmethane, 2-(2-methylpropionyl)cyclohexanone, biphenyl-2-yl(di-tert-butyl)phosphine, ethylidene bis-(diphenylphosphine), N,N-diethylsalicylic acid, 2-hydroxybenzaldehyde oxime, oxo[(2,4,6-trimethylphenyl)amino]acetic acid, or 1H-pyrrole-2-carboxylic acid.

[0588] Suitable palladium salts or complexes include, but are not limited to, palladium chloride, palladium acetate, tetra(triphenylphosphine)palladium (0), bis(dibenzylacetone)palladium (0), tri(dibenzylacetone)dipalladium (0), bis(triphenylphosphine)palladium (II), [1,1'-bis(diphenylphosphine)ferrocene]palladium (II), bis(cinnamyl)dichlorodipalladium (II), bis(allyl)-dichlorodipalladium (II) or [1,1'-bis(di-tert-butylphosphine)ferrocene]palladium (II).

[0589] Palladium complexes can also be formed in the reaction mixture by adding palladium salts and ligands or salts, such as triethylphosphine, tri-tert-butylphosphine, tri-tert-butylphosphine tetrafluoroborate, tricyclohexylphosphine, 2-(dicyclohexylphosphine)biphenyl, 2-(di-tert-butylphosphine)biphenyl, 2-(dicyclohexylphosphine)-2'-(N,N-dimethylamino)biphenyl, 2-(tert-butylphosphine)-2'-(N,N-dimethylamino)biphenyl, 2-di-tert-butylphosphine-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphine-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphine-2,6'-dimethoxybiphenyl, 2-dicyclohexylphosphine-2',6'-diisopropoxybiphenyl, triphenylphosphine, tri-(o-methylphosphine) (Phenyl)phosphine, sodium 3-(diphenylphosphine)benzenesulfonate, tris-(2-methoxy-phenyl)phosphine, 2,2'-bis(diphenylphosphine)-1,1'-binaphthyl, 1,4-bis(diphenylphosphine)butane, 1,2-bis(diphenylphosphine)ethane, 1,4-bis(dicyclohexylphosphine)butane, 1,2-bis(dicyclohexylphosphine)ethane, 2-(dicyclohexylphosphine)-2'-(N,N-dimethylamino)-biphenyl, 1,1'-bis(diphenylphosphine)-ferrocene, (R)-(-)-1-[(S)-2-diphenylphosphine)ferrocene]ethyldicyclohexylphosphine, tris-(2,4-tert-butyl-phenyl)phosphite, di(1-adamantyl)-2-morpholinophenylphosphine, or 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride.

[0590] Suitable catalysts and / or ligands can be selected from commercial catalogs, such as Strem Chemicals' "Metal Catalysts for Organic Synthesis", or from reviews (Chemical Society Reviews (2014), 43, 3525, Coordination Chemistry Reviews (2004), 248, 2337 and references therein).

[0591] Some of the methods described in this article can be performed by metal photo-oxidation-reduction catalysis according to the methods recorded in the literature (Nature Chemistry Review, (2017) 0052 and its references; Science (2016) 352, 6291, 1304; Org. Lett. 2016, 18, 4012, J. Org. Chem 2016, 81, 6898; J. Am. Chem. Soc. 2016, 138, 12715, J. Am. Chem. Soc. 2016, 138, 13862; J. Am. Chem. Soc. 2016, 138, 8034; J. Org. Chem. 2016, 81, 12525, J. Org. Chem. 2015, 80, 7642). The method is then carried out in the presence of a photosensitizer (e.g., Ir and Ru complexes or organic dyes) and a metal catalyst (e.g., Ni complexes). The reaction can be carried out in the presence of ligands and, if appropriate, in the presence of a base under blue or white light irradiation.

[0592] Suitable photosensitizers include, but are not limited to, Ir(III) photocatalysts, such as [Ir(dFCF3ppy)2(bpy)]PF6 (dFCF3ppy = 2-(2,4-difluorophenyl)-5-trifluoromethylpyridine, bpy = 2,2'-bipyridine), [Ir(dFCF3ppy)2(dtbbpy)]PF6 (dtbbpy = 4,4'-di-tert-butyl-2,2'-bipyridine), Ir(ppy)2(dtbbpy)PF6 (ppy = 2-phenylpyridine), Ir(ppy)2(bpy)PF6, Ir(dFppy)3PF6 (dFCF3ppy = 2-(2,4-difluorophenyl)pyridine), and others. Ru(II) photocatalysts, such as Ru(bpy)3Cl2 or Ru(bpy)3(PF6)2; or organic dyes, such as 9-trimethyl-10-acrylamide perchlorate or tetrafluoroborate, or 2,4,5,6-tetra-9H-carbazole-9-yl-1,3-benzenedionitrile, 9-fluorenone and 9,10-phenanthrenequinone.

[0593] Suitable nickel catalysts include, but are not limited to, bis(1,5-cyclooctadiene) nickel (0), nickel chloride (II), nickel bromide (II), nickel iodide (II), nickel acetylacetonate (II), and nickel nitrate (II) hexahydrate, either in anhydrous or hydrated form or as a dimethoxyethane complex. These nickel catalysts can be used in combination with bipyridine ligands (e.g., 2,2'-bipyridine, 4,4'-di-tert-butyl-2,2'-bipyridine, 4,4'-dimethoxy-2,2'-bipyridine, 4,4'-dimethyl-2,2'-bipyridine), or o-phenanthroline (e.g., 1,10-o-phenanthroline, 4,7-dimethyl-1,10-o-phenanthroline, 4,7-dimethoxy-1,10-o-phenanthroline), or diamines (e.g., N,N,N',N'-tetramethylethylenediamine), or diketones (e.g., tetramethylheptanedione).

[0594] The methods described herein can be carried out at temperatures ranging from -105°C to 250°C, preferably from -78°C to 185°C.

[0595] The reaction time varies depending on the scale of the reaction and the reaction temperature, but it is usually between a few minutes and 48 hours.

[0596] The methods described in this article are typically performed at standard pressure. However, they can also be performed at increased or decreased pressure.

[0597] The methods described herein can optionally be performed under microwave radiation at standard or elevated pressure.

[0598] In the methods described herein, the raw materials are typically used in approximately equimolar amounts. However, a relatively large excess of a raw material may also be used.

[0599] Method for preparing compounds of formula (I)

[0600] Method A

[0601] Compounds of formula (Ia-1) (i.e., compounds of formula (I) where A is O, T is hydrogen and m is 1 or 2) can be prepared by the method shown in Scheme 1, which includes the following steps:

[0602] - When W is hydrogen, the compound of formula (4) can be treated with a dehydrating agent in the presence of a base to directly obtain the compound of formula (Ia-1);

[0603] - When W is an amino protecting group, the compound of formula (4) is optionally treated with a dehydrating agent in the presence of a base, and then a deprotection step is performed to obtain the compound of formula (Ia-1).

[0604] Scheme 1: Synthesis of compounds of formula (Ia-1) by method A

[0605]

[0606] U 1 = Hydroxyl group, halogen, C1-C6-alkoxy group

[0607] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl

[0608] m = 1 or 2

[0609] Compounds of formula (Ia-1) can be obtained by treating compounds of formula (4) with a dehydrating agent such as POCl3, P2O5, or trifluoromethanesulfonic anhydride in the presence of a base. Such methods for forming oxadiazine rings are known and documented in the literature (J. Med. Chem. 2017, 60, 2383-2400). The reaction can be carried out in any common inert organic solvent. Preferably, halogenated aliphatic, alicyclic, or aromatic hydrocarbons are used, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene, or decahydronaphthalene; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane, or trichloroethane; ethers, such as diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane, or anisole; nitriles, such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile, or benzoyl ether; and alcohols, such as ethanol or isopropanol.

[0610] When W represents an amino protecting group, step 3 is followed by an additional deprotection step using the reaction conditions described in the literature (Greene's Protective Groups in Organic Synthesis; Peter GMWuts; Wiley; 5th ed.; 2014; 895-1194). For example, the tert-butoxycarbonyl group can be removed in an acidic medium such as hydrochloric acid or trifluoroacetic acid.

[0611] The compound of formula (4) can be obtained in the following ways:

[0612] - The compound of formula (1) is reacted with an amine of formula (2) or a salt thereof to obtain the compound of formula (3);

[0613] -Removing the phthalimide group from compound (3) yields compound (4).

[0614] The reaction conditions used to remove phthalimide groups are well known and documented in the literature (Greene's Protective Groups in Organic Synthesis; Peter GMWuts; Wiley; 5th ed.; 2014; 1012-1014).

[0615] The compounds of formula (1) can be prepared by one or more methods described herein (see methods N, O and P).

[0616] The amine of formula (2) can be prepared by the method described herein.

[0617] Among them U 1 Compounds of formula (1) with a hydroxyl group can be reacted with amines of formula (2) in the presence of a condensing agent by methods described in the literature (e.g., Tetrahedron 2005, 61, 10827-10852). Examples of suitable condensing agents include, but are not limited to, chlorinating agents (e.g., phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, oxalyl chloride, or thionyl chloride), dehydrating agents (e.g., ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate, or methanesulfonyl chloride), carbodiimides (e.g., N,N'-dicyclohexylcarbodiimide (DCC)) or other conventional condensing (or peptide coupling) agents (e.g., phosphorus pentoxide, polyphosphate, bis(2-oxo-3-oxazolyl)phosphine chloride, 1- [bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU), N,N'-carbonyl-diimidazole, 2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ), triphenylphosphine / tetrachloromethane, 4-(4,6-dimethoxy[1,3,5]-triazin-2-yl)-4-methylmorpholine hydrochloride hydrate, tripyrrolidinyl phosphonium hexafluorophosphate or propylphosphonic anhydride (T3P).

[0618] Among them U 1 Compounds of formula (1) containing halogen atoms can react with amines of formula (2) in the presence of an acid-binding agent by well-known methods. Suitable acid-binding agents include any inorganic and organic bases commonly used in this reaction as described herein. Alkali metal carbonates, alkaline earth metal acetates, tertiary amines, or aromatic bases are preferred.

[0619] Among them U 1 Compounds of formula (1) that are C1-C6-alkoxy can react with an excess of an amine of formula (2), optionally in the presence of a Lewis acid (trimethylaluminum).

[0620] Method B

[0621] The compound of formula (Ia-1) (i.e., the compound of formula (I) where A is O, T is hydrogen and m is 1 or 2) can be prepared by the method shown in Scheme 2, which includes the step of reacting the compound of formula (7) with the compound of formula (8) in a base (e.g., an organic or inorganic base) and optionally in the presence of a suitable copper salt or complex.

[0622] Scheme 2: Synthesis of compounds of method B (Ia-1)

[0623]

[0624] U 1 = Hydroxyl group, halogen, C1-C6-alkoxy group

[0625] X = halogen, preferably chlorine.

[0626] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl

[0627] m = 1 or 2

[0628] The compound of formula (7) can be prepared under the same conditions described herein for method A by the following method:

[0629] - The compound of formula (5) is reacted with an amine of formula (2) or a salt thereof to obtain the compound of formula (6a);

[0630] -Removing the phthalimide group from compound (6a) yields compound (6b);

[0631] - When W is hydrogen, the compound of formula (6b) can be treated with a dehydrating agent in the presence of a base to directly obtain the compound of formula (7);

[0632] - When W is an amino protecting group, the compound of formula (6b) is optionally treated with a dehydrating agent in the presence of a base, followed by a deprotection step to obtain the compound of formula (7).

[0633] The reaction of the compound of formula (7) with the compound of formula (8) can be carried out in the presence of a transition metal catalyst (such as a copper salt or complex) and, if appropriate, in the presence of the ligands described herein.

[0634] The compound of formula (5) can be obtained commercially or prepared by the method described herein.

[0635] The compounds of formula (8) can be obtained commercially or by converting or derivatizing another compound of formula (8) according to well-known methods.

[0636] Method C

[0637] The compound of formula (Ia-1) (i.e., the compound of formula (I) where A is O, T is hydrogen and m is 1 or 2) can be prepared by the method shown in Scheme 3, which includes the step of adding a reducing agent to the compound of formula (12) under acidic conditions to obtain the compound of formula (Ia-1).

[0638] Scheme 3: Synthesis of compounds of formula (Ia-1) by method C

[0639]

[0640] R 5 = Hydrogen, hydroxyl, C1-C6-alkoxy

[0641] m = 1 or 2

[0642] The compound of formula (12) can be cyclized under acidic conditions in the presence of a reducing agent (e.g., sodium cyanoborohydride) to obtain the compound of formula (Ia-1). The reaction conditions for forming the oxadiazine ring using this method are known and described in the literature (Heterocycles 2016, 92, 2166-2200).

[0643] The compound of formula (12) can be obtained by reacting the compound of formula (10) with the compound of formula (11) in the presence of a base. Suitable bases may be alkali metal hydrides (such as sodium hydride), alkali metal carbonates (potassium carbonate), alkali metal hydroxides (such as potassium hydroxide), or phosphazene bases (such as BEMP) as described in the literature (Heterocycles 2016, 92, 2166-2200).

[0644] The compound of formula (10) can be obtained by reacting the compound of formula (9) with hydroxylamine or a salt thereof. The reaction conditions for this transformation are known and have been reported in the literature (WO2010138600).

[0645] The compound of formula (9) can be prepared by the method R described herein.

[0646] The compounds of formula (11) are commercially available or can be prepared by methods described in the literature (Eur. J. Med. Chem. 2014, 84, 302; Eur. J. Med. Chem. 2015, 100, 18-23; WO2017031325).

[0647] Method D

[0648] Compounds of formula (Ia-1) (i.e., compounds of formula (I) where A is O, T is hydrogen, L is a direct bond and m is 1 or 2) can be prepared by the method shown in Scheme 4, which includes the following steps:

[0649] - By placing the compound of formula (13) under oxidizing conditions, compound (14) is obtained;

[0650] -When R 6 -H(15) represents the C6-C group of the aromatic genus. 14 -Carbon ring, non-aromatic C7-C14 - When a carbon ring, a non-aromatic 7 to 14-membered heterocycle, or an aromatic 5 to 14-membered heterocycle is used, the compound of formula (14) is treated with the compound of formula (15) under acidic conditions to form the compound of formula (Ia-1).

[0651] -When R 6 -H(15) is an alcohol (R) 6’ -O)-H or thiols (R) 6’ When using -S)-H derivatives, the compound of formula (14) is treated with a halogenating agent (such as SOCl2) and a compound of formula (15) to form R. 6 Compounds of formula (Ia-1) representing oxygen, alkoxy, or thiol groups.

[0652] Scheme 4: Compounds of method D (Ia-1)

[0653]

[0654] L = direct key

[0655] R 6 =Fang C6-C 14 -Carbon ring, non-aromatic C7-C 14 -Carbon rings, non-aromatic 7- to 14-membered heterocycles, aromatic 5- to 14-membered heterocycles, aromatic C6-C 14 -Carbon epoxy group, non-aromatic C6-C 14 -Carbon epoxy groups, non-aromatic 3- to 14-membered heteroepoxy groups, aromatic 5- to 14-membered heteroepoxy groups, non-aromatic C3-C 12 -Carbocyclic sulfinyl group, aromatic C6-C 14 -Carbocyclic sulfinyl group, aromatic 5- to 14-membered heterocyclic sulfinyl group, non-aromatic 5- to 14-membered heterocyclic sulfinyl group, non-aromatic C3-C 12 -Carbocyclic sulfonyl group, aromatic C6-C 14 -Carbocyclic sulfonyl group, aromatic 5- to 14-membered heterocyclic sulfonyl group, non-aromatic 5- to 14-membered heterocyclic sulfonyl group, non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-alkoxy groups, aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy, non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-alkoxy, aromatic 5- to 14-membered heterocyclic substituted C1-C3-alkoxy, non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-haloalkoxy groups, aromatic C6-C 14 -Carbocyclic substituted C1-C3-haloalkoxy, non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-haloalkoxy, aromatic 5- to 14-membered heterocyclic substituted C1-C3-haloalkoxy, non-aromatic C3-C 12-Carbocyclic substituted C1-C3-thioalkyl, aromatic C6-C 14 -Carbocyclic substituted C1-C3-thioalkyl, non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-thioalkyl, and aromatic 5- to 14-membered heterocyclic substituted C1-C3-thioalkyl,

[0656] m = 1 or 2

[0657] Compounds of formula (14) can react with aromatic C6-C compounds under acidic conditions. 14 -Carbon ring, non-aromatic C7-C 14 -Carbon rings, non-aromatic 7- to 14-membered heterocycles, or aromatic 5- to 14-membered heterocycles (R 6 The reaction proceeds by -H) to obtain the compound of formula (Ia-1). The reaction conditions for forming the oxadiazine ring using this method are known and described in the literature (WO2017031325).

[0658] The compound of formula (14) can be obtained from the compound of formula (13) under oxidizing conditions, for example in the presence of osmium trioxide and sodium periodate.

[0659] The compound of formula (13) can be prepared by the method R described herein.

[0660] Method E

[0661] Compounds of formula (Ia-1) (i.e., compounds of formula (I) where A is O, T is hydrogen, and m is 1 or 2) can be prepared by the method shown in Scheme 5, which includes the following steps:

[0662] - The compound of formula (18) is reacted with the compound of formula (19) or a salt thereof to obtain the compound of formula (20).

[0663] -When E 1 When the hydroxyl group is used, the compound of formula (20) is converted into the compound of formula (Ia-1) using the Mitsunobu reaction conditions.

[0664] -When E 1 When the halogen is present, the compound of formula (20) is converted into the compound of formula (Ia-1) in the presence of a base.

[0665] Scheme 5: Synthesis of compounds of method E-form (Ia-1)

[0666]

[0667] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl

[0668] E 1 = Hydroxyl or halogen

[0669] E 2 =Hydroxy

[0670] m = 1 or 2

[0671] Formula (19-a,E 1 Amino alcohols with a hydroxyl group are commercially available or can be prepared by methods described in the literature (Molecules, 9(6), 405-426; 2004; WO2017203474). Formula (19-b, E 1 =A halogen) compound or a salt thereof can be obtained from the corresponding amino alcohol by well-known methods.

[0672] When E 1 When the hydroxyl group is present, the compound of formula (20) can be converted into the compound of formula (Ia-1) by step 4 of the method using typical Mitsunobu reaction conditions known to those skilled in the art (Strategic Applications of Named Reactions in Organic Synthesis; Laszlo Kürti, Barbara Czako; Elsevier; 2005; 294-295 and references therein).

[0673] When E 1 When the base is halogen, the compound of formula (20) can be converted into the compound of formula (Ia-1) by step 4 of the method in the presence of the base described herein.

[0674] When W represents an amino protecting group, an additional deprotection step is performed after step 4 using the reaction conditions described in the literature (Greene's Protective Groups inorganic Synthesis; Peter GMWuts; Wiley; 5th edition; 2014; 895-1194) to obtain the compound of formula (Ia-1).

[0675] The compound of formula (18) can be treated with the compound of formula (19) or one of its salts in the presence of a base (e.g., triethylamine) to form the compound of formula (20).

[0676] The compound of formula (18) can be obtained by step 2 of the method by treating the oxime of formula (17) with a halogenating agent (e.g., NCS). The reaction conditions for such conversion have been reported in the literature (WO2013173672; RSC Advances2015,5,58587-58594).

[0677] The oxime of formula (17) can be obtained from the aldehyde of formula (16) in the presence of hydroxylamine or a salt thereof, optionally in the presence of a base, via step 1. Such transformations are known and have been reported in the literature (Tetrahedron 2000, 56, 1057-1064; ChemMedChem 2013, 8, 1210-1223).

[0678] The aldehyde of formula (16) can be prepared according to methods well known to those skilled in the art; for example, by treating the weinreb amide precursor with DIBAL-H (WO2016045591) or by converting the ester precursor to a primary alcohol and then oxidizing the alcohol to the corresponding aldehyde (WO199850031). The ester precursor for obtaining this aldehyde can be prepared according to the methods described herein using N, O, and P.

[0679] Method F

[0680] Compounds of formula (Ia-1) (i.e., compounds of formula (I) where A is O, T is hydrogen, and m is 1 or 2) or compounds of formula (Ia-2) (i.e., compounds of formula (I) where A is NH, T is hydrogen, and m is 1 or 2) can be prepared by the method shown in Scheme 6, the method comprising the following steps:

[0681] - Under similar conditions as described in Method A, the compound of formula (1) is reacted with an amine of formula (19) or a salt thereof to obtain the compound of formula (21).

[0682] - Treating the compound of formula (21) with a dehydrating agent, followed by treatment with hydroxylamine or hydrazine, yields the compound of formula (20).

[0683] -When E 1 and E 2 When the hydroxyl group is used, the compound of formula (20) is converted into the compound of formula (Ia-1) using the Mitsunobu reaction conditions.

[0684] -When E 1 It is halogen and E 2 When the hydroxyl group or -NH2 is present, the compound of formula (20) is converted into the compound of formula (Ia-1) or (Ia-2) in the presence of a base.

[0685] Scheme 6: Synthesis of compounds of formula (Ia-1) and (Ia-2) by method F

[0686]

[0687] U 1 = Hydroxyl group, halogen, C1-C6-alkoxy group

[0688] E 1 = Hydroxyl or halogen

[0689] E 2 =Hydroxy or -NH2

[0690] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl

[0691] m = 1 or 2

[0692] Steps 2 and 3 of method F can be carried out under similar reaction conditions as described in method E.

[0693] Formula (19-a,E 1 Amino alcohols with a hydroxyl group are commercially available or can be prepared by methods described in the literature (Molecules, 9(6), 405-426; 2004; WO2017203474). Formula (19-b, E 1 =A halogen) compound or a salt thereof can be obtained from the corresponding amino alcohol by well-known methods.

[0694] Method G

[0695] Compounds of formula (Ia-1) (i.e., compounds of formula (I) where A is O, T is hydrogen, and m is 1 or 2) or compounds of formula (Ia-2) (i.e., compounds of formula (I) where A is NH, T is hydrogen, and m is 1 or 2) can be prepared by the method shown in Scheme 7, the method comprising the following steps:

[0696] - Under similar conditions as described in Method A, the compound of formula (5) is reacted with the amine of formula (19) to obtain the compound of formula (22).

[0697] - Treat the compound of formula (22) with a dehydrating agent, and then treat it with hydroxylamine or hydrazine to form the compound of formula (23).

[0698] -When E 1 and E 2 When the hydroxyl group is used, the compound of formula (23) is converted into the compound of formula (7) using the Mitsunobu reaction conditions.

[0699] -When E 1 It is halogen and E 2 When the hydroxyl group or -NH2 is present, the compound of formula (23) is converted into the compound of formula (7) or (24) in the presence of a base.

[0700] - The compound of formula (7) or (24) is reacted with the compound of formula (8) in the presence of a base (e.g., an organic or inorganic base) and optionally in the presence of a suitable copper salt or complex to give the compound of formula (Ia-1) or (Ia-2).

[0701] Scheme 7: Synthesis of compounds of formula (Ia-1) and (Ia-2) by method G

[0702]

[0703] U 1 = Hydroxyl group, halogen, C1-C6-alkoxy group

[0704] X = halogen, preferably chlorine.

[0705] E 1 = Hydroxyl or halogen

[0706] E 2 =Hydroxy or -NH2

[0707] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl; m = 1 or 2.

[0708] Method H

[0709] Compounds of formula (Ia-1) (i.e., compounds of formula (I) where A is O, T is hydrogen and m is 1 or 2), and compounds of formula (Ia-3) (i.e., compounds where A is CR). 1 R 2 Compounds of formula (I) in which T is hydrogen and m is 1 or 2, compounds of formula (Ia-4) in which A is C (=O), T is hydrogen and m is 1 or 2, or compounds of formula (Ia-5) in which A is S (=O)2, T is hydrogen and m is 1 or 2, can be prepared by the method shown in Scheme 8, which includes the following steps:

[0710] - Treating the compound of formula (9) with an alkoxide yields the compound of formula (25).

[0711] - The compound of formula (25) is reacted with an amine of formula (26a-1), (26a-2), (26a-3) or (26a-4), respectively.

[0712] Scheme 8: Synthesis of compounds of method H-form (Ia-1), (Ia-3), (Ia-4) or (Ia-5)

[0713] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl

[0714] Y = C1-C6-alkyl

[0715] m = 1 or 2

[0716] Alternatively, compounds of formula (Ia-5) can be prepared by treating pyridazine 4-formamidinium compounds with trans-styrenesulfonyl chloride, similar to the method described in the literature (J.Org.Chem.1974,39,3080).

[0717] The compound of formula (25) can be obtained by treating the compound of formula (9) with an alkoxide (such as sodium methoxide or sodium ethoxide) according to the method described in the literature (Heterocycles, 34, 1992, 929-935).

[0718] Compounds of formula (25) are treated and cyclized under acidic conditions with compounds of formulas (26-a-1), (26-a-2), (26-a-3), or (26-a-4) to form compounds of formulas (Ia-1), (Ia-3), (Ia-4), or (Ia-5), respectively. Reaction conditions for such transformations based on this method are described in the literature (Heterocycles 2016, 92, 2166-2200).

[0719] Amines of formula (26-a-1), (26-a-2), (26-a-3), or (26-a-4) are commercially available or can be prepared by the methods described in the literature (Molecules, 9(6), 405-426; 2004, WO2017203474; J. Med. Chem 1985, 28, 694-698; J. Med. Chem 2006, 49, 4333-4343) and by method S of the present invention.

[0720] Method I

[0721] Compounds of formula (Ia-6) (i.e., compounds of formula (I) where A is O, T is hydrogen and m is 2) can be prepared by the method shown in Scheme 9, which includes the following steps:

[0722] - In the presence of a suitable base as described herein, the compound of formula (9) was treated with a hydroxylamine derivative (27) to obtain the compound of formula (28).

[0723] - In the presence of a metal catalyst and a suitable ligand, the compound of formula (28) is reacted with the reagent of formula (29) to obtain the compound of formula (30).

[0724] - Treating a compound of formula (30) with iodine and benzylsilane forms a compound of formula (Ia-6).

[0725] Scheme 9: Synthesis of compounds of method I - formula (Ia-6)

[0726]

[0727] X = Halogen

[0728] R 6 =Fang C6-C 14 -Carbon rings, 5- or 6-membered monocyclic aromatic heterocycles, non-aromatic C3-C 12 -Carbon rings, non-aromatic 3 to 14-membered heterocycles

[0729] The reagents in formula (27) are commercially available or can be prepared by methods described in the literature (WO2010099279).

[0730] The reagents in formula (29) are commercially available or can be prepared by known methods.

[0731] Method J

[0732] Compounds of formula (Ia-7) (i.e., where A is CR) 1 R 2 The compound of formula (I) with T being hydrogen and m being 0 can be prepared by the method shown in Scheme 10, which includes the step of reacting the compound of formula (I) with the diamine of formula (31).

[0733] Scheme 10: Synthesis of imidazoline according to method J-form (Ia-7)

[0734]

[0735] U 1 =Hydroxy, halogen

[0736] Method J can be carried out in the presence of a dehydrating agent (such as POCl3).

[0737] The diamine of formula (31) can be obtained commercially or prepared by methods described in the literature (Eur. J. Med. Chem 1990, 25(1), 35-44; J. Org. Chem 2012, 77(9), 4375-4384; WO2009003867).

[0738] Method K

[0739] The compound of formula (Ia) can be converted into the corresponding compound (Ib) or (Ic) in one or more steps shown in Scheme 11 by the methods described in the literature.

[0740] Scheme 11: Synthesis of compounds of formula (Ib) and (Ic) by method K

[0741]

[0742] R 7a = Hydrogen or halogen (preferably chlorine)

[0743] R 7b = Hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R) e )2、-C(=O)(OR g )

[0744] R 7c =Nitro, Formyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-hydroxyalkyl, C1-C6-fluoroalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, -C(=NR) f )R f -C(=O)N(R) g )2、-S(=O)(=NR g )R g -S(=O)2N(R) g )2

[0745] In scheme 11, R e R f R g As described in this article, and with aliphatic and cyclic substituents R 7b R 7c R e R f R g It can be replaced as described in this article.

[0746] The following provides a non-limiting embodiment based on scheme 11.

[0747] Where R 7a Compounds of formula (Ia) containing a chlorine atom can be converted to compounds containing R by methods described in the literature (e.g., WO2016185342, WO2007022937). 7b Compounds of formula (Ib) containing bromine or iodine atoms.

[0748] Where R 7aCompounds of formula (Ia) containing halogen atoms can be converted to compounds containing halogen atoms in the presence of a palladium catalyst, as reported in the literature (Journal of Molecular Catalysis A: Chemical, 2014, 393, 191-209). 7b Compounds of formula (Ib) containing hydrogen atoms.

[0749] Where R 7a Compounds of formula (Ia) containing hydrogen or halogen atoms can be converted into compounds containing R by the transition metal catalysis or metal photoredox catalysis methods described herein. 7b Cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R) e )2 or -C(=O)(OR g Compounds of formula (Ib).

[0750] Where R 7b Compounds of formula (Ib) with C2-C6-alkenyl groups substituted with C1-C3-alkoxy groups can be converted to compounds in which R is derived by methods described in the literature (e.g., J. Org. Chem. 1993, 55, 3114). 7c Compounds of formula (Ic) with a C1-C6-alkyl carbonyl group.

[0751] Where R 7c Compounds of formula (Ic) with a C1-C6 alkyl carbonyl group can be further converted to compounds in which R is derived by methods described in the literature (e.g., Greene's Protective groups in organic Synthesis; Peter GMWuts; Wiley; 5th ed.; 2014; 655, 661, 667). 7c -C(=NR) f Compounds of formula (Ic) with alkyl group (C1-C6).

[0752] Where R 7c Compounds of formula (Ic) with C1-C6 alkyl carbonyl groups can be further transformed into compounds with R by classical functional group interchange (e.g., reduction of a ketone to an alcohol in the presence of NaBH4 in MeOH). 7c Compounds of formula (Ic) that are C1-C6-hydroxyalkyl.

[0753] Where R 7c Compounds of formula (Ic) that are C1-C6-hydroxyalkyl can be further converted in the presence of a fluorinating agent to form R. 7c Compounds that are C1-C6-fluoroalkyl (Ic). Non-limiting examples of fluorinating agents include sulfur fluorides, such as sulfur tetrafluoride, diethylaminosulfur trifluoride, sulfomorpholine trifluoride, bis(2-methoxyethyl)aminosulfur trifluoride, 2,2-difluoro-1,3-dimethylimidazolidine, or 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride.

[0754] The compounds of formula (Ia) can be prepared by one or more methods described herein.

[0755] Method L

[0756] The compound of formula (Ia) can be converted into the corresponding compound of formula (Id) or compound of formula (Ie) by one or more steps shown in Scheme 12 using the methods described in the literature.

[0757] Scheme 12: Synthesis of compounds of formula (Id) and (Ie) by method L

[0758]

[0759] R 7 = halogen

[0760] R 8a = Halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbon rings, 5 to 14-membered aromatic heterocycles, 3 to 14-membered non-aromatic heterocycles;

[0761] R 8b = Halogen, cyano, nitro, amino, mercapto, hydroxyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic 5- to 14-membered heterocycles, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbocyclic oxy group, non-aromatic 3- to 14-membered heterocyclic oxy group, aromatic 5- to 14-membered heterocyclic oxy group, -N(R h )2、-SR i -S(=O)R i and -S(=O)2R i;

[0762] R h and R i As described in this article, and with aliphatic and cyclic substituents R 8a and R 8b It can be replaced as described in this article.

[0763] The following provides a non-limiting embodiment based on scheme 12.

[0764] Compounds of formula (Ia) can be converted to R in the presence of a base and an electrophile (e.g., NCS, NBS, NIS, hexachloroethane, bromine, or iodine) by methods described in the literature (e.g., Org. Lett. 2009, 11, 1837). 8a Compounds of formula (Id) containing halogen atoms. Suitable bases for the method may be selected from lithium diisopropylamino, lithium 2,2,6,6-tetramethylpiperidine, lithium n-butyllithium, methyllithium, TMPZnCl·LiCl, TMP2Zn·2MgCl2·2LiCl (see, for example, Dissertation Albrecht Metzer 2010, University Munich).

[0765] The compound of formula (Ia) can optionally be converted to R in the presence of a base, and, where appropriate, in the presence of a transition metal catalyst (such as the metal salt or complex and ligand described herein) or by the method described in the literature (Heterocycles 1976, 4(8), 1331). 8a It is a C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, or aromatic C6-C 14 Compounds of formula (Id) consisting of a carbon ring, a 5- to 14-membered aromatic heterocycle, or a 3- to 14-membered non-aromatic heterocycle.

[0766] Where R 8a Compounds of formula (Id) containing halogen atoms can be converted in the presence of a base and optionally a transition metal catalyst (such as a metal salt or complex), and if appropriate, in the presence of a ligand, to form a compound in which R... 8b Representing cyano, nitro, amino, mercapto, hydroxyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenoxy, C2-C6-haloalkenoxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic 5- to 14-membered heterocycles, C3-C8-cycloalkyloxy, aromatic C6-C 14-Carbocyclic oxy group, non-aromatic 3- to 14-membered heterocyclic oxy group, aromatic 5- to 14-membered heterocyclic oxy group, -N(R h )2 or SR i Compounds of formula (Ie).

[0767] Where R 8b Compounds of formula (Ie) with a C2-C6-olefinic group can be further converted to compounds of formula (Ie) by reacting them with a nucleophile based on oxygen, sulfur, or amino groups. 8b Compounds of formula (Ie) that are C1-C6-alkyl, wherein the C1-C6-alkyl group is converted by C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, non-aromatic 3- to 7-membered monocyclic heterocycles, and -N(R) a’ )2 replaces, where R a’ It is independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C3-C8-cycloalkyl.

[0768] Where R 8b For SR i Compounds of formula (Ie) can be further converted into compounds of formula (Ia-8) by reacting the starting compound with an oxidizing agent (such as hydrogen peroxide). 8b -S(=O)R i or -S(=O)2R i Compounds with the formula (Ia-8) of the group.

[0769] The compounds of formula (Ia) can be prepared by one or more methods described herein.

[0770] Method M

[0771] The compound of formula (If) (i.e., where T is -C(=O)R) a1 -C(=O)(OR) a1 -C(=O)N(R) a2 )2、-S(=O)R a1 -S(=O)2R a1 and -S(=O)2N(R a2 Equation (I) of 2, where R a1 and R a2 As described herein, the compound (Ia) can be prepared by the method shown in Scheme 13, which includes the step of reacting the compound of formula (Ia) with the compound of formula (32).

[0772] Scheme 13: Synthesis of compounds of method M (If)

[0773]

[0774] W = halogen, -OC (=O)(OR) a1 ), -O-(C=O)R a1 or -OS(=O)2R a1 , where R a1 Selected from C1-C6-alkyl and C1-C6-haloalkyl

[0775] T = -C(=O)R a1 -C(=O)(OR) a1 -C(=O)N(R) a2 )2、-S(=O)R a1 -S(=O)2R a1

[0776] and -S(=O)N(R) a2 )2, where R a1 and R a2 As described in this article.

[0777] Method M can be prepared by methods described in the literature (e.g., Tetrahedron Lett. 1995, 36, 8949; Greene's Protective Groups in organic Synthesis; Peter GMWuts; Wiley; 5th ed.; 2014; 1174-1175).

[0778] The compound of formula (32) is commercially available.

[0779] The compounds of formula (Ia) can be prepared by one or more methods described herein.

[0780] Method for preparing compounds of formula (1)

[0781] The compounds of formula (1) described herein can be obtained directly by performing the method N described below, or by transforming or derivatizing another compound of formula (1) prepared according to the method described herein. The compounds of formula (1-a)-(1-e) are various subsets of formula (1).

[0782] Method N

[0783] Compounds of formula (1-a) (i.e., where R) 7 and R 8 Formula (1) as defined in Scheme 14 can be prepared in the presence of a base by a method as shown in Scheme 14, the method comprising the step of reacting a compound of formula (5) with a reagent of formula (8).

[0784] Scheme 14: Method N - Preparation of compounds (1-a) and (1-b)

[0785]

[0786] U 1 =C1-C6-alkoxy

[0787] U 2 =Hydroxyl group, halogen, -N(CH3)OCH3

[0788] X = Halogen

[0789] R 8 = Hydrogen, C1-C6-alkyl

[0790] R 7 = Hydrogen, halogen, hydroxyl, mercapto, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenoxy, C2-C6-haloalkenoxy, C2-C6-alkynoxy, C2-C6-haloalkynoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbon epoxy group, aromatic 5- or 6-membered monocyclic heterocyclic oxy group, non-aromatic 3- to 7-membered monocyclic heterocyclic oxy group, -N(R e )2

[0791] In scheme 14, R e As stated in this article and R 7 R 8 and R e It can be replaced as described in this article.

[0792] Method N can be carried out in the presence of a suitable transition metal catalyst salt or complex, and, if appropriate, in the presence of a ligand.

[0793] The obtained compound of formula (1-a) can then be converted into the compound of formula (1-b) in one or more steps.

[0794] Non-limiting examples of this transformation are described below.

[0795] Among them U 1 Compounds of formula (1-a) with C1-C6-alkoxy groups can be converted to those with U by well-known functional group interchange methods (e.g., by hydrolyzing the ester group in THF / water with LiOH). 2 Compounds of formula (1-b) with hydroxyl groups.

[0796] Among them U 2Compounds of formula (1-b) with a hydroxyl group can be converted to U in the presence of a halogenating agent by well-known methods. 2 The compound is a halogen of formula (1-b). Suitable halogenating agents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, oxalyl chloride, or thionyl chloride.

[0797] Among them U 2 Compounds of formula (1-b) that are hydroxyl or halogen can be converted to U by well-known methods. 2 The compound of formula (1-b) is -N(CH3)OCH3.

[0798] The compound of formula (5) is commercially available or can be prepared by the method described herein.

[0799] The compounds of formula (8) are commercially available, or can be obtained by transforming or derivatizing another compound of formula (8) using well-known methods.

[0800] Method O

[0801] Compounds of formula (1-c) (i.e., where R) 7 R as defined in Scheme 15 7a Formula (1) can be converted into a compound of the corresponding formula (1-d) by one or more steps using known methods as shown in Scheme 15 (i.e., where R 7 R as defined in Scheme 15 7b Compounds of formula (1) or (1-e) (i.e., where R 7 R as defined in Scheme 15 7c Equation (1)).

[0802] Scheme 15: Method O - Preparation of compounds (1-d) and (1-e)

[0803]

[0804] U 1 =C1-C6-alkoxy

[0805] R 7a = Hydrogen or halogen (preferably chlorine)

[0806] R 7b = Hydrogen, halogen, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14-Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, non-aromatic 3- to 7-membered monocyclic heterocycles, -N(R) e )2、-C(=O)(OR g )

[0807] R 7c =Nitro, Formyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-hydroxyalkyl, C1-C6-fluoroalkyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, -C(=NR) f )R f -C(=O)N(R) g ) 2、 -S(=O)(=NR g )R g -S(=O)2N(R) g )2

[0808] In scheme 15, R e R f R g As described in this article, and with aliphatic and cyclic substituents R 7b R 7c R e R f R g It can be replaced as described in this article.

[0809] Non-limiting embodiments of the transformation can be carried out according to the description provided in method K.

[0810] The obtained compounds of formulas (1-d) and (1-e) can then be converted into U. 1 Compounds of formulas (1-d) and (1-e) in which (C1-C6-alkoxy) is replaced by a hydroxyl group or a halogen.

[0811] Examples of this transformation are described below.

[0812] Among them U 1 Compounds of formula (1-c), (1-d), (1-e) with C1-C6-alkoxy groups can be converted to their U-forms by well-known functional group interchange methods (e.g., hydrolysis of the ester group with LiOH in THF / water). 1 Compounds of formulas (1-b), (1-c), and (1-d) whose hydroxyl groups are replaced.

[0813] Then, where U 1Compounds of formula (1-c), (1-d), and (1-e) with hydroxyl groups substituted can be further converted into compounds of formula (1-b), (1-c), and (1-d) in the presence of a halogenating agent by well-known methods. Suitable halogenating agents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, oxalyl chloride, or thionyl chloride.

[0814] Among them U 1 Compounds of formula (1-c), (1-d), (1-e) that are hydroxyl or halogen can be converted to U by well-known methods. 1 Compounds of formula (1-c), (1-d), and (1-e) of type -N(CH3)OCH3.

[0815] Compounds of formula (1-c) can be prepared by one or more methods described herein.

[0816] Method P

[0817] Compounds of formula (1-f) (i.e., where R) 8 The compound of formula (1) with H can be converted into the corresponding compound of formula (1-g) in one or more steps by the method described in the literature, as shown in Scheme 16 (i.e., where R 8 R as defined in Scheme 16 8a Compounds of formula (1) or formula (1-h) (i.e., where R) 8 R as defined in Scheme 16 8b Equation (1)).

[0818] Scheme 16: Method P-compound (1-g) and (1-h) preparation

[0819]

[0820] U 1 =C1-C6-alkoxy

[0821] R 8a = Halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbon rings, 5 to 14-membered aromatic heterocycles, 3 to 14-membered non-aromatic heterocycles;

[0822] R 8b= Halogen, cyano, nitro, amino, mercapto, hydroxyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic 5- to 14-membered heterocycles, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbocyclic oxy group, non-aromatic 3- to 14-membered heterocyclic oxy group, aromatic 5- to 14-membered heterocyclic oxy group, -N(R h )2、-SR i -S(=O)R i and -S(=O)2R i

[0823] In scheme 16, R h and R i As described in this article, and with aliphatic and cyclic substituents R 8a and R 8b It can be replaced as described in this article.

[0824] Non-limiting embodiments of the transformation can be carried out according to the description provided in method L.

[0825] The obtained compounds of formulas (1-f) and (1-g) can then be converted into U. 1 Compounds of formulas (1-f) and (1-g) in which (C1-C6-alkoxy) is replaced by a hydroxyl group or a halogen.

[0826] Among them U 1 Compounds of formula (1-f), (1-g), (1-h) with C1-C6-alkoxy groups can be converted to their U-forms by well-known functional group interchange methods (e.g., hydrolysis of the ester group with LiOH in THF / water). 1 Compounds of formulas (1-f), (1-g), and (1-h) whose hydroxyl groups are replaced.

[0827] Then, where U 1 Compounds of formula (1-f), (1-g), and (1-h) with hydroxyl groups replaced can be further converted into compounds of formula (1-f), (1-g), and (1-h) in the presence of a halogenating agent by well-known methods. Suitable halogenating agents include, but are not limited to, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, oxalyl chloride, or thionyl chloride.

[0828] Among them U 1 Compounds of formula (1-f), (1-g), (1-h) that are hydroxyl or halogen can be converted into U by well-known methods. 1Compounds of formula (1-f), (1-g), and (1-h) of type -N(CH3)OCH3.

[0829] Compound (1-f) can be prepared by one or more of the methods described herein.

[0830] Method for preparing compounds of formula (5)

[0831] The compounds of formula (5) as described herein are commercially available or can be obtained directly by the following method Q. The compounds of formulas (5-a) and (5-b) are various subsets of formula (5).

[0832] Method Q

[0833] Compounds of formula (5-a) (i.e., where R) 7 Compounds of formula 5 that are halogens can be converted, optionally in the presence of a base, to compounds of formula (5-b) by known methods (WO2000044755) in the presence of a nucleophile based on oxygen (ethanol), sulfur (thioethyl), or amino (methylamine). 7 As shown in Scheme 17, the compound of Formula 5), ​​as shown in Scheme 17.

[0834] Scheme 17: Preparation of compound (5-b) by method Q

[0835]

[0836] U 1 =C1-C6-alkoxy

[0837] X = Halogen

[0838] R 8 = Hydrogen, C1-C6-alkyl

[0839] R 7 = Halogen, hydroxyl, mercapto, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-enoxy, C2-C6-haloenoxy, C2-C6-alkynoxy, C2-C6-haloalkynoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbocyclic oxy group, aromatic 5- or 6-membered monocyclic heterocyclic oxy group, non-aromatic 3- to 7-membered monocyclic heterocyclic oxy group, -N(R e )2; where R e As described in this article, and where R 7 and R e It can be replaced as described in this article.

[0840] The compounds of formulas (5-a) and (5-b) can be converted to the form in which U is derived using the same conditions described in method N. 1 Compounds of formulas (5-a) and (5-b) in which (C1-C6-alkoxy) is replaced by a hydroxyl group or a halogen.

[0841] The raw materials for formula (5-a) are commercially available.

[0842] Methods for preparing compounds of formulas (9) and (13)

[0843] Compounds of formula (9) can be obtained by performing the method R described below, or by transforming or derivatizing another compound of formula (9-a) prepared according to the methods described herein. Compounds of formulas (9-a) and (9-b) are various subsets of formula (9).

[0844] Method R

[0845] The compound of formula (9-a) can be converted into the corresponding compound (13) in one or more steps by the method described in the literature as shown in Scheme 18.

[0846] Scheme 18: Preparation of method R-compounds (9-a), (9-b) and (13)

[0847]

[0848] X = Halogen

[0849] R 8 = Hydrogen, C1-C6-alkyl

[0850] R 7 = Halogen, hydroxyl, mercapto, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-enoxy, C2-C6-haloenoxy, C2-C6-alkynoxy, C2-C6-haloalkynoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkylthioalkyl, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbon epoxy group, aromatic 5- or 6-membered monocyclic heterocyclic oxy group, non-aromatic 3- to 7-membered monocyclic heterocyclic oxy group, -N(R e )2; where R e As described in this article, and where R 7 and R e It can be replaced as described in this article.

[0851] The compounds of formula (33) are commercially available or can be prepared by methods described in the literature (Chemical & Pharmaceutical Bulletin 1977, 25(8), 1856-61).

[0852] The compound of formula (33) can be converted into the compound of formula (9-a) in the presence of the reagent of formula (8) and the base (e.g., an organic or inorganic base) described herein, according to step 1 of method R.

[0853] Non-restrictive examples of the transformations from (9-a) to (9-b) can be made according to scheme 18.

[0854] For example, a compound of formula (9-a) can be further converted into a compound of formula (9-b) by reacting a compound of formula (9-a) with a nucleophile based on oxygen, sulfur, or amino, wherein R 7 The radicals are hydroxyl, mercapto, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-enoxy, C2-C6-haloenoxy, C1-C6-alkylthioalkyl, C1-C6-haloalkylthioalkyl, C3-C8-cycloalkyloxy, and aromatic C6-C. 14 -Carbon epoxy group, aromatic 5- or 6-membered monocyclic heterocyclic oxy group, non-aromatic 3- to 7-membered monocyclic heterocyclic oxy group, -N(R e )2.

[0855] The compound of formula (9-a) can be converted into the compound of formula (9-b) by the transition metal catalysis or metal photo-redox method described herein, wherein R 7 It is cyano, C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-ynyl, C2-C6-haloynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbon rings, aromatic 5- or 6-membered monocyclic heterocycles, and non-aromatic 3- to 7-membered monocyclic heterocycles.

[0856] The intermediate of formula (13) can be obtained by treating the compound of formula (9) with the compound of formula (34) in the presence of a base using a well-known method in step 3 of method R.

[0857] The compound of formula (8) can be obtained commercially or by transforming or derivatizing another compound of formula (8) using well-known methods.

[0858] Methods for preparing compounds of formula (2), -(19), -(26-a-1)

[0859] Method S

[0860] The compounds of formula (35) can be converted into the corresponding compounds (2), (19-a), (19-b) and (26-a-1) in one or more steps by the methods described in the literature as shown in Scheme 19.

[0861] Scheme 19: Preparation of method S-compounds (2), (19-a), (19-b), (26-a-1)

[0862]

[0863] W = hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl

[0864] The amino alcohol of formula (35) is commercially available or can be prepared by methods described in the literature (Molecules, 9(6), 405-426; 2004, WO2017203474).

[0865] The compound of formula (19-a) was obtained by protecting the amino functional group of compound 35 according to known methods.

[0866] Then, the compound of formula (19-a) can be converted into the compound of formula (2) by step 2 of method S using typical Mitsunobu reaction conditions known to those skilled in the art (Strategic Applications of Named Reactions in Organic Synthesis; Laszlo Kürti, Barbara Czako; Elsevier; 2005; 294-295 and references therein).

[0867] The compound of formula (2) can be converted into the compound of formula (26-a-1) by well-known methods.

[0868] intermediate

[0869] The present invention also relates to intermediates for the preparation of compounds of formula (I).

[0870] Therefore, this invention relates to compounds of formula (1):

[0871]

[0872] in

[0873] Q, R 7 and R 8 As described in this article,

[0874] U 1 It is a hydroxyl group, halogen, C1-C6-alkoxy group, or -N(CH3)OCH3, R 7 R 8 As described herein and not simultaneously representing hydrogen and methyl, provided that the compound of formula (1) is not:

[0875]

[0876]

[0877] This invention also relates to compounds of formula (2):

[0878]

[0879] in

[0880] L, R 5 R 6 As described in this article,

[0881] R 3 R 4 Represents hydrogen, halogen, or C1-C6-alkyl or R 3 and R 4 Together with the carbon atoms they are attached to, they form C3-C8-cycloalkyl groups.

[0882] m is 1

[0883] and

[0884] W represents hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl.

[0885] The condition is that the compound in formula (2) is not:

[0886]

[0887] tert-butyl carbamate

[0888] This invention also relates to compounds of formula (3):

[0889]

[0890] in

[0891] Q, L, R 3 R 4 R 5 R 6 R 7 and R 8 As defined in this article,

[0892] m is 1 or 2

[0893] and

[0894] W represents hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl.

[0895] This invention also relates to compounds of formula (4):

[0896]

[0897] in

[0898] Q, L, R 3 R 4 R 5 R 6 R 7 and R 8 As defined in this article,

[0899] m is 1 or 2

[0900] and

[0901] W represents hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl.

[0902] The present invention also relates to compounds of formulas (6a) and (6b):

[0903]

[0904] in

[0905] Q, L, R 3 R 4 R 5 R 6 R 7 and R 8 As defined in this article,

[0906] m is 1 or 2

[0907] W represents hydrogen, tert-butoxycarbonyl, benzyl, allyl, or (4-methoxyphenyl)methyl, and

[0908] X represents halogen.

[0909] This invention also relates to compounds of formula (7):

[0910]

[0911] in

[0912] Q, L, R 3 R 4 R 5 R 6 R 7 and R 8 As defined in this article,

[0913] m is 1 or 2

[0914] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl, and

[0915] X represents halogen.

[0916] This invention also relates to compounds of formula (9):

[0917]

[0918] in

[0919] Q, R 7 and R 8 As defined in this article,

[0920] The condition is R 7 and R 8 Compounds that are not simultaneously hydrogen, methyl, or ethyl and that have formula (9) are not:

[0921]

[0922] This invention also relates to compounds of formula (10):

[0923]

[0924] Q, R 7 and R 8 As defined in this article,

[0925] The condition is R 7 and R 8 Compounds that are not simultaneously hydrogen or methyl and have formula (10) are not:

[0926]

[0927] This invention also relates to compounds of formula (12):

[0928]

[0929] Among them, Q, L, R 3 R 4 R 6 R 7 and R 8 As defined in this article and

[0930] m is 1 or 2.

[0931] This invention also relates to compounds of formula (13):

[0932]

[0933] Among them, Q and R 3 R 4 R 5 R 7 and R 8 As defined in this article and

[0934] m is 1 or 2.

[0935] This invention also relates to compounds of formula (14):

[0936]

[0937] Among them, Q and R 3 R 4 R 5 R 7 R 8 As defined in this article and

[0938] m is 1 or 2.

[0939] This invention also relates to compounds of formula (16):

[0940]

[0941] Among them, Q and R 7 and R 8 As defined in this article.

[0942] The present invention also relates to compounds of formula (17):

[0943]

[0944] Among them, Q and R 7 and R 8 As defined in this article.

[0945] This invention also relates to compounds of formula (18):

[0946]

[0947] Among them, Q and R 7 and R 8 As defined in this article.

[0948] The present invention also relates to compounds of formula (19) and their salts, solvates or salts of solvates thereof:

[0949]

[0950] in

[0951] m is 1,

[0952] L represents -CH2- or -CF2-.

[0953] R 3 and R 4 Represents hydrogen,

[0954] E 1 Represents chlorine, bromine, or iodine.

[0955] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl. This invention also relates to compounds of formula (20):

[0956]

[0957] in

[0958] Q, L, R 3 R 4 R 5 R 6 R 7 and R 8 As defined in this article,

[0959] m is 1 or 2

[0960] E 1 Represents hydroxyl or halogen,

[0961] E 2 Represents hydroxyl or amino groups.

[0962] and

[0963] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl. This invention also relates to compounds of formula (21):

[0964]

[0965] in

[0966] Q, L, R 3 R 4 R 5 R 6 R 7 R 8 And m as defined in this paper, E 1 Represents hydroxyl or halogen,

[0967] and

[0968] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl. This invention also relates to compounds of formula (21):

[0969]

[0970] in

[0971] Q, R 6 R 7 R 8 And m as defined in this paper,

[0972] m is 1,

[0973] L is CH2, CHF, or CF2.

[0974] R 3 R 4 and R 5 Represents hydrogen,

[0975] E 1 Represents hydroxyl or halogen,

[0976] and

[0977] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl. This invention also relates to compounds of formula (22):

[0978]

[0979] in

[0980] L, R 3 R 4 R 5 R 6 R 7 R 8 As defined in this article,

[0981] m is 1 or 2

[0982] X represents halogen.

[0983] E 1 Represents hydroxyl or halogen,

[0984] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl, provided that the compound of formula (22) is not:

[0985]

[0986] This invention also relates to compounds of formula (23):

[0987]

[0988] in

[0989] L, R 3 R 4 R 5 R 6 R 7 R 8 As defined in this article,

[0990] m is 1 or 2

[0991] X represents halogen.

[0992] E 1 Represents hydroxyl or halogen,

[0993] E2 Represents hydroxyl or amino groups.

[0994] and

[0995] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl. This invention also relates to compounds of formula (24):

[0996]

[0997] in

[0998] L, R 3 R 4 R 5 R 6 R 7 R 8 As defined in this article,

[0999] m is 1 or 2

[1000] X represents halogen.

[1001] W represents hydrogen, tert-butoxycarbonyl, benzyl, or (4-methoxyphenyl)methyl. This invention also relates to compounds of formula (25):

[1002]

[1003] Among them, Q, Y, R 7 and R 8 As defined in this article.

[1004] This invention also relates to compounds of formula (28):

[1005]

[1006] Among them, Q and R 3 R 4 R 5 R 7 and R 8 As defined in this article.

[1007] This invention also relates to compounds of formula (30):

[1008]

[1009] Among them, Q and R 3 R 4 R 5 R 6 R 7 and R 8 As defined in this article.

[1010] The present invention also relates to an intermediate of formula (8):

[1011] Q-OH(8)

[1012] Where Q is

[1013]

[1014] in

[1015] A 1 For C or N,

[1016] Q S Selected from C3-C4-cycloalkyl, C3-C8-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, and C2-C6-ynyl.

[1017] The condition is that the compound of formula (8) does not represent:

[1018]

[1019]

[1020] Compositions and Formulations

[1021] The present invention further relates to compositions, particularly compositions for controlling unwanted plant pathogenic microorganisms. These compositions can be applied to the microorganisms and / or their habitats.

[1022] The composition typically comprises at least one compound of formula (I) and at least one suitable agricultural adjuvant, such as a carrier and / or a surfactant.

[1023] The carrier is a generally inert solid or liquid, natural or synthetic, organic or inorganic substance. The carrier typically facilitates the application of the compound to, for example, plants, plant parts, or seeds. Examples of suitable solid carriers include, but are not limited to: ammonium salts, natural rock powders such as kaolin, clay, talc, chalk, quartz, palygorskite, montmorillonite, or diatomaceous earth, and synthetic rock powders such as finely dispersed silica, alumina, and silicates. Typical examples of useful solid carriers for preparing granules include, but are not limited to: pulverized and graded natural rocks such as calcite, marble, pumice, sepiolite, and dolomite; synthetic granules of inorganic and organic powders; and granules of organic materials such as paper, sawdust, coconut husks, corn cobs, and tobacco stalks. Examples of suitable liquid carriers include, but are not limited to: water, organic solvents, and combinations thereof. Examples of suitable solvents include polar and nonpolar organic chemical liquids, such as aromatic and non-aromatic hydrocarbons (e.g., cyclohexane, petroleum ether, alkylbenzene, xylene, toluene, alkylnaphthalene, chlorinated aromatic hydrocarbons or chlorinated aliphatic hydrocarbons such as chlorobenzene, vinyl chloride, or dichloromethane), alcohols or polyols (which may optionally be substituted, etherified, and / or esterified, such as butanol or ethylene glycol), ketones (e.g., acetone, methyl ethyl ketone, methyl isobutyl ketone, or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (e.g., dimethylformamide), lactams (e.g., N-alkylpyrrolidone) and lactones, sulfones and sulfoxides (e.g., dimethyl sulfoxide). The carrier can also be a liquefied gas extender, i.e., a liquid that is gaseous at standard temperature and pressure, such as aerosol propellants like halogenated hydrocarbons, butane, propane, nitrogen, and carbon dioxide. The amount of carrier is typically 1 to 99.99%, preferably 5 to 99.9%, more preferably 10 to 99.5%, and most preferably 20 to 99% by weight of the composition.

[1024] Surfactants can be ionic (cationic or anionic) or nonionic surfactants, such as ionic or nonionic emulsifiers, foaming agents, dispersants, wetting agents, and any mixtures thereof. Examples of suitable surfactants include, but are not limited to: polyacrylates, lignin sulfonates, phenol sulfonates or naphthalene sulfonates, condensates of ethylene oxide and / or propylene oxide with fatty alcohols or with fatty acids or with fatty amines (polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, such as alkyl aryl polyethylene glycol ethers), substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinates, taurine derivatives (preferably alkyl taurine esters), phosphate esters of polyethoxylated alcohols or phenols, fatty esters of polyols, and derivatives of compounds containing sulfates, sulfonates and phosphates (e.g., alkyl sulfonates, alkyl sulfates, aryl sulfonates), as well as protein hydrolysis products, lignin sulfite waste, and methylcellulose. If the compound of formula (I) and / or the carrier are insoluble in water, and when applied in water, a surfactant is generally required. Therefore, the amount of surfactant is typically 5 to 40% by weight in the composition.

[1025] Other examples of suitable additives include waterproofing agents, desiccants, adhesives (glues, tackifiers, fixatives such as carboxymethyl cellulose, natural and synthetic polymers in powder, granule or latex form (e.g. gum arabic, polyvinyl alcohol and polyvinyl acetate), natural phospholipids (e.g. cephalin and lecithin) and synthetic phospholipids, polyvinylpyrrolidone and methylcellulose (tylose)), thickeners, stabilizers (e.g. cold stabilizers, preservatives, antioxidants, light stabilizers or other agents that improve chemical and / or physical stability), dyes or pigments (e.g. inorganic pigments, such as iron oxide, etc.). Titanium oxide and Prussian blue; organic dyes, such as alizarin dyes, azo dyes and metal phthalocyanine dyes; defoamers (such as silicone defoamers and magnesium stearate); preservatives (such as dichlorobenzene and benzyl alcohol hemiacetal); secondary thickeners (cellulose derivatives, acrylic derivatives, xanthan gum, modified clay and finely dispersed silica); adhesives; gibberellins and processing aids; mineral and vegetable oils; fragrances; waxes; nutrients (including micronutrients such as iron salts, manganese salts, boron salts, copper salts, cobalt salts, molybdenum salts and zinc salts); protective colloids; thixotropic substances; penetrants; chelating agents and complexing agents.

[1026] The selection of adjuvants is related to the intended manner of application and / or physical properties of the compound of formula (I). Furthermore, adjuvants can be selected to impart specific properties (technical, physical, and / or biological properties) to the composition or the form of use prepared therefrom. The selection of adjuvants can allow the composition to be customized to specific needs.

[1027] The composition can be in any conventional form, such as solutions (e.g., aqueous solutions), emulsions, wettable powders, water-based and oil-based suspensions, powders, ointments, soluble powders, soluble granules, broadcast granules, suspension concentrates, natural or synthetic substances impregnated with compounds of formula (I), fertilizers, and microencapsulations in polymeric substances. Compounds of formula (I) can exist in suspension, emulsion, or dissolved form.

[1028] The composition can be provided to the end user in the form of a ready-to-use formulation, i.e., a composition that can be applied directly to plants or seeds using suitable equipment such as a sprayer or powderer. Alternatively, the composition can be provided to the end user in the form of a concentrate, which must be diluted before use, preferably with water.

[1029] The composition can be prepared in a conventional manner, for example by mixing the compound of formula (I) with one or more suitable auxiliaries (such as those disclosed above).

[1030] The composition typically comprises 0.01 to 99% by weight, 0.05 to 98% by weight, preferably 0.1 to 95% by weight, more preferably 0.5 to 90% by weight, and most preferably 1 to 80% by weight of a compound of formula (I). A composition may also comprise two or more compounds of formula (I). In this case, the listed ranges refer to the total amount of the compounds of the present invention.

[1031] Mixtures / Compositions

[1032] Compounds of formula (I) and compositions comprising them may be mixed with other active ingredients, such as fungicides, bactericides, acaricides, nematicides, insecticides, herbicides, fertilizers, growth regulators, safeners, and / or chemical pheromones. This can broaden the activity spectrum or prevent the development of resistance. Examples of known fungicides, insecticides, acaricides, nematicides, and bactericides are disclosed in the Pesticide Manual, 17th edition.

[1033] Particularly preferred examples of fungicides that can be mixed with compounds and compositions of formula (I) are:

[1034] 1) Inhibitors of ergosterol biosynthesis, such as (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenhexamide, (1.005) fenpropidin, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole, (1.009) flutriafol, (1.010) imazalil, and (1.011) imazalil sulfate. (1.012) sulfate), (1.013) ipconazole), (1.014) metconazole), (1.015) myclobutanil), (1.016) paclobutrazole), (1.017) prochloraz), (1.018) propiconazole), (1.019) prothioconazole), (1.020) pyrisoxazole), (1.021) spiroxamine), (1.022) tebuconazole), (1.023) tetraconazole), (1.024) triadimenol), (1.025) tridemorph, (1.026) tebuconazole (triticonazole), (1.026) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.028) (2R)-2-(1-chlorocyclopropyl)-4-[ (1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)but-2-ol, (1.029) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)but-2-ol, (1.030) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)prop-2-ol, (1.031)(2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)but-2-ol, (1.032)(2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)but-2-ol, (1.033)(2S)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)prop-2-ol, (1.034)(R)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl]( (1.035)(S)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.036)[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.037)1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolane-2-yl}methyl)-1H-1,2,4-triazole, (1.038)1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl) (1.039)1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.040)1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.041)1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, 1,042)2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.043)2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.044)2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.046) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.0 48) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.049) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.050) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.051) 2-[2-chloro-4-( [2,4-Dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)prop-2-ol, (1.052)2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)but-2-ol, (1.053)2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)but-2-ol, (1.054)2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol, (1.055)Mefentrifluconazole le), (1.056)2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.057)2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.058)2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thione, (1.059) 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.060) 5-(allylthio)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-1H-1,2,4-triazole, (1.061) 5-(allylthio)-1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-1H-1,2,4-triazole, (1.062) 5-(allylthio)-1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)epoxyethylene-2-yl]methyl}-1H-1,2,4-triazole, (1.063)N'-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]thioalkyl}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.064)N'-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]thioalkyl}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.065)N'-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]thioalkyl}phenyl)-N-ethyl-N-methyliminocarboxamide, ( 1.066) N'-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]thioalkyl}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.067) N'-(2,5-dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)thioalkyl]phenoxy}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.068) N'-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)thioalkyl]phenoxy}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.069) N'-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)thioalkyl]phenoxy}phenyl) -N-ethyl-N-methyliminocarbamate, (1.070)N'-(2,5-dimethyl-4-{3-[(pentafluoroethyl)thioalkyl]phenoxy}phenyl)-N-ethyl-N-methyliminocarbamate, (1.071)N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methyliminocarbamate, (1.072)N'-(4-{[3-(difluoromethoxy)phenyl]thioalkyl}-2,5-dimethylphenyl)-N-ethyl-N-methyliminocarbamate, (1.073)N'-(4-{3-[(difluoromethyl)thioalkyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methyliminocarbamate, (1.074) N'-[5-bromo-6-(2,3-dihydro-1H-indene-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methyliminocarboxamide, (1.075) N'-{4-[(4,5-dichloro-1,3-thiazolyl-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methyliminocarboxamide, (1.076) N'-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.077) N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl]-N-ethyl-N-methyliminocarboxamide (1.078)N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.079)N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.080)N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.081)Ipfentrifluconazole.

[1035] 2) Inhibitors of respiratory chain complex I or II, such as (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) furamepyr, (2.009) isofetamid, (2.010) pyridaben (2.011) isopyrazam (trans-episomeric enantiomers 1R, 4S, 9S), (2.012) isopyrazam (trans-episomeric racemics 1RS, 4SR, 9SR), (2.013) isopyrazam (a mixture of cis-episomeric racemics 1RS, 4SR, 9RS and trans-episomeric racemics 1RS, 4SR, 9SR), (2.014) isopyrazam (cis-episomeric enantiomers 1R, 4S, 9R), (2.015) isopyrazam (cis-episomeric enantiomers 1S, 4R, 9S), (2.016) isopyrazam (cis-episomeric enantiomers 1R, 4S, 9S), Racemic mixtures (1RS, 4SR, 9RS), (2.017) penflufen, (2.018) penthiopyrad, (2.019) pydiflumetofen, (2.020) pyraziflumid, (2.021) sedaxane, (2.022) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl)-1H-pyrazole-4-carboxamide, (2.023) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl] -1H-pyrazole-4-carboxamide, (2.024)1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl]-1H-pyrazole-4-carboxamide, (2.025)1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026)2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl)benzamide, (2.027)3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl)-1H-pyrazole-4-carboxamide, (2.028) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl]-1H-pyrazole-4-carboxamide, (2.029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl]-1H-pyrazole-4-carboxamide, (2.030) Fluindapyr, (2.031) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-indene-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) 3-(difluoromethyl)-N-[(3 (2.033) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine, (2.034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazol-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazol-4-carboxamide, (2.036) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazol-4-carboxamide, (2.036) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazol-4-carboxamide, (2.037) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazol-4-carboxamide, (2.038) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazol-4-carboxamide, (2.037)N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.038)isoflucypram, (2.039)N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylenenaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.040)N-[(1S,4R)-9-(dichloromethylene)-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide -1,2,3,4-Tetrahydro-1,4-methylenenaphthyl-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.041)N-[1-(2,4-dichlorophenyl)-1-methoxypropyl-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.042)N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.043)N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047) N-cyclopropyl-3- (difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.048)N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-thiocarboxamide, (2.049)N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.050)N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl) (2.051)N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.052)N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.053)N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide Amides, (2.054)N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055)N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.056)N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.057)pyrapropoyne.

[1036] 3) Inhibitors of respiratory chain complex III, such as (3.001) ametoctradin, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, and (3.009) famoxad. (3.010) Fenamidon, (3.011) Flufenoxystrobin, (3.012) Fluoxastrobin, (3.013) Kresoxim-methyl, (3.014) Metominostrobin, (3.015) Orysastrobin, (3.016) Picoxystrobin, (3.017) Pyraclostrobin, (3.018) Pyrametostrobin (3.019) pyraoxystrobin, (3.020) trifloxystrobin, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-di- (3.024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) 2-methylpropionic acid (3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxane-7-yl ester, (3.026) mandestrobin, (3.027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-carbamate-2-hydroxybenzamide, (3.028)(2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029){5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate, (3.030)metyltetraprole, (3.031)florylpicoxamid.

[1037] 4) Inhibitors of mitosis and cell division, such as (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) pencycuron, (4.006) thiabendazole, (4.007) thiophanate-methyl, (4.008) zoxamide, and (4.009) 3-chloro-4-(2,6-difluorophenyl)-6-methyl 5-Phenyridazine, (4.010)3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (4.011)3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (4.012)4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.013)4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.014)4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.017) 4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H- Pyrazole-5-amine, (4.020)4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.021)4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.022)4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (4.023)N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.024)N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.025)N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine.

[1038] 5) Compounds capable of multi-site action, such as (5.001) Bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorthalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper oxychloride, (5.009) copper sulfate (2+), (5.010) dithianon, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.014) mancozeb, (5.015) metiram, (5.016) metiram (5.017) oxine-copper, (5.018) propineb, (5.019) sulfur and sulfur preparations including calcium polysulfides, (5.020) thiram, (5.021) zineb, (5.022) ziram, (5.023) 6-ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithiainro[2,3-c][1,2]thiazolyl-3-carboxylonitrile.

[1039] 6) Compounds that can induce host defense, such as (6.001) acibenzolar-S-methyl, (6.002) isothiazine, (6.003) probenazole, and (6.004) tiadinil.

[1040] 7) Inhibitors of amino acid and / or protein biosynthesis, such as (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil, and (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinoline-1-yl)quinoline.

[1041] 8) Inhibitors of ATP production, such as (8.001) silthiofam.

[1042] 9) Inhibitors of cell wall synthesis, such as (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamid, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, and (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.

[1043] 10) Inhibitors of lipid and membrane synthesis, such as (10.001) propamocarb, (10.002) propamocarb hydrochloride, and (10.003) tolclofos-methyl.

[1044] 11) Inhibitors of melanin biosynthesis, such as (11.001) tricyclazole and (11.002) 2,2,2-trifluoroethyl 3-methyl-1-[(4-methylbenzoyl)amino]but-2-yl}carbamate.

[1045] 12) Inhibitors of nucleic acid synthesis, such as (12.001) benalaxyl, (12.002) benalaxyl-M, kiralaxyl, (12.003) metalaxyl, (12.004) high-efficiency metalaxyl-M (mefenoxam).

[1046] 13) Inhibitors of signal transduction, such as (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, and (13.006) vinclozolin.

[1047] 14) Compounds that can act as uncoupling agents, such as (14.001) fluazinam and (14.002) meptyldinocap.

[1048] 15) Other compounds, such as (15.001) abscisic acid, (15.002) bethoxazin, (15.003) capsimycin, (15.004) carvone, (15.005) chinomethionat, (15.006) cufraneb, (15.007) cyflufenamid, (15.008) cyflufenamid, (15.009) ciflufenamid, (15.0 ... 09) Cymoxanil, (15.010) Cyprosulfamide, (15.011) Flutianil, (15.012) Fosetyl-aluminum, (15.013) Calcium Fosetyl-aluminum, (15.014) Sodium Fosetyl-aluminum, (15.015) Methyl isothiocyanate, (15.016) Metrafenon, (15.017) Mildiomycin, (15.018) Natamycin, (15.019) Nickel (15.020) dimethyldithiocarbamate, (15.021) nitrothal-isopropyl, (15.022) oxamocarb, (15.023) oxathiapiprolin, (15.024) oxyfenthiin, (15.025) pentachlorophenol and its salts, (15.026) phosphorous acid and its salts, (15.027) propamocarb-fosetylate, (15.028) pyr iofenone (chlazafenone), (15.028) tebufloquin, (15.029) tecloftalam, (15.030) tolnifanide, (15.031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazolyl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl] acetone, (15.032)1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazolyl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetone, (15.033)2-(6-benzylpyridin-2-yl)quinazolin, (15.034)dipymetitrone, (15.035)2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazolyl)piperidin-1-yl Ethyl ketone, (15.036)2-[3,5-bis(difluoromethyl)-1H-pyrazole-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl] ethyl ketone, (15.037)2-[3,5-bis(difluoromethyl)-1H-pyrazole-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl] ethyl ketone, (15.038)2-[6-(3-fluoro-4-methoxyphenyl) (15.039)2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazole-1-yl]acetyl}piperidin-4-yl)-1,3-thiazolyl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonate, (15.040)2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazole-1-yl]acetyl}piperidin-4-yl)-1,3-thiazolyl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonate, (15.041)Ipflufenoquin, (15.042) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}prop-2-ol, (15.043)2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazo-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonate, (15.044)2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazo-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenylmethanesulfonate, (15.045)2-phenylphenol and its salts, (15.046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.047) quinofumelin, (15.048) 4-amino-5-fluoropyrimidin-2-ol (tautomer form: 4-amino-5-fluoropyrimidin-2(1H)-one), (15.049) 4-oxo-4-[(2-phenylethyl)amino]butyric acid, (15.050) 5-amino-1,3,4-thiazolyl Diazol-2-thiol, (15.051) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonylhydrazine, (15.052) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.053) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine, (15.054) 9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazakhine 、(15.055){6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate butyl-3-yn-1-yl ester,(15.056)(2Z)-3-amino-2-cyano-3-phenyl acrylate ethyl ester,(15.057)phenazine-1-carboxylic acid,(15.058) propyl 3,4,5-trihydroxybenzoate,(15.059)quinoline-8-ol, (15.060) Quinoline-8-ol sulfate (2:1), (15.061) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl} tert-butyl carbamate, (15.062) 5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one, (15.063) aminopyrifen.

[1049] All named mixed components of classes (1) to (15) described above may exist in the form of free compounds, and / or in the form of agriculturally acceptable salts if their functional groups are capable of salt formation.

[1050] The compounds and compositions of formula (I) may also be combined with one or more biocontrol agents.

[1051] Examples of biocontrol agents that can be combined with compounds of formula (I) and compositions comprising them are:

[1052] (A) Selected from the following antibacterial agents:

[1053] (A1) Bacteria, such as (A1.1) Bacillus subtilis, particularly strain QST713 / AQ713 (available from Bayer CropScience LP, US under SERENADE OPTI or SERENADE ASO, registration number NRLB21661 and described in US Patent No. 6,060,051); (A1.2) Bacillus amyloliquefaciens, particularly strain D747 (available from Certis, US under Double Nickel). TM (A1.3) Bacillus pumilus, particularly strain BU F-33 (accession number NRRL50185); (A1.4) Bacillus subtilis var. amyloliquefaciens strain FZB24 (available from Novozymes, US). (A1.5) A Paenibacillus sp. strain with accession number NRRL B-50972 or NRRL B-67129, described in the international patent publication text of WO 2016 / 154297; and

[1054] (A2) Fungi, such as (A2.1) budding aureobasidium pullulans, especially budding spores of strain DSM14940; (A2.2) budding aureobasidium pullulans of strain DSM 14941; (A2.3) budding aureobasidium pullulans, especially a mixture of budding spores of strains DSM14940 and DSM14941;

[1055] (B) Selected fungicides from the following:

[1056] (B1) Bacteria, such as (B1.1) Bacillus subtilis, particularly strain QST713 / AQ713 (available from Bayer Crop Science LP, US under SERENADE OPTI or SERENADE ASO, NRRL B21661 and described in U.S. Patent No. 6,060,051); (B1.2) Bacillus pumilus, particularly strain QST2808 (available from Bayer Crop Science LP, US under SERENADE OPTI or SERENADE ASO, NRRL B21661 and described in U.S. Patent No. 6,060,051); (obtained, registration number NRRL B-30087 and described in U.S. Patent No. 6,245,551); (B1.3) Bacillus pumilus, particularly strain GB34 (available from Bayer AG, DE by Yield). (B1.4) Bacillus pumilus, particularly strain BU F-33 (accession number NRRL50185); (B1.5) Bacillus amyloliquefaciens, particularly strain D747 (from Certis, US with Double Nickel). TM (obtained, registration number FERM BP-8234 and disclosed in U.S. Patent No. 7,094,592); (B1.6) Bacillus subtilis Y1336 (available from Bion-Tech, Taiwan, China). WP (registered as a biofungicide in Taiwan under registration numbers 4764, 5454, 5096, and 5277); (B1.7) Bacillus amyloliquefaciens strain MBI 600 (available from BASF SE via SUBTILEX); (B1.8) Bacillus subtilis strain GB03 (available from Bayer AG, DE via SUBTILEX). (B1.9) Bacillus subtilis var. amyloliquefaciens strain FZB24 (available from Novozymes Biologicals Inc., Salem, Virginia or Syngenta Crop Protection, LLC, Greensboro, North Carolina with fungicides) (B1.10) Bacillus mycoides, isolate J (obtainable from Certis USA under BmJ TGAI or WG); (B1.11) Bacillus licheniformis, particularly strain SB3086 (obtainable from Novozymes under EcoGuard TMBiofungicide and Green Releaf); (B1.12) Bacillus strains of the genus Bacillus with accession number NRRL B-50972 or NRRL B-67129, as described in the text of International Patent Publication No. WO2016 / 154297.

[1057] In some implementations, the biocontrol agent is a strain of Bacillus subtilis or Bacillus amyloliquefaciens that produces fengycin or plipastatin-type compounds, iturin-type compounds, and / or subtilis surfactant-type compounds. For background information, see the following review: Ongena, M., et al., “Bacillus Lipopeptides: Versatile Weapons for Plant Disease Biocontrol,” Trends in Microbiology, Vol. 16, No. 3, March 2008, pp. 115-125. Lipopeptide-producing Bacillus strains include Bacillus subtilis QST713 (available from Bayer CropScience LP, US under SERENADE OPTI or SERENADE ASO, NRRL B21661 and described in US Patent No. 6,060,051), and Bacillus amyloliquefaciens strain D747 (available from Certis, US under DoubleNickel). TM Obtained from US Patent No. FERM BP-8234 and published in US Patent No. 7,094,592); Bacillus subtilis MBI600 (available from Becker Underwood, US). Obtained (EPA registration number 71840-8); Bacillus subtilis Y1336 (available from Bion-Tech, Taiwan). WP is registered in Taiwan, China under registration numbers 4764, 5454, 5096, and 5277 as a biological fungicide; Bacillus amyloliquefaciens, especially strain FZB42 (available from ABiTEP, DE). (obtained); and Bacillus subtilis var. amyloliquefaciens FZB24 (available from Novozymes Biologicals Inc., Salem, Virginia or Syngenta Crop Protection, LLC, Greensboro, North Carolina as a fungicide). ECO (EPA registration number 70127-5) obtained); and

[1058] (B2) Fungi, such as: (B2.1) Coniothyrium minitans, especially strain CON / M / 91-8 (accession number DSM-9660; e.g. from Bayer). (B2.2) Metschnikowia fructicola, especially strain NRRL Y-30752 (e.g.) (B2.3) Microsphaeropsisochracea (e.g., from Prophyta) (B2.5) *Trichoderma* spp., including *Trichoderma atroviride*, as described in the international patent publication text of PCT / IT2008 / 000196, strain SC1); (B2.6) *Trichoderma harzianum rifai* strain KRL-AG2 (also known as strain T-22, / ATCC208479, e.g., PLANTSHIELD T-22G from BioWorks, US). (B2.14) Gliocladium roseum, strain 321U from WFStoneman Company LLC; (B2.35) Talaromyces flavus, strain V117b; (B2.36) Trichoderma asperellum, strain ICC 012 from Isagro; (B2.37) Trichoderma asperellum, strain SKT-1 (e.g. from Kumiai Chemical Industry). (B2.38) Trichoderma atroviride, strain CNCMI-1237 (e.g. from Agrauxine, FR) WP); (B2.39) Trichoderma viride, strain V08 / 002387; (B2.40) Trichoderma viride, strain NMI V08 / 002388; (B2.41) Trichoderma viride, strain NMI V08 / 002389; (B2.42) Trichoderma viride, strain NMI V08 / 002390; (B2.43) Trichoderma viride, strain LC52 (e.g., Tenet provided by Agrim Technologies Limited); (B2.44) Trichoderma viride, strain ATCC 20476 (IMI 206040); (B2.45) Trichoderma viride, strain T11 (IMI352941 / CECT20498); (B2.46) Trichoderma harmatum; (B2.47) Trichoderma harmatum harzianum); (B2.48) Trichoderma harzianumrifai T39 (e.g. from Makhteshim, US) (B2.49) *Trichoderma harzianum*, particularly strain KD (e.g., Trichoplus from Biological Control Products, SA, obtained by Becker Underwood); (B2.50) *Trichoderma harzianum*, strain ITEM 908 (e.g., Trianum-P from Koppert); (B2.51) *Trichoderma harzianum*, strain TH35 (e.g., Root-Pro from Mycontrol); (B2.52) *Trichoderma virens* (also known as *Gliocladium virens*), particularly strain GL-21 (e.g., SoilGard12G from Certis, US); (B2.53) *Trichoderma viride*, strain TV1 (e.g., Trianum-P from Koppert); (B2.54) *Ampelomyces quisqualis*, particularly strain AQ 10 (e.g., AQ from IntrachemBio Italia). (B2.56) Budding short-stemmed fungi, particularly budding spores of strain DSM14940; (B2.57) Budding short-stemmed fungi, particularly budding spores of strain DSM 14941; (B2.58) Mixtures of budding short-stemmed fungi, particularly budding spores of strains DSM14940 and DSM 14941 (e.g., provided by bio-ferm, CH). (B2.64) Cladosporium cladosporioides, strain H39 (provided by Stichting Dienst Landbouwkundig Onderzoek); (B2.69) Gliocladium catenulatum (synonym: Clonestachys rosea f. catenulate), strain J1446 (e.g., provided by AgBio Inc.). And, for example, those provided by Kemira Agro Oy (B2.70) Conidia of strain KV01 of *Lecanicillium lecanii* (formerly known as *Verticillium lecanii*) (e.g., provided by Koppert / Arysta) (B2.71) *Penicillium vermiculatum*; (B2.72) *Pichia anomala*, strain WRL-076 (NRRL Y-30842); (B2.75) *Trichoderma var. globosum*, strain SKT-1 (FERM P-16510); (B2.76) *Trichoderma var. globosum*, strain SKT-2 (FERM P-16511); (B2.77) *Trichoderma var. globosum*, strain SKT-3 (FERM P-17021); (B2.78) *Trichoderma gamsii* (formerly *T. viride*), strain ICC080 (IMI CC 392151CABI, e.g., *BioDerma* provided by AGROBIOSOL DE MEXICO, SADE CV); (B2.79) *Trichoderma harzianum*, strain DB 103 (e.g., T-Gro 7456 from Dagutat Biolab); (B2.80) *Trichoderma polysporum*, strain IMI 206039 (e.g., Binab TF WP from BINAB Bio-Innovation AB, Sweden); (B2.81) *Trichoderma stromaticum* (e.g., Tricovab from Cepulc, Brazil); (B2.83) *Ulocladium oudemansii*, especially strain HRU3 (e.g., from Botry-Zen Ltd, NZ). (B2.84) *Verticillium albo-atrum* (formerly *V. dahliae*), strain WCS850 (CBS276.92; e.g., Dutch Trig provided by Tree Care Innovations); (B2.86) *Verticillium chlamydosporium*; (B2.87) a mixture of *Trichoderma asperellum* strain ICC012 and *Trichoderma geysii* strain ICC 080 (e.g., from Bayer CropScience LP, US named BIO-TAM). TM (products).

[1059] Other examples of biocontrol agents that can be combined with compounds of formula (I) and compositions comprising them are:

[1060] The bacteria selected are: Bacillus cereus, especially B. cereus strain CNCM I-1562 and Bacillus firmus strain I-1582 (accession number CNCM I-1582), Bacillus subtilis strain OST 30002 (accession number NRRL B-50421), Bacillus thuringiensis, especially B. thuringiensis subspecies israelensis (serotype H-14), strain AM65-52 (accession number ATCC 1276), or B. thuringiensis subsp. aizawai, especially strain ABTS-1857 (SD-1372), or B. thuringiensis subsp. kurstak. The following strains are listed: Bacillus subsp. kurstaki (HD-1), Bacillus thuringiensis subsp. tenebrionis (NB 176, SD-5428), Bacillus penetrans, Bacillus spp. (Rotylenchulus reniformis nematode)-PR3 (ATCC SD-5834), Streptomyces microflavus (AQ6121, QRD 31.013, NRRL B-50550), and Streptomyces galbus (AQ 6047, NRRL 30232).

[1061] The fungi and yeasts selected are: *Beauveria bassiana*, especially strain ATCC74040; *Lecanicillium* spp., especially strain HRO LEC 12; *Metarhizium anisopliae*, especially strain F52 (DSM3884 or ATCC 90448); *Paecilomyces fumosoroseus* (now known as *Isaria fumosorosea*), especially strain IFPC 200613 or strain Apopka 97 (accession number ATCC 20874); *Paecilomyces lilacinus*, especially strain 251 (AGAL 89 / 030550);

[1062] The viruses selected are: Adoxophyes orana (summerfruit tortrix) granulovirus (GV), Cydia pomonella (codling moth) granulovirus (GV), Helicoverpa armigera (cotton bollworm) nucleopolyhedrovirus (NPV), Spodoptera exigua (beet armyworm) mNPV, Spodoptera frugiperda (fall armyworm) mNPV, and Spodoptera littoralis (African cotton leafworm) NPV.

[1063] Bacteria and fungi that can be added to plants, plant parts or plant organs as "inoculants" and promote plant growth and health through their specific properties. Examples of the bacteria and fungi mentioned are: *Agrobacterium* spp., *Azorhizobium caulinodans*, *Azospirillum* spp., *Azotobacter* spp., *Bradyrhizobium* spp., *Burkholderia* spp., especially *Burkholderiacepacia* (formerly known as *Pseudomonas cepacia*), *Gigasporas* spp. or *Gigaspora monosporum*, *Glomus* spp., *Laccaria* spp., *Lactobacillus buchneri*, and *Paraglomus*. spp.), Pisolithustinctorus, Pseudomonas spp., Rhizobium spp., especially Rhizobium trifolii, Rhizopogon spp., Sclerodermas spp., Suillus spp., Streptomyces spp.

[1064] Plant extracts and microbial products (including proteins and secondary metabolites) that can be used as biocontrol agents include: garlic (Allium sativum), wormwood (Artemisia absinthium), azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, Chenopodium anthelminticum, chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), pyrethrum / pyrethrins, Quassia amara, Quercus, Quillaja, Regalia, and Requiem. TM Insecticides, rotenone, ryania / ryanodine, comfrey (Symphytum officinale), tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, nettle (Urtica dioica), veratrin, viscum album, and extracts from the Brassicaceae family (especially rapeseed powder or mustard powder).

[1065] Examples of insecticides, acaricides, and nematicides that can be mixed individually with compounds of formula (I) and compositions comprising them are as follows:

[1066] (1) Acetylcholinesterase (AChE) inhibitors, such as carbamates, including alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, and furathiocarb. RB), isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, and xylylcarb, or organophosphates such as acephate, azamethiphos, and ethyl glutathione. zinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos / DDVP, didrotophos, dimethoate dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, O-(methoxyaminothiophosphoryl)salicylic acid isopropyl ester, isoxathion.Malathion, mecarbam, methamidophos, methidathion, mevinphos, monocotophos, naled, omethoate, oxydemeton-methyl, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pyrimidine phosphate The following are listed: miphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, and vamidothion.

[1067] (2) GABA-gated chloride channel blockers, such as cyclopentadiene organochlorines, such as chlordane and endosulfan, or fiproles, such as ethiprole and fipronil.

[1068] (3) Sodium channel modulators, such as pyrethroids, including acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, β-cyfluthrin, cyhalothrin, λ-cyfluthrin, γ-cyfluthrin, cypermethrin, α-cypermethrin, β-cypermethrin, θ-cypermethrin, ζ-cypermethrin, and cyphenothrin[(1R)-trans isomer]. isomer]), deltamethrin, empenthrin[(EZ)-(1R)isomer], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, momfluorothrin, permethrin, phenothrin[(1R)-trans isomer] Isomer]), d-propargylpyrene (prallethrin), pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R) isomer] (tetramethrin[(EZ)-(1R)-isomer)], tralomethrin and transfluthrin, or DDT, or methoxychlor.

[1069] (4) Nicotinic acetylcholine receptor (nAChR) competitive modulators, such as neonicotinoids, such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam, or nicotine, or sulfoxaflor, or flupyradifurone.

[1070] (5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators, such as spinosides, such as spintoram and spinosad.

[1071] (6) Glutamate-gated chloride channel (GluCl) allosteric modulators, such as avermectins / milbemycins, such as abamectin, emamectin benzoate, lepimectin and milbemectin.

[1072] (7) Juvenile hormone analogues, such as hydroprene, kinoprene and methoprene, or fenoxycarb, or pyriproxyfen.

[1073] (8) Other non-specific (multi-site) inhibitors, such as alkyl halides, such as methyl bromide and other alkyl halides; or chloropicrine or sulphuryl fluoride or borax or tartar emetic or methyl isocyanate generating agents, such as diazomet and metam.

[1074] (9) Chordonal organ modulators, such as pymetrozine or flonicamid.

[1075] (10) Mite growth inhibitors, such as clofentezine, hexythiazox and diflovidazin, or etoxazole.

[1076] (11) Insect intestinal microbial interference agents, such as Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis and Bt plant proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 / 35Ab1.

[1077] (12) Inhibitors of mitochondrial ATP synthase, such as ATP interfering agents, such as diafenthiuron, or organotin compounds, such as azocyclotin, cyhexatin and fenbutatinoxide, or propargite, or tetradifon.

[1078] (13) Uncoupling agents via oxidative phosphorylation of discontinuous proton gradients, such as chlorfenapyr, dinitrocresol (DNOC) and sulfluramid.

[1079] (14) Nicotinic acetylcholine receptor channel blockers, such as bensultap, cartap hydrochloride, thiocyclam and thiosultap-sodium.

[1080] (15) Type O chitin biosynthesis inhibitors, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron.

[1081] (16) Type I chitin biosynthesis inhibitors, such as buprofezin.

[1082] (17) Molting disruptors (especially for dipterans), such as cyromazine.

[1083] (18) Ecdysone receptor agonists, such as chromafenozide, halofenozide, methoxyfenozide and tebufenozide.

[1084] (19) Octopus amine receptor agonists, such as amitraz.

[1085] (20) Inhibitors of electron transport in mitochondrial complex III, such as hydramethylnoe, acequinocyl, or fluacrypyrim.

[1086] (21) Inhibitors of electron transport in mitochondrial complex I, such as METI acaricides, such as fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, and tolfenpyrad, or rotenone (Derris).

[1087] (22) Voltage-dependent sodium channel blockers, such as indoxacarb or metaflumizone.

[1088] (23) Acetyl-CoA (CoA) carboxylase inhibitors, such as tetramicacid and tetramicacid derivatives, such as spirodiclofen, spiromesifen and spirotetramat.

[1089] (24) Inhibitors of electron transport in mitochondrial complex IV, such as phosphine, such as aluminum phosphide, calcium phosphide, phosphine and zinc phosphide, or cyanides, such as calcium cyanide, potassium cyanide and sodium cyanide.

[1090] (25) Inhibitors of electron transport in mitochondrial complex II, such as beta-ketonitrilederivatives, such as cyenopyrafen and cyflumetofen, and carboxanilides, such as pyflubumide.

[1091] (28) ryanodine receptor modulators, such as diamides, including chlorantraniliprole, cyantraniliprole, and flubendiamide.

[1092] Other active compounds include, for example, afidopyropen, afoxolaner, azadirachtin, benclothiaz, benzoximate, bifenazate, broflanilide, bromopropylate, chinomethionat, chlorpyrifos, cryolite, cyclaniliprole, cycloxaprid, cyhalodiamide, dicloomezotiaz, dicotyl, and ε-methoxybenzylflufenoxuron. metofluthrin, epsilon-Momfluthrin, Flometoquin, Fluazaindolizine, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram, Flularaner, Fluxametamide, Fufenozide, Guadipyr, Heptafluthrin, Imidaclothiz, Iprodione, kappa-Bifenthrin, kappa- Tefluthrin, Lotilaner, Meperfluthrin, Paichongding, Pyridalyl, Pyrifluquinazon, Pyriminostrobin, Spirobudiclofen, Tetramethylfluthrin, Tetraniliprole, Tetrachlorantraniliprole, Tiigolaner, Tioxazafen, Thiofluoximate, Triflumezopyrim, and iodomethane; and also based on Bacillus thuringiensis.Preparations of firmus (I-1582, BioNeem, Votivo), and the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (as per WO2006 / 043635) (CAS 885026-50-6), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indol-3,4'-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl) methyl ketone (as per WO2003 / 106457 ...](2-chloropyridin-4-yl) methyl ketone (as per 637360-23-7), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (as per WO2006 / 003494) (CAS 872999-66-1), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (as per WO 2010052161) (CAS1225292-17-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (as per EP) 2647626 (CAS-1440516-42-6), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (from WO2004 / 099160) (CAS 792914-58-0), PF1364 (from JP2010 / 018586) (CAS Registry No. 1204776-60-2), N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (from WO2012 / 029672) (CAS1363400-41-2), (3E)-3-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridinyl]-1,1,1-trifluoro-prop-2-one (from WO2013 / 144213) (CAS1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (from WO2010 / 051926) (CAS1226889-14-0), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (as obtained from CN103232431) (CAS1449220-44-3), 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxo] -3-thioneheterobutyl)benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxo-3-thioneheterobutyl)benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxo-3-thioneheterobutyl)benzamide (from WO (As learned in 2013 / 050317 A1)(CAS1332628-83-7), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propionamide, (+)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propionamide and (-)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propionamide (from WO 2013 / 162715A2, WO 2013 / 162716) A2, US2014 / 0213448 A1 (CAS1477923-37-7), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carboxylonitrile (obtained from CN 101337937 A) (CAS1105672-77-2), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thiomethyl]phenyl]-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, obtained from CN 103109816A (CAS1232543-85-9); N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (from WO 2012 / 034403)A1 obtained)(CAS1268277-22-0), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide (obtained from WO 2011 / 085575 A1))(CAS1233882-22-8), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)-pyrimidine (obtained from CN 101337940A (CAS1108184-52-6); (2E)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]hydrazine carboxamide and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]hydrazine carboxamide (from CN 101715774 A) (CAS1232543-85-9); 3-(2,2-dichlorovinyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl-cyclopropane carboxylate (from CN 103524422A (CAS1542271-46-4); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-methyl carbamate (from CN 102391261 A) (CAS1370358-69-2); 6-deoxy-3-O-ethyl-2,4-diO-methyl-1-[N-[4-[1-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]-1H-1,2,4-triazol-3-yl]phenyl]carbamate]-α-L-mannopyranose (from US 2014 / 0275503A1 (CAS1181213-14-8); 8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethylpyridazin-3-yl)-3-azabicyclo[3.2.1]octane (CAS 1253850-56-4), (8-trans)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-azabicyclo[3.2.1]octane (CAS933798-27-7), (8-cis)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-azabicyclo[3.2.1]octane (from WO 2007040280 A1、WO 2007040282Known by A1)(CAS934001-66-8), N-[3-chloro-1-(3-pyridyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)thio]propionamide (known by WO 2015 / 058021 A1, WO 2015 / 058028A1))(CAS1477919-27-9) and N-[4-(aminothiomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazol-5-carboxamide (known by CN) 103265527A (CAS1452877-50-7), 5-(1,3-dioxane-2-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]pyrimidine (from WO 2013 / 115391 A1) (CAS1449021-97-9), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1-methyl-1,8-diazaspiro[4,5]dec-3-en-2-one (from WO 2010 / 066780 A1, WO 2011 / 151146A1 (CAS1229023-34-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (from WO 2014 / 187846 A1) (CAS1638765-58-8), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl-ethyl carbonate (from WO 2010 / 066780 A1, WO 2011151146A1 (CAS1229023-00-0), N-[1-[(6-chloro-3-pyridyl)methyl]-2(1H)-pyridyl]-2,2,2-trifluoroacetamide (obtained from DE 3639877 A1, WO 2012029672A1) (CAS1363400-41-2), [N(E)]-N-[1-[(6-chloro-3-pyridyl)methyl]-2(1H)-pyridyl]-2,2,2-trifluoroacetamide (obtained from WO 2016005276) A1 (CAS1689566-03-7), [N(Z)]-N-[1-[(6-chloro-3-pyridyl)methyl]-2(1H)-pyridyl]-2,2,2-trifluoroacetamide (CAS1702305-40-5), 3-one-3-[2-propoxy-4-(trifluoromethyl)propoxy]-9-[[5-(trifluoromethyl)-2-pyridyl]oxy]-9-azabicyclo[3.3.1]nonane (obtained from WO 2011 / 105506 A1, WO 2016 / 133011A1) (CAS1332838-17-1).

[1093] Examples of safeners that can be mixed with compounds of formula (I) and compositions comprising them include, for example, benoxacor, cloquintocet(-mexyl)), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole(-ethyl)), fenclorim, flurazole, fluxofenim, furilazole, and bismuth subcitrate. Isoxadifen(-ethyl) , mefenpyr(-diethyl) , naphthalic anhydride , oxabetrinil , 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS129531-12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4).

[1094] Examples of herbicides that can be mixed with compounds of formula (I) and compositions comprising them are:

[1095] Acetochlor, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryn, amicabazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5- Flupyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor-potassium, aminocyclopyrachlor-methyl, aminopyralid, amitrol, ammonium aminosulfonate, anilofos, asulam, atrazine, azafenidin, azimsulfuron, beflubutamid, and other herbicides. Benazolin, benzolin-ethyl, benzfluralin, benzuresate, benzsulfuron, benzsulfuron-methyl, benzulide, benztazone, benzobicyclon, benzofenap, bicyclopyron, bifenox, bialaphos, bilanafo S-sodium), bispyribac, bispyribac-sodium, bromacil, bromobutide, bromofenoxim, bromoxynil, bromoxynil-butyrate, bromoxynil-potassium, bromoxynil-heptanoate, and bromoxynil-octanoate, busoxinoneButachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butylate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, chlorfenac, and more. chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorthal-dimethyl, chlorsulfuron, cinidon Indole-ethyl, cinidon-ethyl, cinmethylin, cinosulfuron, clacyfos, clethodim, clodinafop, clodinafop-propargyl, cromazine, clomeprop, clopyralid, cloransulam, cloransulam-methyl, cumyluron, cyazine (namide), cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butoxyethyl ester (2,4-D-butoyl), 2,4-D-butyl ester, 2,4-D-dimethylammonium, 2,4-D-diolamine, 2,4-D-ethyl ester, 2,4-D-2-ethylhexyl ester, 2,4-D-isobutyl ester, 2,4-D-isooctyl ester,2,4-D-isopropylammonium, 2,4-D-potassium, 2,4-D-triisopropanolammonium and 2,4-D-trolamine, 2,4-DB, 2,4-DB-butyl ester, 2,4-DB-dimethylammonium, 2,4-DB-isooctyl ester, 2,4-DB-potassium and 2,4-DB-sodium, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosylpyrazolate (DTP), dicamba, dichlobenil, 2-(2,4-di) 2-(2,5-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, 2,4-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, 2,4-dichloropropionic acid (dichlorprop), dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat, diflufenican, diflufenzopyr, diflufenozide sodium (di... Flufenzopyr-sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimetrasulfuron, dinitramine, dinoterb, diphenamid, diquat-dibromide, dithiopyr r), diuron, DNOC, endothal, EPTC, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, etiozin, ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etobenzanid, F-9600,F-5231 refers to N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxo-4,5-dihydro-1H-tetrazole-1-yl]phenyl]ethanesulfonamide; F-7967 refers to 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidin-2,4(1H,3H)-dione; fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenq uinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, floraulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, flucarbazone Flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, fluometuron, flurenol, fluorenol- butyl), flurenol-dimethylammonium, flurenol-methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyrFluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate glyphosate, glyphosate-ammonium, glyphosate-isopropylammonium, glyphosate-diammonium, glyphosate-dimethylammonium, glyphosate-potassium, glyphosate-sodium, glyphosate-trimesium, H-9201 is O-(2,4-dimethyl-6-nitrophenyl)O-ethyl isopropylthiophosphoramide thiocarbonyl ester (O-(2,4-dimethyl-6-nitrophenyl)O-ethyl isopropylphosphoramidothioate, halauxifen, halauxifen-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02 (ethyl (2,4-dichlorophenoxy)acetic acid 1-(dimethoxyphosphoryl) ester), imidazolic acid (imazamethabenz).Methyl imidacloprid (imazamethabenz-methyl), imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, isopropylammonium imidacloprid, imazaquin, imazaquin-ammonium, imazethapyr, imazeth The following are listed: apyr-immonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, ioxynil-potassium, and ioxynil-sodium, ipfencarbazone, and isoproturon. Isouron, isoxaben, isoxaflutole, karbutilate, KUH-043 (3-({[5-(difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole), ketospiradox, lactoferrin, lenacil, linuron, MCPA, MCPA-butotyl, MCPA-dimethylammonium, MCPA-2 MCPA-ethylhexyl ester, MCPA-isopropylammonium, MCPA-potassium, MCPA-sodium, MCPB, MCPB-methyl ester, MCPB-ethyl ester, MCPB-sodium, 2-methyl-4-chloropropionic acid (mecoprop), 2-methyl-4-chloropropionic acid sodium (mecoprop-sodium), 2-methyl-4-chloropropionic acid butoxyethyl ester (mecoprop-butotyl), purified 2-methyl-4-chloropropionic acid (mecoprop-P), purified 2-methyl-4-chloropropionic acid butoxyethyl ester (mecoprop-P-butotyl), purified 2-methyl-4-chloropropionic acid dimethylammonium (mecoprop-P-dimethylammonium)Mecoprop-P-2-ethylhexyl, potassium mecoprop-P-potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron-methyl, mesotrione, methabenzthiazuron, metam, metamifo p), metamitron, metazachlor, metazosulfuron, methabenzthiazuron, methiopyrsulfuron, metizolin, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metazanol (me Tribuzin, metsulfuron, metsulfuron-methyl, molinate, monolinuron, monosulfuron-ester, MT-5950 (N-[3-chloro-4-isopropylphenyl]-2-methylpentanamide), NGGC-011, napropamide, NC-310 ([5-benzyloxy-1-methyl-1H-pyrazol-4-yl](2,4-dichlorophenyl) methyl ketone, glufosinate. (neburon), nicosulfuron, nonanoic acid, norflurazon, oleic acid (fatty acid), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, penochlorophenolPentoxazone, pethoxamid, mineral oil, phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, pro... metryn), propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclostrobin nil), pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, p-bestrazine (p-bestrazine) yributicarb), pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofopQuizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrion, sulfurtrazone, sulfosulfuron Meturon, sulfometuron-methyl, sulfosulfuron, SYN-523, SYP-249 (1-ethoxy-3-methyl-1-oxobut-3-en-2-yl5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate), SYP-300 (1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioimidazolidine-4,5-dione), 2,3,6-TBA, TCA (trichloroacetic acid), TCA-sodium, tebuthiuron. terfuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazin, terbutryn, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron methyl ester Fensulfuron-methyl), thiobencarb, tiafenacil, tolpyralate, toramezone, tralkoxydim, triafamone, triallate, triasulfuron, triaziflam, tribenuron-methyl, tribensulfuron, triclopyr, trietazineTrifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazin, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, XDE-848, ZJ-0862 (i.e., 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline), and the following compounds:

[1096]

[1097] Examples of plant growth regulators are as follows:

[1098] Benzothiadiazole (acibenzolar), benzothiadiazole-S-methyl, 5-aminolevolinic acid, ancymidol, 6-benzylaminopurine, brassinolid, catechol, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothal-dipotassium, endothal-disodium, and endothal-mono(N,N-Dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indol-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprethiolane, probenazole, jasmonic acid, maleic hydrazide, mepiquat chloride, 1-methylcyclopropene, methyljasmonate, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthoxyacetic acid, nitrophenolate mixture The following are listed: mixture, paclobutrazol, N-(2-phenylethyl)-β-aminopropionic acid, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, salicylic acid, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, and uniconazole-P.

[1099] Methods and uses

[1100] The compounds of formula (I) and compositions comprising them have potential antimicrobial activity and / or plant defense modulation potential. They can be used to control unwanted microorganisms, such as unwanted fungi and bacteria. In particular, they can be used for crop protection (where they control microorganisms that cause disease in plants) or for protecting materials (e.g., industrial materials, timber, stored goods) as described in more detail below. More specifically, the compounds of formula (I) and compositions comprising them can be used to protect seeds, germinating seeds, newly emerging seedlings, plants, plant parts, fruits, harvests, and / or the soil in which plants grow from unwanted microorganisms.

[1101] The control measures described in this article include preventative, therapeutic, and eradicative treatments against unwanted microorganisms. Unwanted microorganisms may be pathogens, pathogenic viruses, pathogenic oomycetes, or pathogenic fungi, more specifically, plant pathogenic bacteria, plant pathogenic viruses, plant pathogenic oomycetes, or plant pathogenic fungi. As described in detail below, these plant pathogenic microorganisms are agents of broad-spectrum plant diseases.

[1102] More specifically, compounds of formula (I) and compositions comprising them can be used as fungicides. For the purposes of this invention, the term "fungicide" refers to a compound or composition that can be used in crop protection to control unwanted fungi and / or control oomycetes, such as Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes, and Deuteromycetes.

[1103] Compounds of formula (I) and compositions comprising them can also be used as antibacterial agents. In particular, they can be used in crop protection, for example, to control unwanted bacteria such as Pseudomonadaceae, Rhizobiaceae, Xanthomonadaceae, Enterobacteriaceae, Corynebacteriaceae, and Streptomycetaceae.

[1104] Compounds of formula (I) and compositions containing them can also be used as antiviral agents in crop protection. For example, compounds of formula (I) and compositions comprising them can affect diseases caused by plant viruses such as tobacco mosaic virus (TMV), tobacco rattle virus, tobacco stunt virus (TStuV), tobacco leaf curl virus (VLCV), tobacco nervilia mosaic virus (TVBMV), tobacco necrotic dwarf virus (TNDV), tobacco streak virus (TSV), potato virus X (PVX), potato viruses Y, S, M and A, potato acuba mosaic virus (PAMV), potato mop-top virus (PMTV), potato leaf-roll virus (PLRV), and alfalfa mosaic virus. The following viruses are listed: AMV (Cucumber Mosaic Virus), CMV (Cucumber Mottle Mosaic Virus), CGMMV (Cucumber Green Mottle Mosaic Virus), Cucumber Yellows Virus (Cucumber Yellows Virus), WMV (Watermelon Mosaic Virus), TSWV (Tomato Spotted Wilt Virus), TomRSV (Tomato Ringspot Virus), SCMV (Sugarcanemosaic Virus), SCMV (Rice Dwarf Virus), VBV (Rice Stripe Virus), SCMV (Rice Black-streaked Dwarf Virus), SMoV (Strawberry Mottle Virus), SVBV (Strawberry Vein Banding Virus), and SVBV (Strawberry Mild Yellow Edge Virus).Yellow edge virus (SMYEV), strawberry crinkle virus (SCrV), broad bean wilt virus (BBWV), and melon necrotic spot virus (MNSV).

[1105] The present invention also relates to a method for controlling unwanted microorganisms (such as unwanted fungi, oomycetes and bacteria), comprising the step of applying at least one compound of formula (I) or at least one composition to the microorganism and / or its habitat (applied to a plant, plant part, seed, fruit or soil in which the plant grows).

[1106] Typically, when compounds of formula (I) and compositions comprising them are used in therapeutic or protective methods for controlling plant pathogenic fungi and / or plant pathogenic oomycetes, they are applied to plants, plant parts, fruits, seeds, or to the soil or substrate in which the plants grow, in an effective and plant-compatible amount. Suitable substrates for cultivating plants include inorganic-based substrates, such as mineral wool, especially asbestos, perlite, sand, or gravel; organic substrates, such as peat, pine bark, or sawdust; and petroleum-based substrates, such as polymer foam or plastic beads. An effective and plant-compatible amount is one sufficient to control or destroy fungi present or readily available in farmland without causing any apparent phytotoxic symptoms in the crop. This amount can vary considerably depending on the fungi to be controlled, the type of crop, the growth stage of the crop, climatic conditions, and the various compounds or compositions of formula (I) used. This amount can be determined through systematic field trials, to the extent possible in the skill of those skilled in the art.

[1107] Plants and plant parts

[1108] The compounds of formula (I) and compositions comprising them may be applied to any plant or plant part.

[1109] plant This refers to all plants and plant populations, including both desirable and unwanted wild plants and crop plants (including naturally occurring crop plants). Crop plants can be plants that can be obtained through conventional breeding and optimization methods or throu...

Claims

1. Compounds of formula (I) and their salts, N-oxides and solvates: in A is selected from O, S, C(=O), S(=O), S(=O)2, NR 1 and CR 1 R 2 , where R 1 and R 2 are independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, or R 1 and R 2 Together with the carbon atoms to which they are attached they form a C3-C8-cycloalkyl or a non-aromatic 3- to 7-membered monocyclic heterocycle; m is 0, 1 or 2; T is selected from hydrogen, hydroxy, C1-C6-alkyl, -C(=O)R a1 , -C(=O)(OR a1 )、-C(=O)N(R a2 )2, -S(=O)R a1 、-S(=O)2R a1 and S(=O)2N(R a2 )2, Where R a1 is selected from C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkenyl, Where R a2 independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkenyl; R 3 and R 4 independently selected from hydrogen, halogen, cyano, hydroxyl, formyl, carboxyl, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylcarbonyl, C1-C6-alkoxycarbonyl, C2-C6-alkenyl, C2-C6-alkynyl, C3-C8-cycloalkyl, aromatic C6-C 14 - carbocyclic ring, aromatic 5- to 14-membered heterocyclic ring, non-aromatic 3- to 14-membered heterocyclic ring and -O-Si(C1-C6-alkyl)3, or R 3 and R 4 Together with the carbon atoms to which they are attached, they form a carbonyl group, a methylene group, a C3-C8-cycloalkyl group or a non-aromatic 3- to 7-membered monocyclic heterocycle; R 5 is selected from the group consisting of hydrogen, hydroxy, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylcarbonyloxy, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl and -O-Si(C1-C6-alkyl)3; Among them, aliphatic R 1 , R 2 , R 3 , R 4 and R 5 The substituents may be substituted by one or more substituents independently selected from the group consisting of halogen, cyano, amino, nitro, hydroxy, formyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and non-aromatic 3 to 7-membered monocyclic heterocycle; The cyclic R 1 , R 2 , R 3 , R 4 and R 5 The substituents may be substituted by one or more substituents independently selected from the group consisting of halogen, cyano, nitro, hydroxy, formyl, oxo, methylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and non-aromatic 3 to 7 membered monocyclic heterocycle; R 3 or R 4 and R 5 Together with the carbon atom to which they are attached, they may form a C3-C8-cycloalkyl group; L represents a direct bond or L is selected from carbonyl; C1-C6-alkylene; C1-C6-alkylene substituted on the same carbon atom by two substituents, the two substituents together with the carbon atom to which they are attached form a C3-C8-cycloalkyl; C1-C6-alkylene substituted on the same carbon atom by two substituents, the two substituents together with the carbon atom to which they are attached form a non-aromatic 3 to 7-membered monocyclic heterocycle; C2-C6-alkenylene; C2-C6-alkynylene; C3-C8-cycloalkylene; C1-C6-alkylene-C3-C8-alkylene Cycloalkyl; C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkylene-C1-C6-alkylene; C1-C6-alkylene-(C=O); C(=O)-C1-C6-alkylene; C3-C8-cycloalkenylene; C1-C6-alkylene-C3-C8-cycloalkenylene; C3-C8-cycloalkenylene-C1-C6-alkylene; C1-C6-alkylene-C3-C8-cycloalkenylene-C1-C6-alkylene; non-aromatic 3- to 7-membered monocyclic heterocyclylene; -NR aL1 -;-NR aL1 (C=O)-; -C(=O)NR aL1 -;-NR aL1 S(=O)2-;-S(=O)2NR aL1 -;-C(=NOR aL2 )-;-C(=NN(R aL2 )2) and -C(=NR aL2 )-; Where R aL1 is selected from hydrogen and C1-C6-alkyl, Where R aL2 independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C2-C6-alkylene, The aliphatic L substituent may be replaced by one or more L Sa Substituent substitution, wherein the cyclic L substituent or the cyclic portion of the L substituent may be replaced by one or more L substituents which may be the same or different. Sc Substituent substitution, L sa is selected from halogen, cyano, hydroxy, carboxyl, methylene, halomethylene, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkoxycarbonyl, -O-Si(C1-C6-alkyl)3 and non-aromatic 3- to 7-membered monocyclic heterocycle, L Sc is selected from halogen, cyano, nitro, hydroxy, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and non-aromatic 3 to 7 membered monocyclic heterocycle, and / or two L Sc The substituents together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl group; R 6 Selected from non-aromatic C3-C 12 -Carbocyclic; Aromatic C6-C 14 -Carbocyclic ring; non-aromatic 3- to 14-membered heterocyclic ring; aromatic 5- to 14-membered heterocyclic ring; non-aromatic C3-C 12 -Carbocyclyloxy; aromatic C6-C 14 -Carbocyclyloxy; aromatic 5- to 14-membered heterocyclyloxy; non-aromatic 5- to 14-membered heterocyclyloxy; non-aromatic C3-C 12 -Carbocyclic sulfanyl; aromatic C6-C 14 -Carbocyclylsulfanyl; aromatic 5- to 14-membered heterocyclylsulfanyl; non-aromatic 5- to 14-membered heterocyclylsulfanyl; non-aromatic C3-C 12 -Carbocyclylsulfinyl; aromatic C6-C 14 -Carbocyclylsulfinyl; aromatic 5- to 14-membered heterocyclylsulfinyl; non-aromatic 5- to 14-membered heterocyclylsulfinyl; non-aromatic C3-C 12 -Carbocyclic sulfonyl; aromatic C6-C 14 -Carbocyclic sulfonyl; aromatic 5- to 14-membered heterocyclic sulfonyl; non-aromatic 5- to 14-membered heterocyclic sulfonyl; non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-alkoxy; aromatic C6-C 14 -Carbocyclic substituted C1-C3-alkoxy; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-alkoxy; aromatic 5- to 14-membered heterocyclic substituted C1-C3-alkoxy; non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-haloalkoxy; aromatic C6-C 14 -Carbocyclic substituted C1-C3-haloalkoxy; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-haloalkoxy; aromatic 5- to 14-membered heterocyclic substituted C1-C3-haloalkoxy; non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-sulfanyl; aromatic C6-C 14 -Carbocyclic substituted C1-C3-sulfanyl; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-sulfanyl and aromatic 5- to 14-membered heterocyclic substituted C1-C3-sulfanyl; non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-sulfinyl; aromatic C6-C 14 -Carbocyclic substituted C1-C3-sulfinyl; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-sulfinyl and aromatic 5- to 14-membered heterocyclic substituted C1-C3-sulfinyl; non-aromatic C3-C 12 -Carbocyclic substituted C1-C3-sulfonyl; aromatic C6-C 14 -Carbocyclic substituted C1-C3-sulfonyl; non-aromatic 3- to 14-membered heterocyclic substituted C1-C3-sulfonyl and aromatic 5- to 14-membered heterocyclic substituted C1-C3-sulfonyl; The cyclic R 6 Substituent or R 6 The cyclic portion of the substituent may be replaced by one or more R 6S Substituent substitution, R 6S is selected from halogen, cyano, isocyano, nitro, hydroxyl, mercapto, pentafluorosulfanyl, oxo, methylene, halomethylene, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6- haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C8-cycloalkyl, C3-C8-cycloalkyloxy, C3-C8-cycloalkenyl, aromatic C6-C 14 -carbocyclic ring, aromatic 5- or 6-membered monocyclic heterocyclic ring, non-aromatic 3- to 7-membered monocyclic heterocyclic ring, -N(R c )2. -O-(C=O)R d 、-C(=O)R d , -C(=O)(OR d ), -C(=O)N(R d )2、-S(=O)2N(R d )2, -O-Si(C1-C6-alkyl)3 and -Si(C1-C6-alkyl)3, or two R 6S The substituents may form, together with the carbon atoms to which they are attached, a C3-C8-cycloalkyl radical, Where R c independently selected from hydrogen, C1-C6-alkyl and C3-C8-cycloalkyl, Where R d are independently selected from hydrogen, C1-C6-alkyl and C1-C6-haloalkyl, Among them, aliphatic R 6S , R c and R d The substituents may be substituted by one or more substituents independently selected from the group consisting of cyano, halogen, hydroxy, C1-C6-alkoxy, C1-C6-haloalkoxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, C3-C8-cycloalkyl, C3-C8-halocycloalkyl and non-aromatic 3 to 7 membered monocyclic heterocycles, The cyclic R 6S or R 6S The cyclic part and the cyclic R c The substituents may be substituted by one or more substituents independently selected from the following: halogen, cyano, nitro, hydroxyl, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C3-C8-cycloalkyl and C3-C8-halocycloalkyl, and / or cyclic R 6S Substituent or R 6S The cyclic part of the substituent may be substituted with two substituents which, together with the carbon atoms to which they are attached, form a C3-C8-cycloalkyl group; R 7 is selected from hydrogen, halogen, cyano, isocyano, hydroxyl, mercapto, nitro, amino, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C3-C8-cycloalkylsulfanyl, C2-C6-alkenylsulfanyl, C2-C6-alkynylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkylsulfonyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -carbocyclic ring, aromatic 5- or 6-membered monocyclic heterocyclic ring, non-aromatic 3- to 7-membered monocyclic heterocyclic ring, C3-C8-cycloalkyloxy, aromatic C6-C 14 -Carbocyclyloxy, aromatic 5- or 6-membered monocyclic heterocyclyloxy, non-aromatic 3- to 7-membered monocyclic heterocyclyloxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl) 3、 -N(R e )2, -C(=NR f )R f NR g C(=O)R g , -C(=O)(OR g )、-C(=O)N(R g )2、-S(=O)2N(R g )2 and -S(=O)(=NR g )R g , Where R e independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 - carbocyclic rings, aromatic 5- or 6-membered monocyclic heterocyclic rings and non-aromatic 3- to 7-membered monocyclic heterocyclic rings, Where R f independently selected from hydroxy, amino, cyano, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-alkylamino and di(C1-C6-alkyl)amino, Where R g independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C3-C8-cycloalkyl, Among them, aliphatic R 7 , R e , R f and R g The substituents may be one or more R 7Sa Substituent substitution, The cyclic R 7 or R 7 The ring part, the ring R e and cyclic R g The substituents may be one or more R 7Sc Substituent substitution, R 7Sa is selected from cyano, hydroxyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkoxycarbonyl, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, aromatic C6-C 14 - carbocyclic and non-aromatic 3- to 7-membered monocyclic heterocyclic rings, R 7Sc is selected from halogen, cyano, nitro, hydroxy, formyl, oxo, methylene, halomethylenyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and a non-aromatic 3- to 7-membered monocyclic heterocycle, or two R 7Sc The substituents together with the carbon atoms to which they are attached form a C3-C8-cycloalkyl group; R 8 is selected from the group consisting of hydrogen, halogen, cyano, isocyano, amino, nitro, hydroxyl, mercapto, carboxyl, C1-C6-alkoxycarbonyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C2-C6-alkynyloxy, C2-C6-haloalkynyloxy, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, aromatic C6-C 14 -Carbocyclic ring, non-aromatic 3- to 14-membered heterocyclic ring, aromatic 5- to 14-membered heterocyclic ring, C3-C8-cycloalkyloxy, aromatic C6-C 14 -carbocyclyloxy, non-aromatic 3- to 14-membered heterocyclyloxy, aromatic 5- to 14-membered heterocyclyloxy, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -N(R h )2. -SR i 、-S(=O)R i and -S(=O)2R i , where R h independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C 6- haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 - carbocyclic rings, aromatic 5- to 14-membered heterocyclic rings and non-aromatic 3- to 7-membered monocyclic heterocyclic rings, Where R i is selected from C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, aromatic C6-C 14 - carbocyclic rings, aromatic 5- to 14-membered heterocyclic rings and non-aromatic 3- to 7-membered monocyclic heterocyclic rings, Among them, aliphatic R 8 , R h and R i The substituents may be one or more R 8Sa Substituent substitution, The cyclic R 8 or R 8 The ring part, the ring R h and cyclic R i The substituents may be one or more R 8Sc Substituent substitution, R 8Sa is selected from cyano, amino, nitro, hydroxy, formyl, carboxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, non-aromatic 3 to 7-membered monocyclic heterocyclic ring and -N(R a’ )2, where R a’ is independently selected from hydrogen, formyl, C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl and C1-C6-alkylcarbonyl, wherein the non-aromatic 3 to 7-membered monocyclic heterocyclic ring R 8Sa may be substituted by one or more C1-C6-alkyl substituents which may be identical or different, R 8Sc is selected from halogen, cyano, amino, nitro, hydroxy, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C1-C6-alkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -O-Si(C1-C6-alkyl)3 and a non-aromatic 3- to 7-membered monocyclic heterocyclic ring which may be substituted by one or more C1-C6-alkyl substituents which may be the same or different, or two R 8Sc The substituents, together with the carbon atoms to which they are attached, form a C3-C8-cycloalkyl group or a non-aromatic 3- to 7-membered monocyclic heterocycle, wherein the non-aromatic 3- to 7-membered monocyclic heterocycle may be substituted by one or more C1-C6-alkyl substituents which may be the same or different; Q is selected from aromatic C6-C 14 -Carbocyclic, non-aromatic C3-C 12 - carbocyclic, non-aromatic 3 to 14-membered heterocyclic and aromatic 5 to 14-membered heterocyclic, wherein any of the carbocyclic or heterocyclic groups may be replaced by one or more Q groups which may be the same or different S Substituent substitution, Q S is selected from halogen, cyano, isocyano, nitro, hydroxyl, mercapto, formyl, carboxyl, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkylcarbonyl, C1-C6-haloalkylcarbonyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C2-C6-alkenyl, C2-C6- 6- Halogenated alkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C2-C6-alkenyloxy, C2-C6-haloalkenyloxy, C1-C6-alkylsulfanyl, C1-C6-haloalkylsulfanyl, C1-C6-alkylsulfinyl, C1-C6-haloalkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-haloalkylsulfonyl, C3-C8-cycloalkyl, C3-C8-cycloalkyloxy, C3-C6-cycloalkenyl, non-aromatic 3- to 7-membered monocyclic heterocyclic ring, aromatic C6-C 14 -Carbocyclic ring, aromatic 5- to 14-membered heterocyclic ring, -O-Si(C1-C6-alkyl)3, -Si(C1-C6-alkyl)3, -OC(=O)R j 、-NR j C(=O)R j 、-C(=O)N(R j )2, -C(=S)R j 、-C(=S)N(R j )2, -C(=NR j )R j AND-C(=NOR j )R j and -N(R k )2 Where R j independently selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl and C1-C6-alkoxy, Where R k are independently selected from hydrogen, hydroxy, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C2-C6-alkenyl, C2-C6-haloalkenyl and C3-C8-cycloalkyl, Among them, the aliphatic Q S , R j and R k The substituents may be substituted by one or more substituents independently selected from the following: cyano, amino, nitro, hydroxyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, -Si(C1-C6-alkyl)3 and non-aromatic 3 to 7 membered monocyclic heterocycles, The cyclic Q S or Q S The cyclic part and the cyclic R k The substituents may be one or more independently selected from the following R Qs Substituents: halogen, cyano, amino, nitro, hydroxy, formyl, carboxyl, oxo, methylene, halomethylene, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkoxycarbonyl, C1-C6-haloalkoxycarbonyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C2-C6-alkenyl and non-aromatic 3- to 7-membered monocyclic heterocycles, wherein the cyclic R Qs The substituent may be substituted by two substituents which, together with the carbon atom to which they are attached, form a C3-C8-cycloalkyl group.

2. A compound of formula (I) according to claim 1, wherein Q is selected from phenyl, naphthyl, bicyclo[4.2.0]octa-1,3,5-trienyl, benzodioxolyl, 2,3-dihydrobenzofuranyl, dihydroindole, benzofuranyl, benzothiophenyl, quinolyl, pyridyl, pyrazolyl, thiazolyl, thienyl and indolyl, wherein the Q group may be selected from one to three independently selected from the following Q S Substituents: halogen, cyano, nitro, formyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxycarbonyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylsulfanyl, C1-C4-haloalkylsulfanyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, non-aromatic 3- to 7-membered monocyclic heterocycle, phenyl, aromatic 5- or 6-membered heterocycle and -N(R k )2, where R k independently selected from hydrogen, C1-C4-alkyl, C1-C4-haloalkyl and C3-C6-cycloalkyl, wherein the aliphatic Q S The substituent may be substituted by one or two substituents independently selected from the group consisting of hydroxy, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkoxycarbonyl, C1-C4-haloalkoxycarbonyl and C3-C6-cycloalkyl.

3. A compound of formula (I) according to claim 1 or 2, wherein R 6 is selected from the group consisting of dihydroindanyl, phenyl, naphthyl, 2,3-dihydrobenzofuranyl, 1,3-benzodioxolyl, furanyl, thienyl, pyridyl, indolyl, benzofuranyl, benzothienyl, pyrrolo[2,3-b]pyridin-3-yl, phenoxy, benzyloxy and phenylsulfanyl, wherein R 6 The group may be one to three independently selected from the following R 6S Substituents: halogen, nitro, hydroxy, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-haloalkylsulfanyl, cyclopropyl, cyclobutyl, cyclopentyl, pyridyl, oxetanyl and tetrahydrofuranyl, wherein the cyclic R 6S The substituents may be substituted by one or two substituents independently selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl and C1-C4-alkoxycarbonyl.

4. A compound of formula (I) according to any one of the preceding claims, wherein R 7 is selected from hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-hydroxyalkyl, C1-C4-alkylcarbonyl, C1-C4-alkoxy, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-alkylsulfanyl, C1-C4-alkenylsulfanyl, C1-C4-alkylsulfonyl, C3-C6-cycloalkyl, pyridyl, imidazolyl, pyrazolyl, thiazolyl, oxetanyl, tetrahydrofuranyl, pyrrolidinyl, -N(R e )2, -C(=NR f )R f and -C(=O)N(R g )2, Where R e are independently selected from hydrogen, C1-C4-alkyl and C3-C6-cycloalkyl, Where R f independently selected from C1-C4-alkyl and C1-C4-alkoxy, Where R g are independently selected from hydrogen, C1-C4-alkyl and C3-C6-cycloalkyl, wherein The aliphatic R 7 , R e and R g The substituents may be selected from one to three independently selected from the following R 7Sa Substituents: hydroxy, C1-C4-alkoxy and C3-C6-cycloalkyl, and The cyclic R 7 , R e and R g The substituents may be selected from one to three independently selected from the following R 7Sc Substituents Substitution: halogen, hydroxy, C1-C4-alkyl and C1-C4-alkoxy.

5. A compound of formula (I) according to any one of the preceding claims, wherein A is selected from O, C(=O), S(=O)2, NR 1 and CR 1 R 2 , where R 1 is hydrogen or C1-C4-alkyl and R 2 A hydrogen atom.

6. A compound of formula (I) according to any one of the preceding claims, wherein m is 0, 1 or 2; T is selected from hydrogen and C1-C4-alkyl, R 3 and R 4 are independently selected from hydrogen, fluorine, chlorine, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, and C3-C6-cycloalkyl, R 5 is selected from the group consisting of hydrogen, hydroxy, C1-C4-alkyl and C1-C4-alkoxy.

7. A compound of formula (I) according to any one of the preceding claims, wherein L represents a direct bond or L is selected from C1-C6-alkylene, The aliphatic L substituents may be one to three independently selected from the following L Sa Substituents: fluorine, chlorine, hydroxy, C1-C4-alkoxy, C1-C4-haloalkoxy and C3-C6-cycloalkyl, The cyclic L substituent or the cyclic portion of the L substituent may be selected from one to three independently selected L Sc Substituents: fluorine, chlorine, hydroxy, oxo, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy and C3-C6-cycloalkyl.

8. A method for preparing a compound of formula (Ia-1), Among them, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in any one of claims 1 to 7, and A is O, T is hydrogen and m is 1 or 2, wherein the compound of formula (1) is reacted with the compound of formula (2) or a salt thereof to obtain a compound of formula (3); the phthalimide group of the compound of formula (3) is removed to obtain a compound of formula (4); and then the compound of formula (4) is treated with a dehydrating agent such as POCl3, P2O5 or trifluoromethanesulfonic anhydride, optionally in the presence of a base; Among them, Q, R 7 and R 8 As defined above, and U 1 is hydroxy, halogen or C1-C6-alkoxy, Where m, L, R 3 , R 4 , R 5 and R 6 As defined above, and W is hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, Where m, L, W, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above, Where m, L, W, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above.

9. A method for preparing a compound of formula (Ia-1) or (Ia-2), Among them, Q, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in any one of claims 1 to 7, and T is hydrogen, m is 1 or 2, For the compound of formula (Ia-1), A is O; for the compound of formula (Ia-2), A is NH, wherein the compound of formula (1) is reacted with the compound of formula (19) or a salt thereof to obtain a compound of formula (21); the compound of formula (21) is treated with a dehydrating agent and then treated with hydroxylamine or hydrazine to form a compound of formula (20); and the compound of formula (20) is converted into a compound of formula (Ia-1) using Mitsunobu reaction conditions, when E 1 and E 2 When all are hydroxyl groups, or then the compound of formula (20) is converted into a compound of formula (Ia-1) or (Ia-2) in the presence of a base, when E 1 is halogen and E 2 When it is hydroxyl or amino, Among them, Q, R 7 and R 8 As defined above, and U 1 is hydroxy, halogen or C1-C6-alkoxy, Where m, L, R 3 , R 4 , R 5 and R 6 As defined above, and E 1 Hydroxyl or halogen W is hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, Where m, E 1 , L, Q, W, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above, Where m, E 1 , L, Q, W, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above, and E 2 It is a hydroxyl group or an amino group.

10. A method for preparing a compound of formula (Ia-1) or (Ia-2), Among them, Q, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in any one of claims 1 to 7, and T is hydrogen, m is 1 or 2, For the compound of formula (Ia-1), A is O; for the compound of formula (Ia-2), A is NH, wherein the compound of formula (5) is reacted with the compound of formula (19) or a salt thereof to obtain a compound of formula (22); the compound of formula (22) is treated with a dehydrating agent and then treated with hydroxylamine or hydrazine to form a compound of formula (23); the compound of formula (23) is converted to a compound of formula (7) using Mitsunobu reaction conditions when both E1 and E2 are hydroxyl groups, or the compound of formula (23) is converted to a compound of formula (7) or (24) in the presence of a base when E1 is a halogen and E2 is a hydroxyl group or an amino group; and then the compound of formula (7) or (24) is reacted with a compound of formula (8) in the presence of a base and optionally in the presence of a suitable copper salt or complex to obtain a compound of formula (Ia-1) or (Ia-2), Among them, Q, R 7 and R 8 As defined above, and U 1 is hydroxy, halogen or C1-C6-alkoxy, X is halogen, preferably chlorine, Where m, L, R 3 , R 4 , R 5 and R 6 As defined above, and E 1 Hydroxyl or halogen W is hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, Where m, E 1 , L, W, X, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above, Where m, E 1 , L, W, X, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above, and E 2 is a hydroxyl group or an amino group, Where m, E 1 , L, W, X, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined above, Q-OH (8) wherein Q is as defined above.

11. A compound of formula (3), Among them, Q, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in claim 1, m is 1 or 2, and W represents hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl, or The compound of formula (4), in Q, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in claim 1, m is 1 or 2 and W represents hydrogen, tert-butoxycarbonyl, benzyl, allyl or (4-methoxyphenyl)methyl.

12. A compound of formula (7), in Q, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in claim 1, m is 1 or 2, W represents hydrogen, tert-butoxycarbonyl, benzyl or (4-methoxyphenyl)methyl, and X represents a halogen.

13. A compound of formula (20), in Q, L, R 3 , R 4 , R 5 , R 6 , R 7 and R 8 As defined in claim 1, m is 1 or 2, E 1 represents a hydroxyl group or a halogen, E 2 represents a hydroxyl group or an amino group, and W represents hydrogen, tert-butoxycarbonyl, benzyl or (4-methoxyphenyl)methyl, or The compound of formula (23), in L, R 3 , R 4 , R 5 , R 6 , R 7 , R 8 As defined in claim 1 m is 1 or 2, X represents halogen, E 1 represents a hydroxyl group or a halogen, E 2 represents a hydroxyl group or an amino group, and W represents hydrogen, tert-butoxycarbonyl, benzyl or (4-methoxyphenyl)methyl.

14. A composition comprising at least one compound of formula (I) according to any one of claims 1 to 7 and at least one agriculturally suitable adjuvant.

15. Use of a compound according to any one of claims 1 to 7 and / or a composition according to claim 14 for controlling phytopathogenic fungi.

16. A method for controlling phytopathogenic fungi, comprising the step of applying at least one compound of formula (I) according to any one of claims 1 to 8 or a composition according to claim 14 to plants, plant parts, seeds, fruits or soil in which plants grow.